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1006-146 Composite Measure Performance in Get With The 
Guidelines: CAD, Stroke, Heart Failure
Kenneth A. La Bresh, Vince Bufalino, Gregg C. Fonarow, Li Liang, A. Gray Ellrodt, 
GWTG Steering Committee, Masspro, Waltham, MA, Midwest Heart, Naperville, IL
Background: GWTG is an initiative to improve guidelines adherence in
hospitalized patients, in 3 modules (CAD, stroke, HF). The use of composite measures to 
compare all 3 GWTG modules has not been done.
Methods: GWTG uses a collaborative model with web-based data collection, decision 
support, and on-demand reporting. Data were collected by hospitals at baseline and 
subsequent quarters (Q) for pre-specified performance measures (PM). These data were 
used to construct for each module a defect free measure (% patients who receive all 
eligible PM) and a composite measure (CM) (% successful execution of each opportunity 
across all PM for that module). Time trend is assessed with repeat measure analysis to 
evaluate improvement in sites with at least 30 pts per Q from at least 30 sites for each Q. 
This resulted in 15 Q data for CAD, 12 Q data for stroke and 3 Q data for HF.
Results: Changes in defect free care were similar in all modules from
baseline to Q3: CAD 8.7% Stroke 6.6%, and HF 9%; CM: CAD 4.9%, Stroke 4.4% and 
HF 5.7%. In the longer running CAD and stroke programs continued improvement was 
seen with sites achieving defect free scores of 65.3% for CAD at Q15 and 73.9% at Q12 
for Stroke and respective composite scores of 85.4% and 88.7%.
Conclusions: GWTG hospitals produce comparable improvement in defect free and CM 
performance over time in CAD, Stroke or HF patients. Improvement is sustained and 
continues for up to 15 quarters (CAD). Despite this trend of improving care, more work is 
needed to implement high reliability strategies.
CAD, Stroke, and Heart Failure Preformance Over Time
Baseline Q1 Q2 Q3 Q4 Q8 Q12 Q15 p
CAD Pt n
Site n
7,710
257
22,163
216
23,606
224
23,529
224
21,535
211
15,999
153
8,977
91
2,876
30
Defect Free 
(%) 46.9 52.2 53.3 55.6 57.4 60.3 62.8 65.3 <0.0001
Composite (%) 77.0 79.5 80.6 81.9 83.2 84.8 86.0 85.4 <0.0001
Stroke Pt n
Site n
7,980
266
17,183
209
18,109
224
17,890
226
16,608
205
9,448
115
3,385
51
Defect Free 
(%) 61.4 65.8 67.4 68.0 68.4 71.0 73.9 <0.0001
Composite (%) 81.5 84.3 85.7 85.9 85.6 87.1 88.7 <0.0001
HF Pt n
Site n
3,270
109
10,849
104
8,045
88
4131
40
Defect Free 
(%) 55.7 57.3 58.0 64.7 =0.0168
Composite (%) 77.4 78.8 79.9 83.1 =0.0007
9:00 a.m.
1006-147 The Quality of Care for Patients Hospitalized with 
Ischemic Verses Nonischemic Heart Failure in the 
American Heart Association’s Get With The Guidelines 
(GWTG-HF) Program
Kenneth A. La Bresh, Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, A. Gray 
Ellrodt, Adrian F. Hernandez, Li Liang, Eric D. Peterson, Masspro, Waltham, MA, UCLA 
Medical Center, Los Angeles, CA
Background: GWTG-HF is an initiative to characterize and improve guidelines use in 
hospitalized heart failure (HF) pts. While therapies for HF are effective and recommended 
across etiologies, it is unknown whether quality of care as indexed by specific performance 
measures (PM) differs by HF etiology.
Methods: GWTG-HF uses a collaborative model, and a web-based tool for data 
collection, decision support, and on-demand reporting. Data were collected by 146 
hospitals on 17,416 pts for 5 pre-specified PM: discharge instructions, LV function 
measurement, ACEI/ARB, beta blocker (BB), smoking cessation counseling and a defect 
free measure (DFM) of % pts who receive all of the 5 PM for which they were eligible. 
PM were analyzed based on ischemic (I) or non-ischemic (NI) etiology and adjusted for 
pt characteristics and comorbidities.
Results: Pts with I-HF were older (74.5 + 11.9 vs 70.5 + 16.4 years), with more renal 
dysfunction (22.2% vs. 16.2%, p<0.0001), lower % women (44.1% vs. 57.6%, p<0.0001), 
and more whites (77.4% vs. 64.3%, p<0.0001) compared to the NI-HF group. Adjusted 
data demonstrate that BB use was more likely to occur in I (OR 1.20); all other PM and 
the DFM were similar between the two groups.
Conclusions: I compared to NI etiology of HF is not an independent predictor of quality 
of care for HF, except for the use of BBs. Higher BB use in the I group may be related 
to indications for both HF and ischemic heart disease. Further education and process 
changes should be designed to improve care irrespective of HF etiology.
Adjusted Analysis
for PM in Ischemic vs. Non-ischemic HF
Ischemic
10,312
Non-Ischemic 
7,102
Odds Ration Ischemic 
vs. Non-ischemic
Measures Percent Adherence
Percent 
Adherence
Unadjusted
OR (95% CI)
Adjusted 
OR* (95% 
CI)
Discharge Instructions 73.8% 74.1% 1.05 (0.99-1.12) 1.02  (0.97-1.08)
LV Function Assessment^ 91.6% 91.1% 1.02 (0.88-1.17) 1.04  (0.90-1.20)
ACEI/ARB Use 80.4% 84.0% 0.77 (0.67-0.89) 0.91  (0.78-1.06)
Smoking Cessation Counseling 78.2% 82.3% 0.87 (0.75-1.01) 0.94  (0.79-1.11)
Beta Blocker Use 88.5% 86.6% 1.08 (0.94-1.24) 1.20  (1.02-1.40)
Composite 63.9% 64.8% 0.94 (0.88-1.00) 1.02  (0.95-1.10)
*Variables in model: Age, Gender, Race(Caucasian,African-American, other), BMI at admission, Anemia, 
CVA/TIA, Diabetes-insulin treated, Diabetes-non-insulin treated, Hyperlipidemia, Hypertension,
Pulmonary, Peripheral Vascular Disease, Chronic Renal Insufficiency (SCr >2), LVEF, Systolic BP at 
admission, Heart rate at admission LV Function Assessment not adjusted by LVEF
9:00 a.m.
1006-148 A Meta-Analysis of Smoking Cessation Behavioral 
Interventions
Salvatore Mottillo, Kristian B. Filion, André Gervais, Lawrence Joseph, Jennifer 
O’Loughlin, Gilles Paradis, Robert Pihl, Louise Pilote, Stéphane Rinfret, Michèle Tremblay, 
Mark J. Eisenberg, Jewish General Hospital, McGill University, Montreal, PQ, Canada
Background: Previous studies have reported widely varying smoking abstinence rates in 
populations receiving behavioral interventions for smoking cessation.
Methods: We undertook a meta-analysis of randomized clinical trials (RCTs) evaluating 
each of 4 behavioral interventions to gain more accurate estimates of their efficacy. The 
behavioral interventions studied were minimal clinical intervention (brief advice) as well 
as more resource-intensive interventions including individual, group, and telephone 
counseling. We searched for all RCTs reporting biochemically-validated smoking 
abstinence rates at 6 and/or 12 months. Smoking abstinence was examined in a random-
effects meta-analysis using the most conservative measure of abstinence reported.
Results: We identified 51 RCTs randomizing 28,927 patients (minimal clinical intervention: 
9 RCTs, n=6,456; individual counseling: 23 RCTs, n=10,646; group counseling: 12 RCTs, 
n=3,600; telephone counseling: 10 RCTs, n=8,225). All 4 behavioral interventions were 
efficacious at increasing smoking abstinence rates (figure). Of note, all point estimates 
of ORs were similar for each of the 4 interventions. However, the confidence interval for 
minimal clinical intervention included unity.
Conclusion: The use of behavioral interventions results in a modest increase in smoking 
abstinence rates. Minimal clinical intervention may be as efficacious as more resource-
intensive behavioral interventions. 
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1006-149 Flushing Experience and Discontinuation with Niacin in 
Clinical Practice
Sachin J. Kamal-Bahl, Douglas J. Watson, Barbara Kremer, Leona E. Markson, Merck & 
Co., Inc., West Point, PA
Background: While extended-release (ER) niacin is a highly effective agent for raising 
HDL-C and is proven to reduce CVD risk, it may not be optimally utilized due to niacin 
induced flushing (NIF), leading to poor patient compliance. We examined NIF and its 
relationship with ER niacin discontinuation and nonadherence in actual clinical practice.
Methods: We used a pilot tested questionnaire to conduct a telephone interview of 500 
patients identified from administrative claims data to have newly initiated ER niacin (mean 
time between initiation and interview: 9.26 mos [SD=3.29]).
Results: About 27% of the sample reported having discontinued taking niacin at the 
time of interview (“discontinuers”, n=136) with a mean duration of use of 3.2 mos 
(SD=3.1). About 91% of the discontinuers reported experiencing flushing symptoms 
and 54% reported ‘severe’ or ‘extreme’ flushing (on a scale of none, mild, moderate, 
severe, extreme). Taking into account the possible benefits of ER niacin, 87% of the 
discontinuers who had flushing (n=124) reported that the greatest degree of flushing 
they could tolerate was ‘mild’ to ‘moderate’. Overall, 66% of the discontinuers reported 
that it would be easier to take ER niacin as recommended if the flushing side effects 
were reduced. Even among ER niacin “continuers” (n=364) at the time of interview, 82% 
reported experiencing flushing symptoms and 21% reported ‘severe’ to ‘extreme’ flushing. 
Among the continuers who had flushing (n=299), 21% reported skipping/ delaying doses 
and 19% reported stopping niacin for > 7 days and then restarting. Overall, 21% of the 
continuers reported that ER niacin side effects have made them want to stop taking it. 
Multivariate analyses indicated that flushing symptom severity was a strong predictor of 
discontinuation [‘severe’ OR: 3.2, 95% CI 1.4-7.2; ‘extreme’ OR: 11.3, 95% CI 4.2-30.4] 
and skipping/delaying of doses [‘moderate’ OR: 2.4, 95% CI 1.0-5.9; ‘severe’ OR: 9.4, 
95% CI 3.6-24.7; ‘extreme’OR: 8.0, 95% CI 1.9-33.5] of niacin.
Conclusion: Since long-term continuous treatment is generally necessary in persons 
with dyslipidemia, flushing side effects with ER niacin appear to limit the acceptability of 
this otherwise highly effective therapy.
9:00 a.m.
1006-181 Short-Term Clinical Outcomes of Compensated 
Heart Failure Patients Undergoing Elective Major 
Non-Cardiac Surgery
Olivia Xu Cai, Christopher O. Phillips, Daniel J. Brotman, W. H. Wilson Tang, Franklin 
A. Michota, Christopher M. Whinney, Ashok Panneerselvam, Mario Garcio, Gary S. 
Francis, Amir K. Jaffer, The Cleveland Clinic, Cleveland, OH
Background: Clinical outcomes of compensated patients with heart failure (HF) due 
to impaired or preserved ejection fraction (EF) undergoing elective major non-cardiac 
surgery are not well described. 
Methods: We reviewed data for consecutive patients with HF (mean age 69 ± 12 years, 
54 % men) who underwent a systematic preoperative optimization by hospitalists from 
2003 to 2006. Patients were stratified into impaired (EF ≤ 40%) or preserved ejection 
fraction (EF>40%). Propensity matching with multivariate logistical analysis was used to 
compare outcomes between patients in the two strata.
Results: 562 HF patients (192 EF≤40% and 370 EF>40%) and 10,693 controls without 
HF were followed for a median of 1.9 years post-operatively. In propensity analysis of 
matched cohorts (Table 1), the presence of HF was not associated with significantly 
increased 30-day post-operative mortality risk. 30-day readmission rate and length of 
stay (LOS) were higher in HF, particularly in preserved ejection fraction (p=0.04).
Conclusions: In patients with compensated HF undergoing elective major non-cardiac 
surgery, operative and 30-day mortality were comparable to that of propensity-matched 
controls. However, patients with HF (particularly in those with preserved rather than 
impaired EF) were more likely to have longer length of stay and be readmitted at 30-days 
post-operatively.
Table 1. Clinical Outcomes Among Propensity-Matched HF Patients and Controls
Outcomes
Impaired
Ejection Fraction 
N=180
Control†
N=180
Preserved
Ejection Fraction 
N=365
Control‡
N=365
30-day 
Mortality,
% (95% CI)
1.1
(0.3,3.96)
0.56
(0.10,3.07)
1.37
(0.58,3.2)
0.27 
(0.04,1.53)
30-day
readmission,
% (95% CI)
16.1
(11.4,22.2)
15.56 
(10.99,21.56)
18.6
(14.9,22.90)*
13.2
(10.10,17.00)
LOS 
(days±SD) 5.6 ± 0.41 5.18 ± 0.42 5.77 ± 0.36* 4.80 ± 0.27
*P≤ 0.05 vs. appropriate propensity-matched control group, †control matched for impaired 
EF; ‡control matched for preserved EF.
9:00 a.m.
1006-182 Door-to-Balloon Time: An Opportunity to Showcase 
Quality Improvement Methods
Robert L. Huang, Jeannie Byrd, Ted Speroff, Tom Elasy, Bob Dittus, Marc Mickiewicz, 
Corey Slovis, Tom DiSalvo, David Zhao, VA Tennessee Valley Healthcare Services, 
Nashville, TN, Vanderbilt University Medical Center, Nashville, TN
Background: The ACC/AHA 2006 guideline target for ST-elevation myocardial infarction 
(STEMI) is door-to-balloon time ≤ 90 minutes (min). We hypothesize that quality improvement 
(QI) methods can decrease door-to-balloon (D2B) time and improve care delivery.
Methods: We studied all STEMI patients presenting to Vanderbilt University Medical Center 
from July 2005-June 2006. We created a process flow chart and analyzed all D2B process 
steps including all subinterval time periods. In February 2006, we implemented targeted 
changes in the process including emergency department activation of the catheterization 
lab, insistence of 30 min arrival time for the catheterization team, new role assignments 
for personnel, and use of a diagnostic catheter for non-culprit lesions and use of an 
interventional catheter for suspected culprit lesions. We used statistical process control 
(SPC) methods to monitor D2B in real-time, show changes resulted in improvement, and 
create a dashboard with control limits to identify common and special cause variation.
Results: Our changes led to a 59 min decrease (p=0.0005) in median D2B time from 
123 min (interquartile range = 96.5-156 min) to 64 min (interquartile range = 56-94 min). 
Process flow charting coupled with subinterval time measurement allowed us to identify 
opportunities to eliminate waste and reduce delays. We then implemented process 
changes which improved virtually every process step. After implementation, the new SPC 
charts revealed 1) only common cause variation, 2) a 67% decrease in the new upper 
control limit and 3) a 50% decrease in the central mean line.
Conclusions: By using QI methods incorporating SPC, we mapped a process, identified 
bottlenecks and barriers, and implemented systematic process changes which significantly 
decreased D2B. We used SPC charts to confirm process improvement and provide 
ongoing control of a complex, inherently variable process. As quality measures align 
with financial incentives such as pay for performance, cardiologists and administrators 
will need to systematically utilize QI and SPC methods to analyze, improve and control 
complex processes of care.
9:00 a.m.
1006-183 Impact of Body mass Index on Mortality in Patients 
Presenting with Acute ST Elevation Myocardial Infarctions
Mohan Nandalur, Neel R. Patel, Vikram Raya, Zheni Xue, Howard A. Cooper, 
Washington Hospital Center, Washington, DC, Georgetown University Hospital, 
Washington, DC
Background: Recent studies have indicated that overweight patients may have better 
outcomes in the setting of chronic heart disease. We sought to determine if a similar 
relationship exists among patients with acute ST-elevation myocardial infarction (STEMI).
Methods: 509 consecutive patients with STEMI at a single center were stratified into Body 
Mass Index categories according to the World Health Organization definitions of normal, 
overweight, and obese. Baseline characteristics (age, gender, diabetes, smoking, prior 
CABG, and prior PCI) and clinical outcomes were compared across BMI categories. Muli-
variate analysis was used to assess the independant relationship between BMI category 
and in-hospital mortality.
Results: Clinical outcomes are presented in Table 1. Normal BMI patients had a higher 
rate of in-hospital death than overweight and obese patients (p=.006). Patients with normal 
BMI’s were older (65.9 ± 13.8 yrs) than overweight (61.2 ± 13.2) and obese (58.3 ± 12.6) 
patients (p<.05). However, on multi-variate analysis, overweight status remained an 
independant predictor of a lower rate of in-hospital death compared to normal BMI patients 
(OR 0.42, 95% CI 0.2-0.9, p=0.025). The odds of in-hospital deaths among obese patients 
was similar to that among normal BMI patients (OR .57, 95% CI 0.27-1.20, p=0.14).
Conclusions: In the setting of STEMI, there appears to be a U-shaped relationship between 
BMI and in-hospital mortality, with overweight status associated with the lowest risk of death.
Table 1
EVENTS
Normal Weight-
BMI 18.5-24.9 
(n=134)
Overweight-
BMI 25.0-29.9 
(n=185)
Obese
BMI > 
30.0
(n=186)
p-value
Hospital Death 17.2% 6.67% 8.38% .006
CCU death 12.7% 5.0% 7.82% .047
Need for CABG 8.2% 7.6% 8.6% Not Significant (NS)
Need for Intra-Aortic 
Balloon Pump 32.1% 29.2% 24.7% NS
Need for Mechanical 
ventilation 21.9% 21.1% 20.4% NS
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1006-184 Do Hospitals With Lower Risk-Adjusted Infection 
Rates Among Coronary Artery Bypass Graft Patients 
Have More Evidence Based Clinical Processes and 
Structures In Place?
Phillip P. Brown, Michael J. Mack, Lynn G. Tarkington, April W. Simon, Steve D. Culler, 
HCA CCMN, Nashville, TN, Emory University Rollins School of Public Health, Atlanta, GA
Background: Post-operative infections among patients undergoing CABG surgery are 
concerning. This study examines the relationship between Risk-Adjusted Infection Rates 
(RAIR) and Evidence-Based Clinical Processes and Structures (EBCPS).
Methods: This retrospective study uses data from the Heart Services Standards 
Database, a web-based survey of 158 HCA hospitals concerning EBCPS; and HCA 
Casemix Database, an administrative database of all admissions. The study population 
consists of 75 hospitals that performed > 52 CABG during 2005. Each hospital’s RAIR was 
estimated from a logistic regression model controlling for 19 risk factors. Hospitals, based 
on their RAIR, were divided into four tiers. The EBCPS activities were classified into three 
similar groups: Education (10), Protocols (9), and Communications (4). Student-t tests 
were used to determine if top tier hospitals had more EBCPS than bottom tier hospitals.
Results: The average RAIR for the top tier was 0.8% and 4.6% for the bottom tier. 
There was no significant difference in CABG volume between the two tiers (122 vs. 157, 
p=0.223). The top tier had, on average, more EBCPS implemented than bottom tier 
(13.6 vs. 10.4). This relationship also held for all three groups of activities, although the 
difference in the number of education activities was not significant (p=0.105).
Conclusion: Top tier hospitals have significantly more evidence-based clinical processes 
and structures and lower risk-adjusted infection rates than bottom tier hospitals.
Average Number of Evidence-Based Clinical Processes andStructures 
(EBCPS): Top vs. Bottom Tier
Top Tier Hospitals Bottom Tier Hospitals p-Value
All EBCPS (23) 13.6±3.8 10.4±3.5 0.011
Education(10) 4.6±2.0 3.7±1.5 0.105
Protocols (9) 7.1±1.4 5.7±2.0 0.022
Communication (4) 2.0±1.0 1.1±0.8 0.003
9:00 a.m.
1006-185 Immediate and Long term Outcomes Related to 
Retroperitoneal Bleeding Following Percutaneous 
Coronary Intervention
Mohan Nandalur, Ellen Pinnow, Vikram Raya, Frank Hsu, Joseph Lindsay, Jr., 
Washington Hospital Center, Washington, DC
Background: Retroperitoneal bleeding (RPB) is a rare complication of cardiac 
catheterization. We assessed differences in immediate complications and long term 
outcomes for patients with and without RPB.
Methods: Of 17,650 consecutive patients who underwent PCI at a single center, we identified 
86 RPB (.5% incidence). Fisher’s exact test was used to analyze acute complications, and a 
multi-variate analysis was done to assess the significance of RPB on prognosis.
Results: Significant associated hematologic and vascular adverse events are in Figure 
1. Short and long term prognosis are presented in Figure 2.
Conclusions: There is an increased incidence of associated acute complications in 
patients with an RPB. Development of an RPB was also an independent predictor for 
higher rate of MI and death at 1 month and 1 year. 
9:00 a.m.
1006-186 We Are Getting Fatter - But Are Our Cath Labs Ready?
Donald L. Lappé, Scott B. Allison, Robert R. Pearson, Tami L. Bair, Heidi T. May, 
Benjamin D. Horne, Joseph B. Muhlestein, LDS Hospital, Salt Lake City, UT, University 
of Utah, Salt Lake City, UT
Introduction: In a time when people are gaining weight at epidemic proportions, the ability to 
perform coronary angiography and interventions with acceptable imaging and clinical results 
in the obese may be compromised. This population presents a unique and growing dilemma 
that stretches the limitations of the radiographic equipment with regard to load bearing 
capacity, x-ray penetration, and image quality, but how many patients are involved?
Methods: Patients (N=26,416) who had angiographic assessment of coronary artery 
disease (CAD) and weight measurement were entered into the Intermountain Heart 
Collaborative Study from 1993-2005 and were stratified by year of procedure and the 
following weight categories: <300, 301-350, and >350 pounds (lbs).
Results: Average weight increased from 1993 to 2005: 182.0, 182.0, 180.5, 182.4, 184.7, 
185.5, 184.5, 188.9, 187.9, 188.9, 188.3, 188.9, and 189.2 lbs, respectively (p<0.0001). 
From 1993 to 2005, an increase was observed in the frequency of patients who weighed 
between 301-350 (0.8%, 0.6%, 0.3%, 0.4%, 0.7%, 1.1%, 0.9%, 1.4%, 1.6%, 1.7%, 1.2%, 
1.8%, and 1.7%, respectively) and >350 (0%, 0.2%, 0.3%, 0.4%, 0.4%, 0.7%, 0.3%, 0.5%, 
0.3%, 0.4%, 0.4%, 0.4%, and 0.5%, respectively). Males had a greater increase (+13.5 
lbs) in mean weight than females (+10.5 lbs). Increasing weight was also associated 
with diabetes (p<0.0001) and hypertension (p<0.0001) but not hyperlipidemia (p=0.09) or 
presentation (stable angina vs. unstable angina vs. acute myocardial infarction, p=0.50).
Conclusions: A steady increase in weight was found over the past 13 years, a trend that 
is projected to continue. Cath labs will need to be properly accommodate this super-sized 
trend. Weight limitations will need to expand beyond 400-450 lbs and x-ray generators 
capable of higher than 100KW outputs will be required. With increased radiation dose 
(often 3-4 times that of a normal BMI) and repeat procedures now the norm to treat 
progressive CAD, the cumulative radiation exposure greatly increases risk of malignancy 
for this population. In addition, increasing occupational exposure to Cardiologists and 
staff from scatter radiation may reduce the numbers of patients able to be treated.
9:00 a.m.
1006-187 Impact of Physicians´ Gender on Blood Pressure 
Control in different Age Groups of Treated 
Hypertensives in Swedish Primary Health Care
Gunilla I. Journath, Holger Theobald, Mai-Lis Hellénius, Peter M. Nilsson, Dept of 
Neurobiology, Caring Sciences and Society, Karolinska Institutet, Stockholm, Sweden, 
Dept of Clinical Sciences,University Hospital, Malmö, Malmö, Sweden
Background: The care of treated hypertensives aims to optimise the control of blood 
pressure and other risk factors in order to lower the total cardiovascular risk. Little is 
known whether the gender of the physicians have any impact on this. The objective 
was to study the effect of the primary care physicians´(PCPs) gender on blood pressure 
control in treated hypertensive men and women in different age groups.
Methods: An open, cross-sectional survey performed in Sweden during 2002-2005. Data 
were consecutively collected from medical records and registered in a web-based form. A 
total of 265 PCPs (71 % men) and 6537 hypertensive patients (48% men), with a mean age of 
51.8 (SD 6.1) and 66.2 (SD11.8) years respectively, were studied. Subjects were stratified for 
gender of the PCPs and patients as well as age-groups, <56, 56-70 and > 70years of age.
Results: Female patients 56 years or older had more often a well-controlled blood pressure 
(systolic/diastolic blood pressure <140/90 mmHg) when treated by female PCPs compared 
to when treated by male PCPs (56-70 years: 36% vs. 28%, p<0.01, >70years: 25% vs. 
16%, p<0.001). Female physicians both male and female patients 56 year and older had 
a more well-controlled total cholesterol (<5 mmol/L) compared to when treated by male 
physicians (56-70 years: men 43% vs.34%, p<0.01, women 30% vs. 24%, p<0.05, >70 
years: men 49% vs. 38% p<0.05, women 33% vs. 21%, p<0.001). LDL-cholesterol was 
more well-controlled (<3.0 mmol/L) in the age group 56-70 years both for male (43% vs. 35 
%, p<0.01) and female patients (40% vs.33 %, p<0.05), and for male patients >70 years (51 
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% vs. 40%, p<0.05) when treated by female PCPs compared to male PCPs.
Conclusions: When treated by female PCPs, female hypertensives 56 years or older 
have a more well controlled blood pressure compared to when treated by male PCPs. 
Patients of both gender had more well-controlled lipids when treated by female physicians 
compare to when treated by male physicians. Gender disparities should be minimised.
9:00 a.m.
1006-188 Protective Effect of Chronic Statin use against Post 
Discharge Stroke after CABG in Patients with Acute 
Coronary Syndromes
Sahand Rahnama-Moghadam, David Armstrong, Apurva Motivala, Ameeth Vedre, 
Umesh Tamhane, Aubrey Timm, Eva Kline-Rogers, Vijay S. Ramanath, James Froehlich, 
University of Michigan Medical Center, Ann Arbor, MI
Background: Patients who undergo Coronary Artery Bypass Graft (CABG) surgery have 
a higher rate of follow-up (f/u) stroke than non-CABG patients. The role of medications in 
stroke prevention for these patients is not fully understood. We examined the association 
between chronic use of statins on the incidence of post-CABG stroke in patients wtih 
acute coronary syndromes (ACS).
Methods: We identified 3279 consecutive patient admissions with a discharge diagnosis 
of ACS at the University of Michigan between 1999 and 2005. Data were collected using 
a standardized dataform. Data included demographics, medications on admission, at 
discharge, in-hospital management and outcomes at discharge and at 6-12 months post 
discharge. Chi square and Fisher’s Exact Chi Square tests examined the relationship 
between f/u stroke (6-12 months post discharge), CABG (in-hosp) and chronic statin use. 
Logistic regression was used to test for significant interactions as well as to adjust for 
variables that had been significant in bivariate analysis. If a significant interaction was found, 
stratified logistic regression was carried out to characterize the nature of the interaction.
Results: A significant relationship existed between chronic statin use and incidence 
of stroke in patients that underwent CABG. Stratification revealed that patients not on 
chronic statin therapy had a higher f/u stroke rate even after adjusting for age and gender 
(OR 4.33, p=0.01). Only age was a significant predictor of follow-up stroke.
Conclusions: Pre-operative statins are associated with a lower risk of follow-up stroke 
after CABG for patients admitted with acute coronary syndromes. More and larger studies 
are needed to confirm these results.
9:00 a.m.
1006-189 An Intravascular Ultrasound Simulator of Coronary 
Plaques Based on Histopathology
Nico Bruining, Steffen Groot, Charl P. Botha, Frits H. Post, Ronald Hamers, Erasmus 
MC, Rotterdam, The Netherlands, TU-Delft, Delft, The Netherlands
Background: Intravascular Ultrasound (IVUS) is the reference method to study coronary 
plaques and is the imaging tool in natural history and progression-regression studies. 
IVUS derived plaque compositional techniques are available (IVUS-VH) but still under 
investigation. The validation method to evaluate the capabilities of plaque tissue 
composition imaging by IVUS is ex-vivo imaging of coronary specimens followed by 
histopathology. However, this is difficult, time-consuming and not all pathologies can 
be covered. An unambiguous tool to evaluate and validate grey-scale coronary plaque 
imaging by IVUS is still lacking. Therefore, an IVUS grey-scale image simulator was 
developed using color-coded histopathology or pathology drawings as input.
Methods: a simulator using a combination of scatters and ray tracing was developed 
using Matlab (The Mathworks, Natick, MA, USA). Ex-vivo specimens imaged first with 
IVUS and which later underwent histopathology was used for development. The grey-
scale images of the real- and the simulated IVUS of the specimens were used to tune 
the simulator.
Results: The simulator is capable of generating realistic clinical looking images when 
compared to real IVUS. It has the flexibility to generate a large variety of pathologies with 
different aspects of ultrasound behavior in the field of IVUS (figure).
Conclusion: Simulation of grey-scale IVUS images of coronary pathologies based on 
histopathology is possible and could be a valuable validation and teaching tool. 
9:00 a.m.
1006-190 A New Automated Method For Quantitative Coronary 
Plaque Compositional Imaging By Multi-slice 
Computed Tomography: An Ex-vivo Feasibility Study
Nico Bruining, Stefan Verheye, Michiel Knaapen, Pamela Somers, Jurgen Ligthart, 
Evelyn Regar, Filippo Cademartiri, Glenn van langehoven, Ronald Hamers, Erasmus 
MC, Rotterdam, The Netherlands, Antwerp Cardiovascular Institute Middelheim, 
Antwerp, Belgium
Background: Multi-slice computed tomography coronary angiography (MSCT-CA) is 
making rapid progress into clinical practice. Although only recently introduced it seems to 
become a standard imaging tool for diagnosing patients with suspected cardiovascular 
diseases. The big advantage over coronary angiography is the capability of also 
visualizing coronary plaques. However, would it be possible to determine plaque tissue 
composition by MSCT-CA?
Material and methods: Explanted human LAD’s were imaged with both MSCT-CA, 
(Sensation 16, Siemens, Germany) applying different concentrations of contrast, and 
optical coherence tomography (OCT). OCT, with an image resolution similar to that of 
histology, was used to register MSCT results to quantitative three-dimensional histology. 
Histology was performed at 5 different sub-segments of 15 histology slices each.
Results: The individual results of each sub-segment were averaged for both techniques 
and are presented in the figure. There were no statistical significant differences 
between both techniques. The measurements with saline instead of a medium contrast 
concentration (HU=300), to explore the influence of the contrast onto the HU appearance 
of the plaque, showed similar results. In sub-segment C a deviation was found due to a 
small plaque size, difficult to detect by MSCT-CA.
Conclusion: This ex-vivo feasibility study of quantitative plaque compositional imaging 
by MSCT-CA showed promising results, encouraging further in-depth research. 
9:00 a.m.
1006-191 The Safety of High Risk Elective Percutaneous 
Coronary Interventions in a Remote Center a few hours 
away from Cardiac Surgical Support
Brendan Gunalingam, Andrew Hill, Nicholas Wilkes, Fraser Bates, Dennis Wang, 
Gosford Hospital, Gosford, Australia
Background: The current American College of Cardiology guidelines recommend 
that elective percutaneous coronary interventions (PCI) should not be performed in 
institutions without on-site cardiac surgery. We sought to determine the safety of PCI 
without cardiac surgical support on-site and report the results of the first 921 elective 
procedures performed at our institution which is a remote centre 80 kilometres (50 miles) 
from the nearest cardiac surgical facility.
Methods: Between September 2002 and April 2006 a total of 921 elective PCI 
procedures were performed in 814 patients at our institution. Patients were not selected 
and included both high and low risk cohorts. Clinical and procedural outcomes were 
recorded and prospectively followed. An ambulance was not available on stand-by for 
emergency transfer and so it was expected that if transfer to a cardiothoracic surgical unit 
was required, it would reflect “real world” experience and could take a few hours. All 3 
Interventionalists participating in the program were experienced “high-volume” operators 
who also performed procedures at other institutions.
Results: 1 138 vessels were treated & 1 429 stents deployed. A 95 % procedural success 
rate was recorded. Males comprised 69.3% with a mean age of 62.9years. The mean 
age for females was 69.3years. Complex PCI was performed with multi-vessel PCI in 
13%, Bifurcation PCI in 8%, Chronic total Occlusions (CTO) in 5%, Saphenous vein 
graft interventions in 5%, Unprotected Left Main interventions in 0.8% and rotational 
atherectomy in 0.8%. Of the cohort, 75% of the lesions treated were either ACC/AHA 
type B or C lesions.
In the 921 elective procedures the following major complications occurred:1 death, 6 sub 
acute stent occlusions, 1 case of contrast nephropathy requiring short-term dialysis, 2 
cases of cardiac tamponade, 2 significant femoral pseudo-aneurysms and 1 misplaced 
stent .There were no urgent transfers for CABG surgery to salvage a complication of PCI.
Conclusion: PCI including high risk elective procedures can safely be performed 
without on-site cardiac surgery provided the program is restricted to experienced & 
“high-volume” Interventionalists. 
9:00 a.m.
1006-192 The Blog Web Site: a New Educational Tool for 
Cardiology
Vesselin Dimov, Wassim Fares, Joshua Schwimmer, Shahid Randhawa, Ajay Kumar, 
Ashish Aneja, J. Michael Koch, Richard Christie, Cleveland Clinic, Cleveland, OH, 
Case Western Reserve University (St. Vincent/St. Luke) Internal Medicine Residency 
Program, Cleveland, OH
Background: A blog is a web site which requires only basic computer skills to create 
and maintain. Most blogs have a commenting feature which allows authors to receive 
immediate feedback from readers. The population of blogs on the Internet has grown 
explosively over the last 2 years, doubling in size every 5 months. Few studies have 
explored the effect of this new medium on medical education.
Methods: Our goal was to evaluate the impact of a blog as an educational medium 
for cardiology. Clinical Cases and Images (clinicalcases.org) was created in 2005 at a 
teaching hospital with the goal of enhancing the medical education of internal medical 
residents by publishing cases in cardiology and other specialties. The authors were 
members of the Section of Hospital Medicine at the Cleveland Clinic and faculty members 
at Case Western Reserve University (CWRU). The blog was provided and hosted free of 
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charge by Blogger.com, a service owned by Google, Inc. Electrocardiograms (ECGs) and 
other clinical images were scanned and uploaded to the web site. Audio commentary on 
each ECG was recorded by residents and cardiologists by making 5-minute long phone 
calls which were automatically converted to audio files posted to the blog website. The 
source and number of visits to the blog were recorded. The medical residents at CWRU/
St.Vincent were anonymously surveyed regarding the blog usefulness.
Results: After 18 months, the blog received 780,000 page views and had 270,000 visitors 
from more than 90 countries. Most of the visitors came from the British Medical Journal 
and Medscape.com, which reviewed the blog favorably; search engines; and from links 
posted on other medical web sites. The blog has been one of the top Google search 
results for “cardiology clinical cases”, just behind the official web site of the American 
College of Cardiology, among more than 4.9 million web sites.
All residents rated the web site as useful, 78% stated that it had changed the way they 
learn in a positive way, and 87% would like to participate in expanding the blog. Residents 
voted the ECGs with audio commentary as the best feature of the blog.
Conclusion: A web blog is an easy-to-use medium for publishing that has the potential 
to enhance education in cardiology.
9:00 a.m.
1006-193 Rapid Rise in Cardiac Auscultation Skill After a Single 
90 Minute Intervention: A Quality Improvement Study
Michael J. Barrett, Archana Saxena, Katherine A. Thomas, Temple University School of 
Medicine, Philadelphia, PA
Background: The ability of non-cardiologists to recognize common heart murmurs is 
only fair at best. Recent research suggests that cardiac auscultation is, in part a technical 
skill that improves dramatically with intensive drilling and repetition. In this quality 
improvement study, we measured the effect of listening to intensive repetition (400 times) 
of 5 common heart murmurs during a single 90 minute training session in a group of 
general internists.
Methods: A group of 149 general internists took a pretest consisting of common heart 
murmurs played in random order. Immediately following the test, they listened to auditory 
recognition exercises of five heart murmurs including aortic stenosis, aortic regurgitation, 
mitral stenosis, mitral regurgitation and innocent systolic murmur in a monitored session. 
These auditory recognition exercises consisted of 400 repetitions of each of the five murmurs 
played during a single 90 minute audio session. Immediately following the intervention, all 
participants took a post test consisting of the same murmurs played in a random order. The 
murmurs used in the training session were simulated heart sounds while the murmurs used 
in both pre and post tests were high quality recordings of human heart sounds.
Results: On the pretest, the average correct score was 60 +/-15% and increased 
significantly to 80.5 +/-15% on the post test, p< .001 by paired t-test. These posttest 
scores were similar to those reported for cardiologists.
Conclusions: Auditory recognition exercises of five common cardiac murmurs delivered in a 
single 90 minute session significantly improve cardiac auscultation skill in general internists. 
These results support the hypothesis that this is a technical skill which can be readily mastered 
by non-cardiologists using intensive repetition and drilling in a short timeframe.
9:00 a.m.
1006-194 Web-based Recruitment Facilitates Collection of 
Patients With Peripartum Cardiomyopathy
Jordan G. Safirstein, Joonun Choi, Angela Ro, Sree Grandhi, Eileen Hermance, Cezar 
Staniloae, Saint Vincent’s Catholic Medical Center, New York, NY
Background: Peripartum cardiomyopathy (PPCM) is a rare disease associated with 
significant morbidity and mortality. Low prevalence, geographic dispersion and high 
cost limit the establishment of a large database for PPCM. While more than 100 million 
Americans use the Internet to seek health information, a web-based tool to recruit, enroll, 
and survey PPCM survivors is logical but not yet described.
Methods: In collaboration with the largest PPCM education and support website 
we created an on-line information portal describing our retrospective, survey-based 
study. Informed and HIPAA consent documents were available online for prospective 
participants. Once enrolled, participants were asked to complete a standardized 
questionnaire detailing their PPCM clinical presentation, timing of diagnosis, postpartum 
management, subsequent pregnancies and psychosocial impact. Accuracy of diagnosis 
was confirmed via echocardiographic data.
Results: Over the course of nine months more than 4 million hits to the PPCM education 
and support website were recorded from over 60 different countries and 6 continents. 390 
unique visitors requested information regarding our study and 119/235 (50.6%) visitors who 
downloaded consent documents completed the enrollment process electronically, including 
women from 32 different states and 3 different countries. Mean rate of enrollment was 13.2 
participants per month and is ongoing. At this rate of enrollment we will exceed the largest 
cohort of PPCM patients reported to date in less than twelve months. Limitations of this 
method include selection bias as enrollment requires use of the Internet.
Conclusions: We report a novel method for recruiting, enrolling and surveying patients 
with PPCM via the Internet. Web-based recruitment facilitates the collection of data in 
patients with rare diseases, such as PPCM, more efficiently and at much lower cost than 
traditional methods. This unique modality will enable physicians to use a single source 
outcome tool to assess treatment outcomes, experiences from subsequent pregnancies 
and morbidity associated with PPCM as well as other rare diseases.
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1204-262 Real-Time Assessment of Clinical Appropriateness in 
Ad Hoc Percutaneous Coronary Intervention for 1,211 
Consecutive Patients
Michael J. Hearne, Mirle A. Kellett, Jr., Thomas J. Ryan, Jr., David J. Malenka, Catholic 
Medical Center, Manchester, NH, Maine Medical Center, Portland, ME
Background: Health care purchasers are increasingly interested in the appropriateness 
of clinical care but current guidelines are difficult to operationalize in a format that lends 
itself to the a priori determination of appropriateness.
Methods: Guidelines define PCI appropriateness on the basis of 3 variables: clinical 
presentation, evidence of ischemia, likelihood of procedural success. Clinical presentation 
and evidence of ischemia are known prior to angiography and can be used to evaluate 
appropriateness of ad hoc PCI. We adapted the existing PCI guidelines using these 2 
variables and piloted this tool at 2 centers on 1211 patients.
Results: Table. Of 1211 procedures, 1179 (97%) could be classified using this tool and 
32 (3%) could not. There were 598 procedures (51%) classified as appropriate by clinical 
presentation alone. The other 581 (49%) required additional evidence of ischemia to 
be classified as appropriate. This was present for 472 (81%) but not for 109 (19%). Of 
these 109, 74 (68%) had low risk unstable angina for which catheterization-PCI is an 
alternative to stress testing (Class IIa). Appropriateness was questionable for only 35 
(3%) of patients.
Conclusions: In this pilot project we showed that clinical appropriateness can be 
evaluated prior to angiography in the vast majority of ad hoc PCI procedures and that 
appropriateness criteria are well-met. Future research should focus on those patients 
difficult to classify and on how to integrate the likelihood of procedural success.
Clinical Presentation # of Patients Evidence of Ischemia
Ischemic by Definition
Cardiogenic Shock
Primary PCI
Rescue PCI
Unstable Angina-High Risk
Post MI Angina
Post MI Anatomy
Restenosis
16
160
19
228
71
66
38
-
-
-
-
-
-
-
Requires Evidence of Ischemia
Unstable Angina-Low Risk
Stable Class II or III Angina
Atypical Chest Pain
Asymptomatic
248
269
26
38
174
246
25
27
Other 32 0
Noon
1204-263 Patient Radiation Dose in Invasive Cardiology
Jerome Clerc, Catherine Le Gac, Bernard Glatt, Thierry Royer, Bernard Chevalier, 
Philippe Guyon, Centre Cardiologique du Nord, Saint Denis, France, Centre Hospitalier 
de Creil, Creil, France
Background: Patient radiation protection needs to be promoted. However pt dosimetry 
audit is not a current practice in Cardiology. The aim of this study is to evaluate the 
radiation exposures during invasive coronary investigations.
Methods: Between 2002 and 2005 skin dose absorption and body equivalent dose 
(biological effect) were measured and analyzed for 7803 consecutive procedures (6703 
pts) performed on the same flat panel detector system. Mean age was 64±12 years 
(74% men) corresponding to a standard French population investigated for coronary and 
valvular disease (LM 5%, normal coronary angiogram 25%, one vessel lesion 27%, two 
21%, three 29%, valvular disease and others 8%).
Results: Equivalent doses were respectively, 1.08±0.44 mSv (0.45-7.63) for the coronary 
angiograms (n=4427), 1.72±1.02 mSv (0.48-5.47) for the PTCA (n=738), 2.05±0.97 mSv 
(0.48-8.35) if the 2 phases were performed in the same session (n=2597).
Male gender, age, body mass index, previous bypass, cardiogenic shock, emergency, left 
ventriculography, aortography, other vessel angiographies, PTCA site number, chronic 
total occlusion, frame speed acquisition, junior operators were associated with patient 
radiation dose increasing. No radiation related complication could be observed during 
the hospitalisation phase.
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Conclusions: Pt radiation doses are not high in invasive cardiology suggesting a low 
determinist and stochastic effects. However reducing dose is a daily goal, and significant 
gains could be expected.
Noon
1204-264 Comparison of Hospital Door-to-Balloon Times Reported 
by Centers for Medicare and Medicaid Services and the 
American College of Cardiology-National Cardiovascular 
Data Registry: Apples and Oranges?
Brahmajee K. Nallamothu, Yongfei Wang, Elizabeth H. Bradley, Jeptha P. Curtis, John 
S. Rumsfeld, Frederick A. Masoudi, Harlan M. Krumholz, on behalf of the NCDR(tm), 
University of Michigan, Ann Arbor, MI
Background: Hospital performance on door-to-balloon (DTB) times in patients 
undergoing primary PCI is now publicly reported and may be tied to future pay-for-
performance programs. However, no assessment of the “comparability” of hospital DTB 
times measured across different national registries has been performed.
Objective: To compare hospital DTB times between the Centers for Medicare & Medicaid 
Services (CMS) data and the ACC National Cardiovascular Data Registry (NCDR).
Methods: CMS and NCDR data collected from July 2004 to July 2005 on patients 
undergoing PCI with ST-elevation MI were used. For the 185 hospitals that reported to 
both data sources, we calculated 1) hospital median DTB times and 2) the percentage 
of patients undergoing PCI within 90 mins. We then ranked hospitals into quintiles of 
performance based on these measures using CMS and NCDR data. Comparability 
between the 2 data sources was assessed by determining how often hospitals remained 
within similar quintiles of rankings and by constructing Bland-Altman plots.
Results: When rankings by hospital median DTB times in CMS and NCDR data were directly 
compared, only 73 (40%) hospitals were ranked in the same quintile in both data sources, 
and 53 (29%) differed by >2 quintiles. The results were slightly more concordant at extremes 
of performance: e.g., among the 37 hospitals identified in the top-performing quintile by CMS 
data, 21 (57%) were in the top-performing quintile by NCDR data while 10 (27%) differed by 
>2 quintiles. Bland-Altman plots demonstrated that the 95% limits of agreement for hospital 
median DTB times between the 2 data sources were -27 to +33 mins, suggesting that 
differences in hospital median DTB times derived from the data sources may be up to 60 mins 
at the same facility. Similar findings were noted when we evaluated hospital performance 
based on the percentage of patients undergoing PCI within 90 mins.
Conclusions: Substantial differences exist in hospital DTB times reported by CMS and 
NCDR. Understanding reasons for these differences and their impact on hospital rankings 
is critical for public reporting and pay-for-performance programs to move forward.
Noon
1204-265 Projecting an Impending General Cardiology 
Workforce Shortage
Jeffrey L. Williams, University of Pittsburgh, Pittsburgh, PA
Background: There is a declining number of US medical graduates and those matching 
in Internal Medicine residencies. It was hypothesized this decline combined with an 
increasingly complex cardiovascular disease patient requiring the care of multiple, distinct 
cardiovascular specialists will lead to a shortage of General Cardiologists (GC’s). A model 
was developed to project need for general Cardiologists from 2005-2050.
Methods: A model was developed using Matlab (Mathworks, Inc., Natick, MA) assuming 
the baseline number of first-, second-, and third-year GC fellows numbered 709, 726, and 
725, respectively, and the current total of existing GC’s was 16800. The growth in need for 
GC’s was estimated by incorporating the effect of retirement, prevalence of heart disease, 
and physician-patient load. Fast-tracking was defined as 2 years of General Cardiology 
followed by 2 years of EP or Interventional Training.
Results: At the peak demand in the year 2038 (see Figure), there is a projected need 
for 62,452 GC’s. Current training durations would result in 29043 GC’s and Fast-Tracking 
would result in 32533 GC’s.
Conclusions: There is evidence of an impending shortage of GC’s that will peak in 2038 
resulting in only 46.5% of the projected need for GC’s. This may result from a complex 
cascade of declining US medical graduates and those matching in Internal Medicine 
residencies, combined with an increasingly complex cardiovascular disease patient 
requiring the care of multiple, distinct cardiovascular specialists. 
Noon
1204-266 Lung Echo and Cardiac Doppler Study Can Diagnose 
the Etiologies of Acute Respiratory Distress in the 
Emergency Room
Masao Takeda, Hiroshi Ito, Katsuomi Iwakura, Shigeo Kawano, Atsunori Okamura, 
Toshiya Kurotobi, Yasushi Koyama, Motoo Date, Koichi Inoue, Kenshi Fujii, Sakurabashi 
Watanabe Hospital, Osaka, Japan
Background: Ultrasound lung comet (ULC), that consists of multiple comet-tails fanning 
originating from the lung surface, are simple echographic sign of lung edema. It, however, 
are also observed in cases of organic lung disease. In this study, we investigated 
whether we can accurately diagnose etiology of acute respiratory distress (ARD) with the 
combination of ULC and Doppler study in emergency setting.
Method: Study population consisted of 32 patients admitted our CCU complaining of 
ARD. We performed ultrasound scanning from the third intercostals space on the anterior 
axial line and counted number of ULC. We also measured the ratio of peak-E velocity 
to early diastolic mitral annulus velocity, E/e’, and regarded E/e’ > 15 as a sign of high 
pulmonary capillary wedge pressure.
Results: ULC was detected in all patients. Number of ULC increased with an increase in 
Killip class (Ivs. II vs. III vs. IV: 1.0 vs. 2.0 vs. 2.3 vs. 3.4, p<0.0001). Twent-two patients 
showed E/e’ > 15 and there was correlation between number of ULC and E/e’ in them 
(r=0.62, p<0.02). E/e’ and number of ULC decreased (pre vs. post, 22.2vs. 15.5, p=0.002, 
2.6 vs. 0.5, p=0.002, respectively) after treatment. ULC disappeared in 15 patients 
(68.2%) after treatment. Ten patients showed E/e’<15 and number of ULC was lower 
compared those with E/e’ > 15 (1.3 vs. 2.6, p=0.02). 8 patients had only one ULC. All of 
them showed pneumonia and its shadow extended to the sub-pleural lesion diagnosed 
with lung CT. ULC disappeared after treatment of pneumonia that was inferior to fibrosis 
confirmed with radiologic study . 
Conclusion: 1) ULC is common findings in patients with ARD and appears not only in 
lung edema due to heart failure but also in pneumonia. 2) Additional measurement of E/e’ 
is useful to make differential diagnosis of ARD caused by lung edema.
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1012-146 Lower Rate of Dietary Advice Given to Heart Failure 
Patients with Preserved Systolic Function is 
Associated with Adverse Short-Term Clinical Outcomes 
After Hospital Discharge
Scott L. Hummel, Cecilia K. Montoye, Anthony C. DeFranco, Stephen Skorcz, Theresa 
K. Aldini, Vipin Kheterpal, Daniel Lee, Japhet Joseph, Trissa Torres, Suresh Gupta, 
Laura Carravallah, Michael James, Jeffery Harris, Frederick VanDuyne, Rodney Diehl, 
Kim A. Eagle, Todd M. Koelling, University of Michigan, Ann Arbor, MI
Background: It is not known whether application of ACC/AHA disease specific 
performance measures primarily designed for systolic heart failure (SHF) benefits 
patients with heart failure and preserved systolic function (HFPSF), although many of 
these measures are recommended regardless of ejection fraction (EF).
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Conclusion: There exists a significant independent association between admission NLR 
and mortality in patients with ACS. This relatively inexpensive marker of inflammation can 
aid in the risk stratification and prognosis of future patients diagnosed with ACS.
1:30 p.m.
1012-149 Discharge Medications and 6 Month Outcomes in 
Acute Coronary Syndrome (ACS) Patients with Minimal 
versus Moderate to Severe Coronary Artery Disease 
(CAD)
David Armstrong, Sahand Rahnama-Mohagdam, James Froehlich, Fadi Saab, Apurva 
Motivala, Susie Hiniker, Tessa Dake, Kelly Gordon, Kim A. Eagle, University of Michigan 
Medical Center, Ann Arbor, MI
Background: Evidence-based medicine (EBM) use and outcomes in symptomatic 
acute coronary syndrome (ACS) patients with minimal obstructive disease on cardiac 
catheterization (Cath) are poorly understood. We compared the discharge use of four 
EBMs (ASA, ACE inhibitor Beta Blockers, Statins) and outcomes in ACS patients stratified 
by severity of coronary artery disease (CAD).
Methods: We identified 3279 consecutive patients with a discharge diagnosis of ACS. 
We included 2,358 that had undergone Cath; 1,490 of which had 6 to 12 month follow-
up(f/u) data. We divided these 1,490 patients into two groups: Group A included 109 
patients (7.3%) with minimal CAD (<50% blockage in any vessel), and Group B included 
1,381 patients (92.7%) with moderate to severe CAD (>50% blockage in >1 vessel). 
Data were collected on demographics, medications at discharge, and self-reported 
adverse outcomes at 6 to 12 months. We compared adverse outcomes at f/u (MI, stroke, 
unscheduled rehospitalization for cardiac causes, death) between patients with minimal 
(Group A) and moderate to severe (Group B) CAD.
Results: There were more women in group A (49.54%) vs Group B (31.72%) (p = 
0.0001.Patients in group B were more likely to receive ASA (95.08 vs. 88.99, p = 0.007), 
beta blockers (89.5 vs. 70.64, p < 0.0001), and statins (81.97 vs. 66.06, p < 0.0001) on 
discharge. F/U rates of death and stroke were similar between both groups. F/U MI and 
rehospitalization rates were greater for the moderate to severe group (p = 0.015 and p 
= 0.007, respectively). However, odds ratio revealed that regardless of disease severity, 
discharge on less than 3 EBMs created a 3.5X greater chance of death at f/u (OR: 3.52, 
CI 1.57, 7.88, p=0.002). Fewer Group A patients, compared with Group B patients, were 
discharged on at least 3 of 4 EBMs (65% vs 87%, respectively; p<0.0001).
Conclusions: Women with ACS have a larger relative proportion of minimal CAD on 
Cath. F/U rates of stroke and death were similar between the two groups, but f/u MI and 
rehospitalization rates were higher for those with moderate to severe CAD. Evidence 
based medical therapy improved outcomes in all groups and should be emphasized for 
all ACS patients, even those with minimal CAD.
1:30 p.m.
1012-181 Comparison of Health Status Recovery after Mital 
Valve Repair and Replacement in Patients with Mitral 
Regurgitation
Liping Zhao, Paul Kolm, Cheryl Lewis, Grant Anderson, Michael A. Borger, Harlan 
Krumholz, Michael Borkon, William Weintraub, Christiana Care Health System, Newark, DE
Background: Patients’ postoperative health status is an equally critical issue in 
deciding the type and timing of mitral valve (MV) surgery. Longitudinal data regarding 
the comparative improvement in health status after MV repair versus MV replacement 
are limited.
Methods: 267 patients undergoing primary MV surgery (163 repair; 104 replacement) 
were prospectively followed at baseline, 1, 3 and 12 months. Health related quality of 
life (HRQOL) was assessed with the SF-36 and the KCCQ. The generalized estimating 
equations approach was utilized to compare HRQOL at each time point between the 2 
Methods: The ACC Guidelines Applied in Practice - Heart Failure (GAP-HF) study tracked 
guideline-based quality improvement metrics and clinical outcomes in HF patients admitted 
to 15 community hospitals. We performed Chi-square analysis to compare guideline 
adherence in patients with systolic heart failure (SHF, EF < 40%, n=1420) and HFPSF (EF 
≥ 50%, n=1079). We then performed binary logistic regression to assess the relationship 
between the HF quality indicators and 30-day clinical outcomes in patients with HFPSF.
Results: At discharge, patients with HFPSF were less likely to receive written instructions 
for daily weights (35.2% vs 42.0%), activity level (83.1% vs 88.4%), and low sodium diet 
(48.3% vs 56.3%) than patients with SHF (p < 0.05 for all). No difference was found in 
the rates of patients receiving appropriate information regarding discharge medications 
(65.2% vs 68.7%), follow-up appointments (97.0% vs 97.2%), or a plan for what to do 
if their symptoms worsen (48.5% vs 50.6%). Patients with HFPSF were less likely to 
receive complete (all six elements) discharge instructions than patients with SHF (24.5% 
vs 30.9%, p = 0.002). Multivariable regression analysis revealed that documentation of 
advice given to follow a low sodium diet was strongly associated with a lower risk of 
adverse outcomes at 30-days post discharge (death at 30 days - (OR, 95% CI, p value) 
0.246, 0.098 - 0.620, 0.003; readmission at 30 days - 0.578, 0.362 - 0.925, 0.022; death 
or readmission at 30 days - 0.404, 0.256 - 0.636, <0.001)
Conclusions: Appropriate HF discharge instructions are documented less frequently in 
the management of HFPSF compared to SHF. The prescription of a low-sodium diet is 
independently associated with decreased event rates in the 30 days following admission 
for HFPSF. Further study is needed to determine if this relationship is causal or simply a 
marker of better overall care.
1:30 p.m.
1012-147 Effect of Diabetes and Glomerular Filtration Rate on 
6-month Outcomes in Patients Undergoing Cardiac 
Catheterization
Tessa Dake, Sahand Rahnama-Moghadam, Eva Kline-Rogers, Susie M. Hiniker, Fadi 
Saab, Apurva Motivala, David Armstrong, Aubrey Timm, James Froehlich, Univerisity of 
Michigan Medical Center, Ann Arbor, MI
Background: Nearly 1.3 million Americans are diagnosed with diabetes mellitus (DM) 
yearly, increasing their risk of a myocardial infarction (MI) two to three fold. DM is also 
the leading cause of end stage renal disease (ESRD), resulting in 44% of new cases 
annually. In kidney failure, decreased glomerular filtration rate(GFR) (below 60 mL/min) 
is associated with an increased risk for major adverse coronary events (MACE) after 
percutaneous coronary intervention. There is significant overlap between patients with 
DM and renal disease in diabetic nephropathy making it difficult to determine how these 
two disease pathologies interact and relate to adverse cardiac events. When controlling 
for these overlaps, we propose that the relationship between GFR and MACE, following 
cardiac catheterization, is dependent upon diabetic status.
Methods: We evaluated 3209 consecutive patients with acute coronary syndromes 
admitted to the University of Michigan between September 1999 and October 2005. 
For all patients undergoing cardiac catheterization, we analyzed the DM and non-DM 
populations, dividing them into quartiles according to GFR (<=40, 41-60, 61-80, >80 
mL/min) to test for interaction and independent trends. We also combined the DM and 
non-DM populations to test for other significant factors, including: gender, history of MI, 
percutaneous coronary intervention, coronary artery bypass graft, DM, hyperlipidemia, 
hypertension, and age.
Results: Having DM increased risk of MACE (OR 1.4, CI: 1.08, 1.69), as did a history of 
MI (OR 1.3, CI: 1.05, 1.71). Moderate and severe renal impairment also increased risk 
of MACE (OR 1.6,CI: 1.14, 2.10; OR 1.5, CI: 1.03, 2.15 respectively). Female gender 
was also found to be a significant risk factor for increased MACE following cardiac 
catheterization (OR 1.3, CI: 1.02, 1.58). An interaction test between GFR and DM was 
not significant. This shows that GFR and DM status interact additively, not multiplicatively, 
as risk factors for MACE.
Conclusions: GFR and cardiac outcomes after cardiac catheterization are independent 
of DM status. Our data support previous findings of increased risk of MACE below a GFR 
of 60 mL/min, and show increased risk for females.
1:30 p.m.
1012-148 Association Between Admission Neutrophil to 
Lymphocyte Ratio and 6-Month Mortality in Patients 
with Acute Coronary Syndrome
Sanjay Aneja, Daniel Montgomery, Rebecca Juliar, Charles Burney, Aubrey Timm, 
Jessica Socha, David Armstrong, Kim A. Eagle, Hitinder Gurm, University of Michigan 
Medical Center, Ann Arbor, MI
Background: Neutrophil to lymphocyte ratios (NLR) as measured by a differential cell 
count has emerged as a powerful predictor of mortality in patients undergoing PCI. We 
investigated the utility of admission NLRs in predicting outcome in patients with acute 
coronary syndromes..
Methods: We followed 3500 patients admitted to the University of Michigan Health 
Systems with a diagnosis of ACS from 1/1/1999 to 10/14/05.A differential white cell count 
was available in 2980.The primary outcome of our analysis was all-cause mortality and 
was obtained by 6-12 month phone follow-up or Social Security Death Index search. 
Patients were divided into tertiles of NLR and a Kaplan-Meier curve was used to plot their 
survival. Cox’s regression modeling was used to analyze the association of NLR and 6-
month mortality after logarithmic transformation.
Results: There were 196 deaths on follow up. Patients in the highest tertile had a 
dramaticaly higher risk of death (figure). The log NLR was a significant independent 
predictor of mortality after multivariate adjustment.(HR 1.33 , p=.010).
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treatment arms with adjustment for propensity scores.
Results: NYHA functional class was significantly improved from baseline for both 
treatment groups, especially in repair group (p<0.01). For SF-36, dramatic improvements 
were achieved in most domains for both groups at 3 and 12 months. Repair patients 
showed significant improvements in mental component scale compared to replacement 
patients at both 3 and 12 months (p<0.01). For KCCQ, patients in repair group were 
consistently doing better than those undergoing replacement at each follow-up, however, 
the difference did not reach significance due to the small percentage of heart failure at 
follow-up (see Table).
Conclusion: Patients undergoing MV repair achieved better post-operative health status 
compared to MV replacement, and the optimal timing of MV surgery may be earlier in the 
course of the disease when repair is possible. 
1-Month 3-Month 12-Month
SF-36
Physical Component Scale
Repair
Replacement
-2.81
-1.53
5.98
6.28
9.02
8.14
Mental Component Scale
Repair
Replacement
0.34
-2.18
4.24
-0.60
5.73
-0.19
KCCQ
Total Symptom Score
Repair
Replacement
8.14
7.24
18.10
15.01
20.64
16.78
Overall Summary Score
Repair
Replacement
4.30
1.45
20.57
17.73
25.61
21.54
Clinical Summary Score
Repair
Replacement
4.65
2.63
16.39
14.19
19.45
16.52
1:30 p.m.
1012-182 Risk Factors for Stroke Complicating Coronary Angioplasty
William E. Lawson, Lisa Wilbert, Joseph Chernilas, Anil Mani, Luis Gruberg, Zoltan Egri, 
Mary Maliszewski, David Brown, SUNY Stony Brook, Stony Brook, NY
Background: Stroke (CVA) is a rare but feared complication of coronary angioplasty. 
Despite changes in adjunctive therapy and advances in technique the incidence of stroke 
has remained relatively constant.
Methods: All angioplasty (PCI) cases between 1998-2005 were reviewed to evaluate 
the incidence of CVA (hemorrhagic and thrombotic) and identify potential contributing 
demographic or therapeutic associations. Statistical testing for significance was by chi 
square with p<0.05.
Results: There were 10,666 angioplasties (69.2% male) performed between 1998-
2005 with an overall mortality rate of 0.83%. PCI for acute myocardial infarction was 
performed in 1,814 patients; 25.1% received a thrombolytic (lytic) and were referred for 
salvage PCI. There was no difference in the administration of ASA and a thienopyridine 
which was administered to essentially all patients in the periprocedural period. There 
were no significant correlations of CVA with the use of heparin, LMWH, bivalirudin. PCI 
was complicated by 26 CVA (incidence of 0.24%; 23.1% mortality), 9 hemorrhagic and 
17 thrombotic. Women had a greater incidence of CVA (0.46 vs 0.14%; p<0.01) and of 
hemorrhagic CVA (0.21 vs 0.001%; p<0.001). Hemorrhagic CVA was associated with the 
use of lytics (0.66 vs 0.06%; p<0.001) and lytic + glycoprotein IIbIIIa inhibitors- GP2B3A 
(0.79 vs 0.06%; p<0.001) compared to PCI without their use. No significant demographic 
or therapeutic correlates were noted with thrombotic CVA. Mortality was significantly 
increased (p<0.001) for both hemorrhagic (50%) and thrombotic (17.6%) CVA and length 
of stay (LOS) was significantly prolonged in CVA survivors (9.4 days vs 3.9 days). The 
incidence of CVA did not vary significantly over the 8 year period.
Discussion: CVA is a persistent and often lethal complication of PCI. Hemorrhagic 
CVA is clearly associated with lytic and lytic+GP2B3A use, and women appear to be at 
particular risk with this combination.
Conclusions: CVA is a major contributor of PCI related death and markedly prolongs 
LOS in survivors. Women are at greater risk of CVA, particularly of hemorrhagic CVA and 
particular attention to anticoagulation is required.
1:30 p.m.
1012-183 Prevalence of and Recovery From Hospital-Acquired 
Anemia in Patients With Myocardial Infarction
Mikhail Kosiborod, John S. Rumsfeld, Philip G. Jones, Karen Alexander, John A. 
Spertus, Mid America Heart Institute of Saint Luke’s Hospital, Kansas City, MO
Background: Prior studies have suggested that anemia is common, and prognostically 
important in patients with acute myocardial infraction (AMI). However, whether anemia in 
this patient group is predominantly a chronic condition or an acute, hospitalization-related 
event is unknown.
Methods: TRIUMPHANT is an ongoing 16-center study of AMI treatment and outcomes. 
Data from the first 233 patients with complete admission, discharge and 1-month follow-
up hemoglobins were analyzed to describe the patterns of anemia during and following 
hospitalization for AMI. The World Health Organization definition of anemia (hemoglobin <12 
g/dL for women and <13 g/dL for men) was used to classify patients at each time point.
Results: The mean age of the cohort was a 60±12 years, 66% were male and 76% 
were Caucasian. The mean hemoglobin at admission, discharge and 1-month was 
14.1±1.9, 12.4±1.9 and 13.7±1.8 g/dL, respectively. Only 19% of patients were anemic 
on admission, while 50% were anemic at the time of hospital discharge. Of the 116 
patients who were anemic at discharge, 74 (62%) did not have anemia on admission. 
Among these 74 patients who developed “new” anemia during hospitalization, 37% were 
persistently anemic at 1 month follow up.
Conclusions: Half of AMI patients have anemia at discharge. The majority of these 
patients develop anemia during hospitalization, and many have persistent anemia 1 
month later. These findings suggest that in most AMI patients, anemia is hospitalization-
related, and potentially preventable. Understanding the determinants of hospital-acquired 
anemia and its prognosis warrants further investigation.
1:30 p.m.
1012-184 Comparison Of Quality Of Life In Patients With/without 
Normal Sinus Rhythm After TEE-Guided Cardioversion: 
Results From The Acute II Study
Liping Zhao, Paul Kolm, Cheryl Lewis, Susan E. Jasper, Daniel Elliott, Allan L. Klein, 
William S. Weintraub, Christiana Care Health System, Newark, DE
Background: The ACUTE II study compared use of low molecular weight heparin 
(LMWH, enoxaparin) with unfractionated heparin (UFH) in patients with atrial fibrillation 
(AF), and showed similar clinical outcomes in the two groups. The present study sought 
to explore the impact of restoration of normal sinus rhythm (NSR) on patients’ quality of 
life after TEE-guided cardioversion.
Methods: 155 patients who were scheduled for TEE-guided cardioversion were 
randomized to enoxaparin (n=76) versus UFH (n=79), and followed up for 5 weeks. 
Quality of life (QOL) was evaluated using Duke Activity Status Index (DASI), Health Utility 
Index Mark 3 (HUI-3), and RAND 36-Item Health Survey (RAND-36). ANOVA methods 
was used to compare QOL scores at baseline and 5-week follow-up.
Results: LMWH group had more NSR at 5 weeks (76% vs. 57%, p=0.01). There were 
no significant differences in the adjusted baseline QOL scores (DASI, HUI-3, and 
RAND-36) between patients who did or did not restore NSR at 5-week after TEE-guided 
cardioversion. At 5-week follow-up, HUI-3 score and physical component scale (PCS) 
were significant higher in patients with NSR compared with those without NSR (P=0.04). 
There was a tendency for patients with NSR to have higher DASI score and mental 
component scale (MCS) than those without NSR (p=0.09) (see Table).
Conclusion: TEE-guided enoxaparin strategy was more effective in helping patients 
restore NSR. Patients with NSR had better QOL compared with those who did not restore 
NSR after cardioversion. 
No NSR (n=41) NSR (n=77) p-value
DASI 19.3±3.7 23.4±3.7 0.09
HUI-3 0.64±0.05 0.71±0.06 0.04
RAND-36
PCS 34.9±2.6 38.3±2.7 0.04
MCS 50.8±2.9 53.3±2.9 0.09
1:30 p.m.
1012-185 Prevalence, Treatment and Control of Hypertension and/or 
Dyslipidemia Among Hispanic Adults in US Communities
Simon S. Tang, EunMee Lee, Sean D. Candrilli, Heather J. Laird, Stewart S. Levy, 
Stanley Bassin, Nathan D. Wong, Pfizer, Inc., RTI Health Solutions, New York, NY, 
Heart Disease Prevention Program, UC Irvine, Irvine, CA
Background: Hispanics represent a substantial growing segment of the US population 
and are the largest minority group; however, little data exist on the extent of hypertension 
(HTN) and dyslipidemia (DYS) in this group. We examined the prevalence of HTN, DYS 
and concomitant HTN and DYS among a large screened population free of diabetes and 
coronary heart disease.
Methods: 4,700 participants without diabetes and coronary heart disease (mean age 
46.7 years; 62.0% female) enrolled in Hispanic Community Outreach programs in Miami 
(n = 301), New York (n = 188), Los Angeles (n = 3,633) and Houston (n = 578) received 
measures of total cholesterol (TC), blood pressure (BP) and review of their self-reported 
medical history, including use of antihypertensive and lipid-lowering medications.
Results: The prevalence of HTN and/or DYS, their treatment rates and the respective 
control rates of those treated are shown in the table below: 
Prevalence 
Treatment 
among prevalent 
cases
Control 
among the 
treated
HTN (BP ≥140/90 mmHg or on 
medication) 32.7% 37.1% 43.5%
DYS (TC ≥240 mg/dL or on 
medication) 22.2% 40.8%
79.8%* / 
48.7%**
Both HTN and DYS 11.2% 36.1% 31.1%* / 21.1%**
Control definitions: For HTN, BP <140/90 mmHg; for DYS, TC <240 mg/dL* or 
TC<200mg/dL**; For both HTN and DYS, BP <140/90 mmHg and TC <240 mg/dL* or 
BP <140/90 mmHg and TC<200mg/dL**
Furthermore, the prevalence of pre-hypertension (BP 120-139/80-89 mmHg and not 
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treated) was 38.4%, while the prevalence of borderline high cholesterol (TC 200-239 
mg/dL and not treated) was 26.5%.
Conclusion: Our results demonstrate a substantial prevalence of HTN and DYS among 
healthy US Hispanic adults. The control rate of DYS with therapy appears to be better 
than that of HTN with therapy, and the control rate of both HTN and DYS is low. Intensified 
efforts to identify and treat those Hispanics with these conditions are especially needed.
1:30 p.m.
1012-186 Percutaneous Coronary Intervention: It is Safe for 
Women as Long as They Receive the Right Medications
Heidi T. May, Jeffrey L. Anderson, Tami L. Bair, Brianna S. Ronnow, Brian S. McClure, Joseph 
B. Muhlestein, LDS Hospital, Salt Lake City, UT, University of Utah, Salt Lake City, UT
Background: Several observational studies have reported that women have worse 
outcomes with percutaneous coronary intervention (PCI) than men. It is proposed 
this might due to women being less likely to be discharged on appropriate secondary 
prevention medications (ASA, statins, ACEI, BB). We assessed outcomes after PCI by 
sex in a large cohort of patients (pts) undergoing PCI.
Methods: Consecutive pts (N=7,896) who underwent PCI and had longterm (mean 5 y) 
follow-up were included. Logistic and Cox regression models adjusting for standard risk 
factors and medications prescribed were developed to determine differences in death (D), 
incident myocardial infarction (MI), target lesion revascularization (TLR), or any of these 
coronary events (MACE) by sex among men (n=5754) and women (n=2142).
Results: Women had greater baseline risk: older (68 vs 62 years) and more frequently 
had hypertension (68% vs 56%), diabetes (25% vs 18%), and heart failure (14% vs 8%) 
(all: p<0.001) but less often smokers (16% vs 25%, p<0.001). They were just as likely 
to be on secondary prevention medications upon discharge for (men vs women) ASA: 
79.6%, 78.7%; statins: 58.3%, 58.7%; and ACEI: 38.1%, 38.1%; and even more likely for 
BB: 73.7%, 77.5% (<0.0001). Adjusted outcomes for women, compared to men, were: 
At 30 days: MACE: OR=0.96, p=0.77; D: OR=0.98, p=0.93; MI OR=0.91, p=0.24; TLR: 
OR=1.04 p=0.86. At 6 months: MACE: OR=1.19, p=0.02; D: OR=1.2, p=0.18; MI: OR=1.3, 
p=0.01; TLR: 1.2, p=0.16. At 5 years, MACE: OR=0.91, p=0.18; D: OR=1.07, p=0.38; MI: 
OR=1.08, p=0.35. The effect of being discharged on appropriate medications (at least 3 
of the 4 medication classes) provided a similar 5 year benefit (women compared to men: 
MACE: OR=1.07, p=0.59; D: OR=01.19, p=0.47; MI: OR=1.39, p=0.30).
Conclusion: In a large, consecutive, series of patients treated with PCI, risks were similar at 
30 days and 5 years for women and men. Women were found to be just as likely to receive 
appropriate secondary prevention medications at discharge and received just as much clinical 
benefit as men. Thus, women can undergo PCI in the current technology era with similar safety 
as men as long as they are given appropriate secondary prevention medications after.
1:30 p.m.
1012-187 Refractory End-Stage Chronic Heart Failure Day Care 
Service: A Five-Year Single Center Expirience
Dov Freimark, Michael Arad, Shlomi Matetzky, Liron Gershovitz, Isabel Langerman, Nira 
Koren Morag, Naomi Hochberg, Yafit Makmal, Michael Shechter, The Heart Institute, 
Sheba Medical Center, Tel Hashomer, Israel
Background: Chronic heart failure (CHF) is a common problem associated with frequent 
admissions to hospital and a poor prognosis.
Methods: To summarize a single center 5-year experince we retrospectively analysed all patients 
admitted to our CHF day care service between September 2000 and September 2005.
Results: One-hundred and ninety refractory end-stage (Stage D, NYHA IV) CHF patients 
(86% males) were treated in the day care clinic for 6 hour visits, twice a week, mean age 
65±12 years (range 28-82), mean left ventricular ejection fraction 25±11% and mean body 
mass index 27.4±4.9 kg/m2. Seventy-seven percent had ischemic and 23% non-ischemic 
cardiomyopathy. Of the 41(22%) heart transplantation candidates only 20 patients 
underwent transplant. In addition to their previous chronic concomitant oral medications, 
91% patients received combinations of intravenous diuretics, 87% intermittent low-dose 
dobutamine (≤ 5 μg/kg/min), 38% low dose dopamine (≤ 3 μg/kg/min), 47% intravenous 
iron preparation and/or blood, 36% intravenous nitropruside. Pleural/peritoneal fluid 
extraction, nitric oxide inhalation or continuous positive airawy pressure (C-PAP) were 
done/used as needed. In 158/190 (83%) patients with follow-up of ≥ 1 year from initiation 
of therapy, 46 (29.3%) died: 23% CHF exacerbation, 5.7% infectious, 4.4% sudden 
cardiac death, 3.8% malignancies, 2.5% malignant arrhythmias, 1.9% renal failure, 1.3% 
CVA and 0.6% myocardial infarction. In a person/year analysis there were only 0.68 
rehospitalizations/patient/year. The most frequent reason for rehospitalization was CHF 
exacerbation (16.5%).
Conclusion: A day care service intensively supports severe, end-stage CHF patients. A 
multi-drug therapy and intensive care monitoring of electrolytes, hemoglobin, and cardiac 
rhythm in addition to education and psychological support facilitate patients’ active 
daily living and may contribute to the relatively lower-than expected rate of mortality 
and hospitalizations. A CHF day care service is relatively safe but further prospective 
studies are needed to evaluate the impact of various treatment strategies on survival, 
hospitalizations and quality of life of these patients.
1:30 p.m.
1012-188 Short- and long-term Health Related Quality of Life 
and Anginal Status after Randomization to Coronary 
Stenting versus Bypass Surgery for the treatment of 
Multivessel Disease: Results of the ARTS-1 Study
Ron T. van Domburg, Andrew T. Ong, Susanne Pedersen, M. Bressers, Brian G. Firth, 
Felix Unger, Patrick W. Serruys, Erasmus Medical Center, Rotterdam, The Netherlands
Background: Health related quality of life (HRQL) beyond one year of treatment of 
multivessel coronary artery disease with stenting or coronary artery bypass grafting 
(CABG) is yet unknown. The Arterial Revascularization Therapy Study (ARTS) was 
designed to compare CABG and stenting in multivessel disease.
Methods and Results: HRQL was evaluated at baseline, at 1- month and at 6-, 12- and 
36 months after revascularization using the Short Form Health Survey (SF-36) in patients 
randomized to stenting (n=483) versus CABG (n=492). Both stenting and CABG resulted 
in significant improvement of HRQL and anginal status. Although there was a trend for 
better HRQL after CABG, the disparity between the two procedures decreased long-term. 
Most of the difference between the two procedures was attributed to repeat interventions 
in the stent group; at 3 years, 19% of stent patients versus 13% of CABG patients 
(p<0.0001) had undergone a repeat intervention. On most of the SF-36 scores, there was 
no difference between diabetics and non-diabetics, with diabetic patients having a worse 
score only on general health and physical functioning at all time points (p<0.0001).
Conclusions: Both stenting and CABG resulted in a significant improvement in HRQL 
and angina. There was a trend for better HRQL after CABG, but this difference was 
mainly attributed to repeat revascularization in the stent group. Therefore, using HRQL 
outcomes as part of the clinical decision making, there seems no need to prefer CABG 
above stenting in order to relief pain on the long-term.
1:30 p.m.
1012-189 Artificial Neural Networks Are A Potential Tool For 
Estimating Prognosis In Coronary Artery Disease - 
Are Standard Algorithms Sufficient?
Jaroslaw D. Kasprzak, Anna Michalak, Andrzej Nowakowski, Jaroslaw Drozdz, Maria 
Krzeminska-Pakula, II Chair of Cardiology, Medical University of Lodz, Lodz, Poland
Aim: Artificial neural networks (ANN) may be used for creation of expert systems in 
cardiology. We aimed to create and test the ability of ANN for the prediction of individual 
risk in patients with coronary disease.
Methods: We based our study on the database of 250 patients with coronary disease 
with known follow-up of 18±6 months duration. Every patient was represented with one 
input vector, containing data on age, sex, BMI, CSS, history of infarction, diabetes, 
dyslipidemia, smoking and hypertension and output vector was expressed as 4 
grades of clinical course: death / infarction or revascularizations / other acute coronary 
syndromes / uneventful course. Tested ANNs were prepared using different methods: 
1. Backpropagation algorithm - networks with one or two hidden layers included 3-40 
neurons, with tanh activation function; 2.Radial Basis Function Network (RBFN) with 
20-30 neurons in hidden layers; 3. Cascade Correlation of Fahlman (CCF) with 50,60 
and 100 maximal neuron in hidden layer, tanh or Gauss activation function; 4. Kohonen 
Algorithm (40 neurons).
Results: Tested ANNs differed in their ability to predict the clinical course: 50-75% 
correct answers for Backpropagation algorithm, 40-75% for RBFN, 50% for CCF and 
75% for Kohonen ANN. The most promising approach was using linked Kohonen 
learning algorithm with Backpropagation algorithm (different networks had 1 or 2 hidden 
layers with 20-70 neurons), providing 85% correct answers when 1 hidden layer with 40 
neurons, 0.6 learning rate and 500 learning cycles in Kohonen algorithm, 0.1 learning rate 
and 500 cycles in Backpropagation algorithm was used. We expected that neurons would 
specialize in recognizing certain samples in the same disease categories, but this was not 
observed. Increasing learning cycles numbers gave the effect of overfiting.
Conclusions: ANNs are potential means for creation of advanced prognostic tools 
in cardiovascular disease. Standard ANN algorithms may not be optimal for clinical 
expert systems, however, with a proper combination of network structure and learning 
algorithms, it is possible to obtain >80% correct prediction of clinical course. Our results 
warrant validation using larger test cohorts.
1:30 p.m.
1012-190 Smart Ecg: Solution For Mobile Heart Work Analysis And 
Medical Interventions In Case Of Heart Work Problems
Marko Velic, Miroslav Novak, Marko Oreskovic, Ivan Padavic, Hrvoje Pedljo, Zlatko 
Stapic, Neven Vrcek, Sinisa Car, Faculty of Organisation and Informatics, University of 
Zagreb, Varazdin, Croatia, General Hospital, Varazdin, Croatia
Background: Chronic ishemic heart disease is the most common cause of death in 
industrialized countries and is usually associated with fatal sustained ventricular tachycardia. 
Early recognition and emergency procedure is a key for surviving of these patients.
Goals: In this paper we discuss abilities and advantages of new information and 
communication technologies (ICT) in continuous heart work monitoring and analysis. Goals 
of “Smart ECG” system are: to enable medical intervention in case of heart conditions just 
on time and integration of ICTs in a way they have not been integrated before.
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Methods: Smart ECG is information system which integrates many different ICT 
solutions. Smart ECG includes six main components: portable bluetooth ECG device, 
Pocket PC application, Web service, central database, Web application and GPS 
integrated support. ECG recorded data is transmitted via wireless bluetooth connection 
to a PDA application for display and analysis of QRS. If irregularities are detected, data 
is sent in main database via GPRS and doctor is alarmed via SMS. Afterwards, doctor 
can log onto his Web application where he can monitor patient’s condition and see what 
happens. There is also built in GPS support, so that patient can be located on the map 
which allows medical intervention just on time. Web forum allows exchange of data and 
doctors’ opinions.
Conclusions: Smart ECG integrates many ICTs and enables heart work monitoring in 
different situations, emergency reaction and GPS location of patient. 
1:30 p.m.
1012-191 A Comparative Study on the Feasibility and Safety of 
Transulnar Artery Versus Transradial Artery Access for 
PCI in Patients With Coronary Heart Disease
Xianghua Fu, Xinshun Gu, Weize Fan, Yunfa Jiang, Guozhen Hao, Weili Wu, Shiqiang 
Li, Xiaokun Liu, Ning Ma, 2nd Hospital of Hebei Medical University, Shijiazhuang, 
People’s Republic of China
Background: The diameter in ulnar artery is similar to that in radial artery, but the ulnar 
artery approach as alternative of forearm access for PCI has still been a few application. 
Since 2001 we early started TUA (transulnar artery)access for PCI in the world, we have 
been continually performing PCI via TUA approach for 160 patients whose ulnar artery 
were suitable for PCI. This study was to compare the feasibility and safety of TUA-PCI vs. 
TRA-PCI (transradial artery PCI).
Methods: Total of 320 CHD patients (38 to 80 years old) were divided into TRA-PCI 
group (male 131,female 29) and TUA-PCI group (male 133, female 27) whose ulnar 
artery pulsation is clear and strong. The time of manipulative duration for each protocol 
of PCI was recorded. The time of Allen’s test, lumen diameter (mm), cross area of vessel 
lumen (mm2), blood velocity (Vs max) and blood flow resistance index(RI) in ulnar and 
radial artery were measured, respectively, as well were compared quantitatively before 
and 6 months after PCI procedure.
Results: The puncture success rate of TUA-PCI group was 95.7% equal to that of 
TRA-PCI group, and among them the first puncture success rate was 83.6% in TUA-
PCI group and 84.2% in TRA-PCI group. All of 212 lesion segments in 178 vessels 
were angioplasticized and 215 stents were implanted in TUA-PCI group by 6F guiding 
catheter, while 210 lesion segments in 177 vessels were angioplasticized and 214 stents 
were implanted in PCI-TRA group, successfully. The average time of guiding catheters 
engaging in ostium of target vessles, the average time of under X ray fluoroscopy and 
the total time of whole procedure were no significant difference between two groups, 
respectively ( 4.25±0.56 vs. 4.22±0.49min, 23.8±0.46 vs. 22.9±0.57min, 54.6±12.4 vs. 
52.8±14.2min; all p>0.05). No significant changes in above vessel investigated results 
and no serious complications such as occlusion of ulnar artery and ulnar nerve injury 
were found follow-up 6 months after PCI procedure.
Conclusions: The feasibility and safety via TUA-PCI in CHD patients whose ulnar artery 
is suitable to as an approach for PCI are same as those via TRA-PCI, and ulnar artery 
might be as an alternative choice for PCI via the forearm access.
1:30 p.m.
1012-192 A Unique Animal Model of Aortic Valve Calcification 
Using High Adenine Diet
Mony Shuvy, Suzan Abedat, Ronen Beeri, Haim D. Danenberg, David Planer, Chaim 
Lotan, Heart Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Background: Aortic valve calcification (AVC) Is a central component in the 
pathophysiology of aortic stenosis. It involves accumulation of inflammatory cells, 
osteoblast transformation and bone formation.
Parathyroid hormone (PTH) Is essential for osteoblast activity, tissue calcification and 
bone formation. Since a diet containing high levels of Adenine and Phosphate has been 
shown to induce polyuric renal failure and secondary hyperparathyroidism, our aim was 
to assess whether this diet induces AVC.
Methods: 15 rats were fed daily With the Adenine diet (diet group) for 7 weeks and With 
normal bovine serum albumin (BSA) for 2 additional weeks.
10 control rats received BSA alone. Renal function tests, electrolytes and PTH levels were 
assessed After 4 and 9 weeks. Echocardiography and multislice computed tomography 
(MSCT) were performed at 9 weeks. Valve tissue was stained for calcium (Von Kossa), 
macrophages (CD68), and Osteopontin ( an osteoblast marker). Osteopontin and 
activated P38- MAPK levels were assessed using Western blot. 
Results: After 4 weeks, all diet group rats developed renal failure and secondary 
hyperparathyroidism compared to the controls (PTH 2330 ± 280 pg/mL Versus 281±168 
pg/ml, respectively, p<0.01 ). At 9 weeks (2 weeks After cessation of the Adenine diet) 
renal failure completely resolved, With improvement of the hyperparathyroid state (PTH 
750 ± 477 pg/mL p<0.01). Echocardiography demonstrated valve calcification in all diet 
group valves, but in none of the controls. Calcium score by MSCT was significantly higher 
in the diet group (145 ± 118 Versus 0; p<0.01). Histological examination showed calcium 
deposits in all parts of the valve, and stains for Osteopontin and CD68 were positive only 
in diet group valves. Both Osteopontin and activated P38-MAPK levels were significantly 
elevated in the diet group as compared to the controls.
Conclusion: We developed a simple diet-induced animal model for AVC quantifiable 
by MSCT and echocardiography. The calcification process involves activation of typical 
signaling pathways, macrophage accumulation and osteoblast transformation. This 
model may serve as an important tool in the study of aortic valve disease.
1:30 p.m.
1012-193 Elective Percutaneous Coronary Intervention Without On-
Site Surgical Backup: A Community Hospital Experience
Mohamed Djelmami-Hani, Mouatou Mouanoutoua, Abdelazim Hashim, Joaquin Solis, 
Lawrence Bergen, Neil Oldridge, Leo C. Egbujiobi, Masood Akhtar, Suhail Allaqaband, 
Tanvir Bajwa, Aurora Sinai/St. Luke’s Medical Ctrs, Univ of Wisconsin School of 
Medicine and Public Health-MCC, Milwaukee, WI, Beloit Memorial Hospital, Beloit, WI
Background: Current American College of Cardiology (ACC) guidelines support primary 
percutaneous coronary intervention (PCI) without on-site surgical backup (OSB) only in 
acute ST segment elevation myocardial infarction (STEMI) (Class IIb) While elective PCI 
without OSB is considered a class III indication.
Methods: We analyzed initial elective PCI experience without OSB at our satellite 
institution. A predefined protocol was designed to transfer patients to a cardiac surgical 
facility if necessary. An experienced interventional cardiologist reviewed the diagnostic 
angiograms. Patients with technically complex lesions were excluded from the study. 
The primary endpoints were any procedure-related death or complications requiring an 
emergency coronary artery bypass graft (ECABG) and 6-month outcome was analyzed.
Results: From January 2003 to April 2006, a total of 321 elective PCI’s were performed. 
The mean age was 64±12, 68% of the patients were male. The prevalence of diabetes, 
hypertension and peripheral arterial disease was 28%, 82.5% and 2% respectively. A 
total of 352 vessels were stented. Multi-vessel PCI was performed in 61 patients (19%). 
Lesion morphology was Type A in 252 (66%), Type B in 99 (26%), Type B2 in 11 (2.9%) 
and type C in 20 (5.1%). A total of 437 stents were deployed; 35 (8%) bare metal, 149 
(34%) sirolimus-eluting and 253 (58%) paclitaxel-eluting. IIb-IIIa inhibitors were used in 
77 (24%) cases. Procedural success was 99.7%. One patient had a heavily calcified 
lesion that could not be dilated with balloon and was electively transferred to a facility with 
OSB for PCI. Three patients had hematoma without need for blood transfusion. There 
were no deaths, myocardial infarctions or need for ECABG.
Conclusion: Our experience suggests that elective PCI, in carefully selected patients 
with non-complex lesions, can be performed safely without OSB. In contrast to the current 
ACC guidelines, we propose that non-complex lesions can be recommended for PCI by 
an experienced interventional cardiologist in facilities without OSB but with a predefined 
protocol to transfer patients to a surgical site in case of emergency.
1:30 p.m.
1012-194 The Cardiovascular Disease Prevention Model: a Model 
That Predicts Future Incidences of Cardiovascular 
Disease in Any Given Population and Undertakes 
Cost-Effectiveness Analyses of Primary Preventive 
Interventions
Danny Liew, Dianna Magliano, Kate Webb, Mendel Grobler, NHMRC Centre for Clinical 
Research in Therapeutics, DEPM, Monash University, Melbourne, Australia, Pfizer 
Australia, Sydney, Australia
Background: The cardiovascular (CVD) Prevention Model (CPM) was developed to 
predict the future incidence of CVD (comprising coronary heart disease and stroke) in 
any given population and to undertake cost-effectiveness analyses of primary preventive 
strategies for CVD in that population.
Methods: The CPM is a Markov model comprising four initial health states: ‘Alive 
without CVD’, ‘Alive with CVD’, ‘Dead after CVD’ and ‘Dead from other causes’. Subjects 
transition through the states based on the risks of CVD derived from Framingham and 
UKPDS risk equations for non-diabetic and diabetic individuals, respectively. The risks of 
death after incident CVD are drawn from MONICA registry data. Life-course analysis is 
applied to account for changes to risks with age. To illustrate the function of the CPM, it 
was populated with cross-sectional data from the 2000-2001 Australian Diabetes, Obesity 
and Lifestyle study. The population (n=1105) comprised men and women initially aged 
35-73 years and without CVD, simulated to follow until death or 74 years. The cost-
effectiveness of atorvastatin for primary prevention was modelled via a decision analysis, 
using efficacy data from a recent meta-analysis of randomised trials and Australian cost 
and utility data. The perspective was that of the health sector in 2005. An annual discount 
rate of 5% was applied to future costs and health gains and discontinuation of atorvastatin 
was assumed to be 40% in the first year.
Results: With ‘No treatment’ the incidence of CVD until 74 years (per 1,000 person 
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years) was 15.20 compared to 12.17 for ‘atorvastatin’ treatment, relative risk (RR) of 
0.80. The incremental cost effectiveness ratio per year of life saved was AUD$46,200. 
The incremental cost effectiveness ratio per quality adjusted life year was AUD$35,200.
Conclusions: The CPM allows for the prediction of future incidences of CVD in any 
population where representative cross-sectional data on cardiovascular risk factors 
are available. With the availability of cost data, cost-effectiveness analyses of primary 
preventive interventions can also be undertaken. Atorvastatin represents a cost-effective 
means of preventing first-onset CVD among Australian adults.
ACC.POSTER SESSION
1018 
Special Topics
Monday, March 26, 2007, 9:00 a.m.-12:30 p.m.
Hall H
9:00 a.m.
1018-146 Do the Results of the Arterial Revascularization 
Therapies Study Trial Generalize to Current 
Revascularization Practices in Northern New England
David J. Malenka, Craig W. Langner, John F. Robb, Lawrence J. Dacey, Mirle A. 
Kellett, Jr., Reed D. Quinn, Theodore M. Silver, Bruce J. Leavitt, Michael J. Hearne, 
Winthrop D. Piper, Elaine M. Olmstead, Gerald T. O’Connor, The Northern New England 
Cardiovascular Disease Study Group, Lebanon, NH, Dartmouth-Hitchcock Medical 
Center, Lebanon, NH
Background: ARTS, which compared multi-vessel stenting to CABG, reported 5-
year revascularization rates of 8.8% for CABG and 30.3% for PCI with stenting. The 
generalizability of these results to a more diverse group of patients treated outside a 
randomized trial has not been determined.
Methods: Linking the Northern New England PCI and CABG registries with NDI survival 
data, we identified all patients with 2- or 3-vessel CAD who might have been candidates 
for either procedure (no prior revascularization, age < 80, LM24 hours from MI, non-
emergent) from 1997-2001 (PCI-3,038; CABG-7,759). Adjusted, revascularization-free 
survival rates are reported and compared.
Results: CABG patients were older, had more co-morbidities, lower EFs, and more 3-
vessel disease. Stents were used in 88% of PCIs, IMAs in 95% of CABGs, and 40% 
of PCI patients were completely revascularized. The 5-year adjusted risk of repeat 
revascularization (Figure) was 36% for PCI and 6% for CABG (HR 0.13, p<0.001) with 
a disproportionate early risk for PCI of 20% during year 1, decreasing to 5% per annum 
over years 2-5.
Conclusions: Despite a more diverse patient population and less complete initial 
revascularization with PCI, the 5 year risks of repeat revascularization for CABG and PCI 
in Northern New England are comparable to those reported in ARTS. This suggests that 
trials comparing newer revascularization strategies, such as drug-eluting stents, may be 
generalizable to broader patient populations. 
9:00 a.m.
1018-147 Impact of Coordinated Process of Care on Individual 
Components of Treatment Delays Among ST Elevation 
Myocardial Infarction Patients Treated with Primary 
Percutaneous Coronary Intervention
Joji J. Varghese, Frank V. Aguirre, Syeda Rumman, Sushma Koneru, David L. Griffen, 
Jayne Thompson, Karen Baur, Gary Mangold, Jack Gruwell, Conrad Davis, John B. Gill, 
Wilfred Lam, Michael P. Kelley, Frank L. Mikell, Prairie Cardiovascular Consultants, Ltd., 
Springfield, IL, Southern Illinois University School of Medicine, Springfield, IL
Background: Despite current ST elevation myocardial infarction (STEMI) guideline 
recommendations, door-balloon times among patients receiving primary percutaneous 
coronary intervention (PPCI) remains excessive. Overcoming intra-hospital barriers which 
limit identification, triage and PPCI performance remains a major goal of expeditious 
performance of PPCI.
Methods: In this single center community hospital study, we examined the impact of a 
6-year continuous institutional policy review and protocol modification process on 3 time 
intervals reflective of overall STEMI process of care. Time intervals evaluated were: a. MI 
identification (door-ECG), b. Emergency department treatment (ED) and triage (door-cath 
lab arrival) and PPCI-related care (cath lab arrival-balloon).
Results: 
Year (Median, 25th, 75th Percentile)
Year 2001 2002 2003 2004 2005 2006 P value
Variable (n=66) (n=46) (n=53) (n=57) (n=78) (n=36)
Symptom Onset-Door 
(min.)
100 
(57,189)
107 
(53,415)
107 
(60,347)
99 
(62,199)
109 
(59,190)
91 
(67,360) NS
Door-ECG(min.) 13 (5,19) 9 (5,19) 7 (3,12) 5 (2,9) 3 (1,9) 4 (1,6) <0.0001
Door-Cath Lab (min.) 72 (56,96) 53 (40,102) 49 (33,68) 50 (36,66) 43 (26,63) 41 (27,47) <0.0001
Cath Lab-Balloon (min.) 24 (15,34) 30 (23,40) 27 (23,38) 32 (23,41) 29 (22,36) 25 (19,39) NS
Door-Balloon (min.) 99 (78,129) 83 (69,161) 78 (61,100) 80 (67,101) 71 (56,96) 73 (50,88) <0.0001
Door-Balloon < 90 
min.(%) 46 59 68 67 71 83 0.003
Door-Balloon < 120 
min(%) 70 74 81 84 83 97 0.02
Conclusions: Over a 6-yr time span, continuous institutional monitoring and PPCI protocol 
refinement resulted in a 37% reduction in overall door-balloon time and acheivement of a 
door to balloon time < 90 mins. in approximately 80% of patients. This time reduction was 
largely attributable to a 73% reduction in STEMI identification and a 43% reduction in ED 
treatment and triage, without significant change of PPCI-related times.
9:00 a.m.
1018-148 Increased Use of Cardiovascular Drugs Explains 
Recent Trends in Prognosis after Myocardial Infarction
Soko Setoguchi, Raisa Levin, Wolfgang C. Winkelmayer, Brigham and Women’s 
Hospital, Boston, MA
Background: The uses of statins, beta-blockers (BB), and angiotensin converting 
enzyme-inhibitors (ACEI) or angiotensin-II-receptor blockers (ARB) after myocardial 
infarction (MI) have been increasing over the past decade. Little is known, however, 
about the recent trends in long-term prognosis after MI, and whether increasing use of 
cardiovascular medications contributed to improvement of survival after MI.
Methods: We identified 21,848 patients hospitalized for MI who survived >= 30 days after 
discharge using data from Medicare and pharmacy assistance programs in two states 
(1995-2004). We assessed age, gender, race, comorbidities, length of stay and use of 
coronary interventions during the MI hospitalization as well as filled prescriptions for any 
statin, BB, ACEI/ARB or antiplatelet agents within 30 days after discharge. We followed 
all patients from the index date (30 days after discharge) until they died, or the end of 
eligibility/study period. Multivariate Cox regression was used to study trends in long-term 
mortality. To assess the contribution of the use of the recommended drugs and coronary 
interventions after MI, we sequentially introduced these variables into the fully-adjusted 
models and evaluated the change in adjusted hazard ratios (aHR) for calendar year.
Results: Of 21,484 patients identified, we observed 12,142 deaths during 74,982 person-
years of follow-up. After adjusting for demographics and comorbidities, the mortality after 
MI decreased significantly from 1995 to 2004 (aHR for trend=0.97; 95% CI 0.97-0.98), 
corresponding to a 3% reduction in mortality each year. After introducing variables for 
statin, BB, ACEI/ARB or antiplatelet drug use, calendar year was no longer associated 
with mortality (aHR for trend=1.00; 95% CI 0.99-1.01), indicating that the observed 
improvement in mortality after MI was explained by increasing use of these drugs. We 
also observed a smaller attenuation of the effect of calendar year after adjusting for MI-
related procedures.
Conclusions: Long-term prognosis in elderly patients with MI has improved considerably 
over time, which appeared to be fully attributable to increasing use of cardiovascular 
medications after MI.
9:00 a.m.
1018-149 Interaction Between Social Support, Marital Status and 
Gender After Acute Myocardial Infarction
Rasha N. Bazari, Sanjaya Khanal, Homaa Ahmad, Kimberly Reid, Judith Lichtman, 
Viola Vaccarino, Donna Buchanan, John A. Spertus, Henry Ford Health System, Detroit, 
MI, Mid America Heart Institute, Kansas city, MO
Background: Lower social support is known to be associated with worse outcomes 
after myocardial infarction (MI). Since men and women have different marital roles, we 
examined the gender-related association of marital status with social support after MI.
Methods: Among 2426 AMI patients in the 19-center PREMIER study, we quantified 
the interaction between gender, marital status and social support using the ENRICHD 
Social Support Inventory (ESSI, range=1-32) at baseline, 1, 6 and 12 months after 
discharge. ESSI scores were categorized into the lowest (≤27) vs. the highest 3 quartiles. 
Covariates in the multivariable repeated measures logistic regression analysis included 
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demographics, clinical data, MI type, depression and use of coronary revascularization.
Results: Overall, 68.8% of men and 43.5% of women were married. At baseline, low 
social support was present in 19.5% of married females, 38.6% of unmarried females, 
12.1% of married males, and 49% of unmarried males, p<0.001. Multivariable adjustment 
revealed a significant interaction between marriage and gender (p < 0.001), with females 
having higher social support than men among unmarried patients, odds ratio (OR) 1.37, 
(95% confidence interval [CI], 1.06-1.77) and, conversely, higher social support for 
married men than married women, OR 0.62, (95% CI, 0.46-0.84; Figure).
Conclusion: Efforts to improve the social support of married women and single individuals 
warrant further investigation.
Abbreviations: SS, Social support.
9:00 a.m.
1018-181 Long-Term Mortality Benefits From Early Enalapril 
Therapy in Patients With Left Ventricular Systolic 
Dysfunction : A 20-Year Follow-Up of SOLVD
Sylvie A. Ahn, Philip Jong*, Michel F. Rousseau, University of Louvain, Brussels, 
Belgium, University of Toronto*, Toronto, ON, Canada
Background: In an extended follow-up of the Studies of Left Ventricular Dysfunction 
(SOLVD), we showed that enalapril had a sustained mortality benefit at 12 years. We 
reported here a 20-year follow-up of SOLVD to determine the effect of early in-trial 
treatment with enalapril on long-term survival post trial.
Methods: Among the 558 Belgium patients from SOLVD randomized to either enalapril 
or placebo, post-trial mortality data were collected on all 433 survivors (218 enalapril vs. 
215 placebo) at closeout. All patients were placed on enalapril after the trial. Long-term 
survival was compared between patients who received early enalapril therapy and those 
who received delayed therapy.
Results: No patient was lost to follow-up. The median duration of follow-up was 18.1 
(range 16.1-20.0) years. All-cause mortality was significantly reduced among patients 
treated early with enalapril as compared with placebo (77 vs. 82 %, p=0.03). This 
reduction was attributed to a decrease in cardiac deaths. Early therapy with enalapril had 
an added mortality benefit in the post trial period beyond that derived in trial (71 vs. 77 
%, p=0.01). Life expectancy was significantly increased by 28.3 months among patients 
treated early with enalapril over those treated late (p=0.006).
Conclusion: In a 20-year follow-up of SOLVD, survival and life expectancy were 
increased in patients with left ventricular systolic dysfunction who received early therapy 
with enalapril as compared to those who received delayed therapy. 
9:00 a.m.
1018-182 Differences in Complication Rates among Medicare 
Beneficiaries Undergoing Coronary Artery Bypass 
Graft Surgery: Do Graft Types and Cardiopulmonary 
Bypass Matter?
Phillip P. Brown, Aaron D. Kugelmass, April W. Simon, Steve D. Culler, Cardiac Data 
Solutions, Inc., Atlanta, GA, Emory University Rollins School of Public Health, Atlanta, GA
Background: This research examines gender differences in five adverse events 
associated with Medicare beneficiaries undergoing CABG surgery by type of graft and 
use of cardiopulmonary bypass.
Methods: A retrospective analysis was conducted using the Medicare Provider Analysis 
and Review (MedPar) Files for fiscal year 2004. The study sample consists of all hospitals 
that performed at least 52 CABG surgeries during a fiscal year. The final sample consisted 
of 123,436 Medicare beneficiaries who underwent CABG surgery without concomitant 
valve surgery. Separate logistic regression equations (controlling for 25 demographic 
characteristics and co-morbidities) were estimated to predict each Medicare beneficiary’s 
probability of experiencing in-hospital death, new onset hemodialysis, post-operative 
stroke, infection and adult respiratory distress syndrome. Average risk-adjusted rates 
for each adverse event were calculated separately by gender, type of graft and use of 
cardiopulmonary bypass.
Results: Overall, 66.9% of the Medicare beneficiaries were men, 70.4% of the surgeries 
used a pump and 82.8% of the grafts involved arteries. The table provides the average risk 
adjusted adverse event rate by gender for each sub-population. Women had significantly 
higher adverse event rates than men in each category.
Conclusion: For both women and men, risk adjusted adverse event rates were lowest for those 
patients using arterial grafts on pump and highest for those patient receiving only veins off pump. 
Men Women
On Pump Off Pump On Pump Off Pump
At Least 
One Arterial 
Graft
Vein 
Grafts 
(only)
At Least 
One Arterial 
Graft
Vein 
Grafts 
(only)
At Least 
One Arterial 
Graft
Vein 
Grafts
(only)
At Least 
One Arterial 
Graft
Vein 
Grafts 
(only)
Patients 50,322 8,590 19,269 4,403 22,617 5,329 10,011 2,895
RA Mortality 2.69% 4.01% 3.05% 4.43% 4.12% 5.74% 4.54% 6.33%
RA New Onset 
Hemodialysis 0.84% 0.97% 0.90% 1.00% 1.10% 1.11% 1.09% 1.15%
RA Post 
Operative 
Stroke
1.43% 1.59% 1.48% 1.63% 1.70% 1.86% 1.76% 1.92%
RA Infection 2.35% 3.03% 2.58% 3.39% 2.69% 3.33% 2.93% 3.77%
RA Post 
Operative 
ARDS
5.35% 6.64% 5.76% 7.18% 6.40% 7.70% 6.89% 8.43%
9:00 a.m.
1018-183 National Patterns of Glucose Control Among Patients 
Hospitalized With Acute Myocardial Infarction
Mikhail Kosiborod, Silvio Inzucchi, Bobby Clark, Harlan M. Krumholz, Philip G. Jones, 
James O’Keefe, Jr., John A. Spertus, Mid America Heart Institute of Saint Luke’s 
Hospital, Kansas City, MO, Cerner Corporation, Kansas City, MO
Background: Elevated blood glucose (BG) level is a major modifiable risk factor for 
adverse outcomes among patients hospitalized with acute myocardial infarction (AMI). 
Insulin therapy remains the treatment of choice for glucose control in this setting. Current 
national practice patterns regarding in-hospital BG control in AMI patients are not known.
Methods: We conducted a study using Cerner Corporation’s Health Facts™, a national 
database derived from electronic medical records at 39 medical centers that contribute 
patients’ demographic, clinical, comprehensive laboratory and pharmacy data. Hospitals 
are located in the Northeast (53%), Midwest (23%), South (17%) and West (7%), 24% are 
teaching, 92% urban, and 23% have >500 beds. We analyzed patterns of BG control and 
documented insulin therapy among 16,534 patients hospitalized with AMI from January 
2000-December 2005.
Results: Of the 4940 patients (30%) with recognized diabetes (DM), nearly half (2412 
patients, 49%) had mean BG >200 mg/dL during the first 24 hours after hospital admission. 
When the entire hospitalization was considered, 34% DM patients had mean BG >200 
mg/dL, while 61% had mean BG between 110-200 mg/dL, and only 5% maintained mean 
BG <110 mg/dL. Among patients without recognized DM, 8% had mean BG >200 mg/dL 
during the first 24 hours. When entire hospitalization was considered, 4% of patients 
without known DM had mean BG >200 mg/dL, while 65% had mean BG between 110-200 
mg/dL, and 31% had mean glucose <110 mg/dL.
Among DM patients with mean hospitalization BG of >200 mg/dL, only 138 patients (8%) 
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received intravenous insulin infusion, while nearly a third (498 patients, 30%) received 
no insulin therapy at all. Among patients without known DM and mean hospitalization BG 
>200 mg/dL, only 23 patients (5%) received intravenous insulin infusion, while over a half 
(264 patients, 58%) received no insulin therapy at all.
Conclusions: In patients hospitalized with AMI, average BG control is poor. Even among 
patients with marked hyperglycemia, few receive intravenous insulin infusion. Large 
proportions of hyperglycemic patients do not receive any insulin therapy at all, particularly 
among those without prior history of diabetes.
9:00 a.m.
1018-184 Importance of Pain and Hypertension in Acute Type 
B Aortic Dissection: Insights from the International 
Registry of Acute Aortic Dissection (IRAD)
Santi Trimarchi, Kim A. Eagle, Christoph A. Nienaber, Toru Suzuki, Patrick T. O’Gara, 
Stuart J. Hutchison, Vincenzo Rampoldi, Eduardo Bossone, Arturo Evangelista, Thomas 
T. Tsai, James B. Froehlich, Jeanna V. Cooper, Dean E. Smith, Gabriel W. Meinhardt, 
Thoralf M. Sundt, III, Truls Myrmel, Eric M. Isselbacher, On Behalf of the International 
Registry of Acute Aortic Dissection (IRAD) Investigators, University of Michigan Medical 
Center, Ann Arbor, MI
Background: In patients with acute type B aortic dissection (ABAD), presence of 
recurrent or refractory pain and/or hypertension on medical therapy may be considered 
as an indication for surgery/intervention. We evaluated this subgroup of patients to 
assess in-hospital results of medical, endovascular or surgical management of patients 
enrolled in the International Registry of Acute Aortic Dissection (IRAD).
Methods: There were 365 patients affected by ABAD enrolled in the IRAD from 1996-
2004 and categorized according to risk profile into two groups: Intermediate risk group (G 
I): patients with recurrent or refractory pain and/or hypertension. Patients not presenting 
clinical complications at presentation were categorized as low risk or uncomplicated (G 
U). “High risk” patients with any of shock, periaortic hematoma, spinal cord ischemia, pre-
op mesenteric ischemia/infarction, acute renal failure, limb ischemia were excluded in this 
analysis. In-hospital outcomes and 1-year follow-up were reported.
Results: Overall in-hospital mortality was 6.5%, in G I (69 patients) was 17.4%, compared 
to 4.0% in G U (296 patients, p<0.01) (Table). Overall survival at 1 year was 84.6% for G 
I and 90.7% for G U (log rank p=0.46).
Conclusions: In ABAD uncomplicated patients, medical therapy is associated with 
excellent in-hospital mortality outcomes whereas patients with continuing pain/
hypertension had poorer outcomes when medically managed. Randomized studies 
are needed in order to identify best management.
Results
Variable IntermediateN=69 (18.9%)
Uncomplicated
N=296 (81.1%) p-value
Management
Surgery (%) 25 (36.2) 25 (8.4) <0.001
Medical (%) 17 (24.6) 260 (87.8) <0.001
Endovascular(%) 27 (39.1) 11 (3.7) <0.001
Mortality Rate
Overall (%) 12 (17.4) 12 (4.0) <0.001
Surgical (%) 5 (20.0) 7 (28.0) 0.74
Medical (%) 6 (35.6) 4 (1.5) <0.001
Endovascular (%) 1 (3.7) 1 (9.1) 0.50
9:00 a.m.
1018-185 Meta-Analysis of Randomized Controlled Trials Found 
No Benefit of Fish Oil or Omega-3 Fatty Acids on 
Sudden Cardiac Death or Ventricular Arrhythmias
Peter Danyi, Roger S. Blumenthal, Kashif Chaudhry, Jurga Adomaityte, Rehan Qayyum, 
Johns Hopkins University School of Medicine, Baltimore, MD
Background: Observational studies have suggested that regular intake of fish may 
reduce the risk of sudden death and cardiac arrhythmias. However, clinical trials have not 
found a consistently a benefit of treatment with fish oil or omega-3 fatty acid (O3FA).
Methods: We performed a meta-analysis of clinical trials that had evaluated the effect of 
treatment with fish oil or O3FA on sudden cardiac death and ventricular fibrillation (VF) 
or ventricular tachycardia (VT). Randomized controlled trials of fish oil or O3FA treatment 
versus no treatment were identified by searching PubMed, EMBASE, Cochrane Clinical 
Trials Register, hand-search of the references of retrieved articles, and by soliciting help 
from experts in the field. Studies that included sudden death, VT, or VF as outcomes were 
included in this meta-analysis.
Results: Six trials, including 31,356 patients, (median age 61 years, range 48 to 66 
years; males 85%, range 31% to 95%, median follow-up 18 months, range 12 to 55 
months) met inclusion criteria. There were 138 sudden deaths among the subjects who 
were given fish oil or O3FA as compared to 185 sudden deaths among the non-treated 
subjects with an odds ratio (OR) of 0.77 and 95% confidence interval (CI) of 0.49 to 1.22. 
Similarly, treatment with fish oil or O3FA had no effect on VT or VF (198 vs. 211 events, 
OR = 0.97, 95% CI = 0.54 to 1.75).
Conclusions: We did not find a benefit of treatment with fish oil or O3FA on decreasing 
the risk of sudden death or ventricular arrhythmias.
9:00 a.m.
1018-186 Variability in the Hospital Use of Insulin to Control Sustained 
Hyperglycemia Among Acute Myocardial Infarction Patients
Mikhail Kosiborod, Silvio Inzucchi, Bobby Clark, Harlan M. Krumholz, Philip G. Jones, 
John A. Spertus, Mid America Heart Institute of Saint Luke’s Hospital, Kansas City, MO, 
Cerner Corporation, Kansas City, MO
Background: American Heart Association recommends “normalization” of blood glucose 
(BG) in patients with acute myocardial infarction (AMI). Insulin, given subcutaneously 
or as intravenous infusion (IV) is the most effective method of BG control in-hospital. 
National patterns of insulin use to control hyperglycemia in AMI patients are unknown.
Methods: We used Cerner Corporation’s Health Facts™, a national database based on 
electronic medical records at 39 hospitals that contribute patients’ demographic, clinical, 
comprehensive laboratory and pharmacy data. Hospitals are located in the Northeast 
(53%), Midwest (23%), South (17%) and West (7 %); 24% are teaching, 92% urban, and 
23% have >500 beds. We an alyzed rates of documented insulin use in 2132 AMI patients 
with mean hospitalization BG>200 mg/dL admitted from January 2000-December 2005.
Results: Only 1370 patients (64%) received any insulin, and 161 patients (7.5%) received 
IV insulin. There was marked variability among hospitals in the frequency of insulin use 
(Fig.). Rates for any insulin varied from 0%-100%, and for IV insulin from 0%-26%. In 
39% of hospitals, majority of patients with marked hyperglycemia received no insulin. 
Nearly a third of hospitals (28 %) did not use IV insulin even once.
Conclusions: Although there is variability in the use of insulin to control hyperglycemia in 
AMI patients, the rates of use in most hospitals are inappropriately low. Few hospitals use 
IV insulin even in the setting of significant, sustained hyperglycemia. 
9:00 a.m.
1018-187 The Relationship Between Change in Hematocrit and 
Change in Health Status in Patients With Heart Failure 
After Myocardial Infarction
Mikhail Kosiborod, Harlan M. Krumholz, Philip G. Jones, Bertram Pitt, John A. Spertus, 
Mid America Heart Institute of Saint Luke’s Hospital, Kansas City, MO
Background: Studies have identified anemia as a potential target for intervention in 
patients (pts) with heart failure (HF), with the goal of improving survival and health status. 
However, whether changes in hematocrit (Hct) are associated with changes in health 
status among HF pts is unknown.
Methods: We studied 1474 pts with HF after myocardial infarction that participated in the 
EPHESUS study and had serial assessments of Hct and health status with the Kansas-
City Cardiomyopathy Questionnaire (KCCQ). Linear regression models assessed the 
relationship between change in Hct and concomitant change in health status between 1 
month (baseline) and 3 month after hospitalization.
Results: During follow up, 12.6% of pts had >2% decline in Hct, 32.5% had >2% increase 
in Hct, and 54.9% had no change in Hct. After multivariable adjustment, there was a 
highly significant interaction between baseline Hct, change in Hct and change in health 
status. The association was non-linear. Pts with severe anemia at baseline (Hct ≤33%) 
who’s Hct further declined, had marked decrements in health status, while health status 
gains associated with Hct improvements were small. The magnitude of Hct-associated 
health status change was less pronounced in pts with baseline Hct >33-39%, and not 
significant in pts with normal Hct (>39%) at baseline (Figure).
Conclusions: Among anemic pts with HF, decrease in Hct is associated with marked decline 
in health status, while health status gains associated with Hct improvements are minimal.
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1018-188 i-Trial: An Innovative Internet System for fhe Complete 
Management and Monitoring of International 
Multicenter Clinical Studies.
Domenico Cianflone, Nicole Cristell, Stefano Coli, Marco Magnoni, Sara Pagani, Azeem 
Latib, Susan Spears, Neal Uren, Hui Li, Daji Hu, Attilio Maseri, on behalf of the FAMI 
Study Investigators, Universita’ Vita-Salute San Raffaele, Milano, Italy
Management, monitoring and quality control of multicenter, international clinical studies 
and trials are complex and resource consuming. Electronic off- and on-line Case Report 
Forms (CRF) are sometimes used to shift the burden of data entry to the investigators. 
Still, study monitoring relies on human resources that have to travel and follow complex 
data verification procedures. To overcome these limitations, time constraints and related 
costs, we developed a real-time, internet framework (i-Trial) for data collection, control 
and verification of CRFs and for management, progress monitoring and quality control.
No single data management or office package is capable of fulfilling all the complex 
requirements for these tasks, thus we integrated a set of commercially available tools. The 
core is an industry standard SQL database (Oracle 9i) and its web-portal. This combination 
provides the internet CRFs, granting each individual investigator access to, and only to, his/
her cases while providing immediate feedback with first tier warnings for inconsistencies, 
incompleteness, and deadlines. The study monitor can access all data from all investigators 
to perform control procedures on data completeness and deadlines.
We then obtained a higher level of control by developing procedures, reports and charts 
that query the on-line database through a secure ODBC connection. The front-end includes 
a querying and reporting application (via DataEase 6.5), executive reports (via Crystal 
Reports) and summary tables and charts (via Graph Pad Prism4). Data security was 
implemented by server access control policies, SSL, data codification and encryption.
We applied i-Trial to the ongoing First Acute Myocardial Infarction (FAMI) Study, which 
has enrolled over 1000 cases and controls in Italy, China and Scotland to study the 
inflammatory, genetic and environmental pathogenetic components of acute myocardial 
infarction in three populations. We hence developed 32 relational tables, the corresponding 
data-entry forms/CRFs and over 40 control reports. As a result, this integrated managing 
system enabled study monitors and the steering committee to remotely manage 31 
centers and over 1000 study cases.
9:00 a.m.
1018-189 Use of an Automated Monitoring Tool in the Evaluation 
of Retroperitoneal Hemorrhage following the use of a 
Vascular Closure Device in PCI
Michael E. Matheny, Nipun Arora, Timothy C. Lee, Frederic S. Resnic, Brigham & 
Women’s Hospital, Boston, MA
Background: Increasing use of clinical outcomes databases has created new 
opportunities for automated safety surveillance of medical devices. We used an 
automated monitoring system to monitor the rate of retroperitoneal hemorrhage (RPH) 
after the use of a vascular closure device (VCD) following PCI.
Methods: A local prospective outcomes registry was used consisting of 3, 947 consecutive 
patients receiving a VCD after undergoing PCI through the transfemoral route from 
January 1, 2002 to December 31, 2004. There were 25 cases complicated by RPH, all of 
which were confirmed by CT Imaging. A real-time automated monitoring system (DELTA) 
was used to analyze this data using a logistic regression adjusted statistical process 
control method. Expected event rates and confidence intervals (CI) were established 
from the literature.
Results: The cumulative event rate ranged from 0.39% to 0.88%. The final cumulative 
event rate was 0.63%, and generated alerts for the last 6 months when the observed 
event rate exceeded the upper CI threshold of the expected event rate (0.50%). After 
adjustment for other clinical and demographic factors, high femoral arterial puncture was 
found to independently predict the risk of RPH, while the use of a VCD did not.
Conclusions: Automated safety surveillance of medical devices is feasible using routine 
clinical outcomes databases. This example illustrates the benefit of automated safety 
surveillance to support identification of low frequency safety signals in cardiovascular care. 
9:00 a.m.
1018-190 Ultrasound Lung Comet Is Useful And Specific Sign 
Of Lung Disease: Importance Of Doppler Study To 
Diagnose Lung Congestion
Masao Takeda, Hiroshi Ito, katsuomi Iwakura, Shigeo Kawano, Atsunori Okamura, 
Toshiya Kurotobi, Yasushi Koyama, Motoo Date, Koichi Inoue, Kenshi Fujii, Sakurabashi 
Watanabe Hospital, Osaka, Japan
Background: Ultrasound lung comet (ULC), that consists of multiple comet-tails fanning 
originating from the lung surface, is a simple echographic sign of lung edema. It, however, 
are also observed in cases of organic lung disease. In this study, we investigated whether 
we can diagnose the presence of lung disease with ULC and whether additional Doppler 
examination can differentiate heart failure from (HF) lung disease.
Method: Study population consisted of 60 patients admitted our hospital complaining of 
acute respiratory distress (ARD). 100 patients without HF or lung disease were served as 
controls. We performed ultrasound scanning from the third intercostals space on anterior 
axial line and counted number of ULC. We measured the ratio of peak-E velocity to early 
diastolic mitral annulus velocity, E/e’, and E/e’ > 15 was regarded as a sign of lung edema.
Results: ULC was detected in all ARD patients but was not observed in normal subjects. 
In 30 patients (50%), E/e’ was > 15 and right-heart catheterization confirmed the presence 
of HF. Number of ULC was correlated with NYHA class (II vs. III vs. IV: 2.0 vs. 2.5 vs. 
3.3, p<0.01). There was good correlation between number of ULC and E/e’ (r=0.64, 
p<0.0001). ULC disappeared in 20 patients (66.7%) after diuretics and the patients 
with permanent ULC had baseline lung disease. The presence of the organic lung 
disease was confirmed in all 30 patients with E/e’<15, including pneumonia, interstitial 
pneumonia, lung emphysema, old tuberculosis and pulmonary asbestosis. Among these 
patients, there was no correlation between number of ULC and E/e’(r=0.018,p=0.93). 
Conclusion: ULC is useful and specific sign to diagnose ARD. There are two etiologies 
of ULC; lung edema and organic lung disease. An increase in E/e’ > 15 is useful to 
diagnose the contribution of HF to acute respiratory distress.
9:00 a.m.
1018-191 Global Cardiovascular Disease Research Census
Poornima Prabhakaran, Vamadevan S Ajay, Arunkumar Gottumukkala, Shrihari 
JS, Uma Snehi, Bijoy Joseph, Dorairaj Prabhakaran, Srinath K Reddy, Initiative for 
Cardiovascular Health Research in the Developing Countries, New Delhi, India
Background: The exact quantification of cardiovascular disease (CVD) related research 
is not known from the developing countries. In this context we undertook a census 
on CVD related publications with an objective to estimate the quantum and profile of 
published literature on CVD in developed and developing countries.
Methods: We searched the PUBMED database using the search terms Cardiovascular 
(*), heart (*), Coronary (*), heart failure (*) rheumatic (*), disease (*), “Country name” for 
top 21 countries from each categories of high income (HIC), High middle income (HMIC), 
low middle income (LMIC) and low income countries (LIC). Purposive additions of large/
most populous countries (China, Russia, South Africa, Argentina, Egypt, Indonesia and 
Bangladesh) were also made. Search was limited to publications involving human studies 
for the periods 1994-95 and 2004-2005 published in all languages.
Results: Of all the publications from the 91 countries, CVD related publications accounted 
for 6.4%. United States had highest number of publications (6161). 82% of the CVD related 
publications were from top 21 HIC comprising 11% of the global population while top 21 LIC 
with 25% of the world’s population had just 3% of the publications. Top 21 LMIC, with 28% of 
global population, had 7% of the CVD related publications while 5% of the CVD publications 
came from top 21 HMIC which accounted for 4% of the world population. Studies on health 
system, cost effectiveness/costing and quality of care related to CVD care comprised 7% of 
the articles from HIC while LIC had no such publications.
Conclusions: This study points to the dearth of evidence based strategies for combating 
the CVD epidemic in developing countries. Hence research needs to be supported 
in these countries to provide knowledge and evidence for policies, to improve health 
systems and to evaluate cost effectiveness of CVD control strategies.
9:00 a.m.
1018-192 Preliminary Outcome of Web-based Telemedicine 
Clinical Trial for Disease Management: Comparison of 
4-versus 8-months follow-up visits
Abul Kashem, William P. Santamore, Robert C. Cross, Carol J. Homko, Linda Zamora, 
Philip T. Berger, Francis Menapace, Timothy McConnell, Alfred A. Bove, Temple 
University, Philadelphia, PA, Geisinger Health System, Danville, PA
Background: We hypothesize that a web-based telemedicine (T) monitoring system 
in underserved inner city and rural Pennsylvania subjects would help to reduce the 
cardiovascular risk factors.
Methods: A total of 465 patients were recruited for a clinical trial and randomized to 
a Telemedicine (T) and control arm (C-usual practice). We reviewed 295 patients who 
have been followed for 4-(v1) and 8-months visits (v2). Each patient received a digital 
sphygmomanometer and a pedometer. T-patients transmitted weekly blood pressure, 
weight, step data and cigarette smoking using the T system. All patients were followed 
by their primary care physicians who were provided 4 and 8 month summary data. We 
compared the v1 vs. v2 clinical outcome in this population (T vs. C).
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Results: T-147 patients, mean age-62±9, BMI-31±6, HbA1C 6.8±1.6, CRP 0.4±0.6; C-
148 patients, mean age-63±10, BMI-31±6; HbA1C 6.3±1.2, CRP-0.4±0.4. The graph 
shows baseline hemodynamics and demographics in T and C-patients. Framingham risk 
score during v1 and v2 was reduced for both T and C (T: v1-16.9%→v2-14.3%; p=0.001; 
C: v1-16.9%→v2-14.8%; p=0.001). Interval changes (v1→v2) showed significant 
improvement for systolic blood pressure (p=0.016), metabolic syndrome score (p=0.041), 
HbA1C (p=0.003), fasting blood sugar (p=0.037) only in the T-group.
Conclusions: These data suggest a web-based telemedicine monitoring system may 
work for disease management and help in reducing cardiovascular risk factors. 
9:00 a.m.
1018-193 Patient Refined Expectations Deciding Invasive Cardiac 
Treatment (PREDICT)
Carole J. Decker, Homaa Ahmad, Gabriel E. Soto, Mikhail Kosiborod, Kimberly J. Reid, 
Philip G. Jones, John A. Spertus, Mid America Heart Institute, Kansas City, MO
Background: The Institute of Medicine (IOM) challenged healthcare to be more evidence 
based, transparent and patient centered. Excellent risk adjusted models for percutaneous 
coronary intervention (PCI) have been developed, yet have not been used clinically to 
inform patients about potential risks and benefits. We developed a web-based program, 
PREDICT, to embed validated multivariable models into individualized informed consents 
(IC) for PCI.
Methods: PREDICT was integrated into the IC process at Mid America Heart Institute 
in Kansas City on 8/28/2006. Prior to implementation, 93 patients were interviewed to 
quantify their understanding and reaction to the standard IC. The first 30 patients who 
used PREDICT were assessed.
Results: The pre and post PREDICT cohorts had similar patient characteristics (age, 
gender, cardiac history and co-morbidities). There was a significant increase in the 
proportion of patients who read the IC (from 32% to 63%) with the introduction of PREDICT 
(p=0.003). Improvements in comprehension and physician-patient communication, as 
well as reduction in patient anxiety about the procedure were observed (Figure).
Conclusion: Individualized consent forms with patient-specific risks for PCI are 
associated with improved patient reading of the IC, increased comprehension, and 
reduced anxiety. Increased patient involvement moves practice towards shared decision-
making. This preliminary data suggests the PREDICT tool can be used to support IOM 
goals of improved healthcare.
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1024-146 Retroperitoneal Hematoma after PCI: Prevalence, Risk 
Factors, Predictors, Management and Outcomes. 
Results from The Blue Cross Blue Shield of Michigan 
Cardiovascular Consortium (BMC2) Registry.
Santi Trimarchi, Dean E. Smith, David Share, Michael O’Donnell, Richard McNamara, 
Arthur Riba, Eva Kline-Rogers, Mauro Moscucci, University of Michigan Medical Center, 
Ann Arbor, MI, Policlinico San Donato, San Donato, Italy
Background: To determine the prevalence, risk factors and outcome of retroperitoneal 
hematoma (RPH) after contemporary percutaneous coronary intervention (PCI).
Methods: The study sample included 68,735 patients undergoing contemporary PCI in a 
large, multicenter, validated, regional PCI registry between October 2001 and December 
2005. The primary endpoint evaluated was the development of retroperitoneal hematoma. 
Multivariate logistic regression modeling was used to identify independent predictors for 
the development of RPH.
Results: RPH occurred in 290/68,735 patients (0.4%). Of the patients who developed 
RPH, 94.8% were treated medically and 5.2% underwent surgical repair. Multivariate 
logistic regression analysis identified female gender (adjusted OR 3.60), body surface 
area <1.8 m2 ( adjusted OR 1.73), emergency procedure (adjusted OR 1.57), history of 
atrial fibrillation (adjusted OR 1.53), cardiogenic shock (adjusted OR 2.14), use of pre-
procedural IV heparin (adjusted OR 1.51), use of GP IIB/IIIA (adjusted OR 1.98), and use 
of vascular closure devices (adjusted OR 1.76) as independent predictors of RPH. Prior 
history of PCI appeared to be protective (adjusted OR 0.72) The development of RPH 
was associated with a higher frequency of post procedure MI (6.6% vs. 1.7%, p<0.0001), 
infection and/or sepsis (15.2% vs. 2.8%, p<0.0001), and congestive heart failure (9.7% 
vs. 2.0%, p<0.0001). In-hospital mortality was significantly higher in patients who 
developed RPH when compared with patients who did not (7.2% vs. 1.1%; p<0.0001). 
In addition, a non significant trend toward a higher in-hospital mortality was observed 
in patient with RPH treated surgically when compared with patients treated medically 
(13.3% vs. 6.9% P=0.34).
Conclusions: RPH is an uncommon complication of contemporary PCI, and it is 
associated with high morbidity and mortality. It remains to be determined whether the 
identification of risk factors for the development of RPH might lead to modification of 
procedure strategies aimed toward reducing its incidence.
1:30 p.m.
1024-147 Impact Of Guidelines Based Protocol On Timeliness Of 
Reperfusion For Patients Presenting During Regular-
hours And Off-hours
Henry H. Ting, David R. Holmes, Bernard J. Gersh, Luis H. Haro, Christine M. Bjerke, 
Choon-Chern Lim, Ryan J. Lennon, John F. Bresnahan, Allan S. Jaffe, Malcolm R. Bell, 
Charanjit S. Rihal, Mayo Clinic, Rochester, MN
Background: Previous studies have shown that off-hours presentation with ST-elevation 
myocardial infarction (STEMI) is associated with delayed door-to-balloon (DTB) and door-
to-needle (DTN) times. We evaluated a guidelines based protocol to improve timeliness 
of reperfusion during regular-hours and off-hours.
Methods: From 2004 to 2006, 417 consecutive patients were enrolled in a Fast Track 
protocol for STEMI. The catheterization lab committed to a response time of 20-30 
minutes after activation. Off-hours patient presentation was defined as Saturday, Sunday, 
or Monday - Friday from 5PM to 8AM. Patients presenting to the emergency department 
(ED) in Rochester, Minnesota were treated with primary PCI (ED PCI, n=203). Patients 
presenting to one of 25 regional hospitals (RH) located within 120 nautical miles from 
Rochester were treated with fibrinolysis (LYTIC) if symptom duration was < 3hours (RH 
LYTIC, n=125) and with primary PCI if symptom duration was > 3hours (RH PCI, n=103).
Results: A total of 149 (35.7%) patients presented during regular-hours versus 268 
(64.3%) patients during off-hours. DTB, DTN, and in-hospital outcomes for regular-hours 
versus off-hours presentation for each subgroup are shown in the Table. 
Regular-hours
n=149
Off-hours
n=268 P
ED PCI DTB, median (minutes) 63 68 0.32
ED PCI DTB <90 minutes 84% 80%
RH PCI DTB, median (minutes) 118 116 0.68
RH PCI DTB <90 minutes 9% 14%
RH LYTIC, DTN, median (minutes) 23 28 0.64
RH LYTIC DTN <30 minutes 69% 60%
Death 5 (3.4%) 11 (4.3%) 0.67
Death or myocardial infarction 9 (6.0%) 20 (7.5%) 0.58
Conclusions: A guidelines based Fast Track protocol achieved similar DTB, DTN, and 
in-hospital outcomes for patients presenting during regular-hours or off-hours. These 
findings were consistent for patients presenting to a hospital ED with on-site PCI or to 
RH without on-site PCI.
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1024-148 Ten Year Secular Trends And Characteristics 
Associated With Patient Delay From Symptom Onset 
To First Hospital Arrival In St-elevation Myocardial 
Infarction
Henry H. Ting, Elizabeth H. Bradley, Yongfei Wang, Brahmajee K. Nallamothu, Jeptha P. 
Curtis, Judith H. Lichtman, Veronique L. Roger, Bernard J. Gersh, Harlan M. Krumholz, 
Mayo Clinic, Rochester, MN, Yale University, New Haven, CT
Background: Despite improvements in door-to-balloon and door-to-needle time in ST-
elevation myocardial infarction (STEMI), patient delay (PD) from symptom onset to first 
hospital arrival remains prolonged.
Methods: We analyzed 10 year secular trends and characteristics associated with PD among 
482,327 patients with STEMI enrolled in the National Registry of Myocardial Infarction from 
1995 to 2004. PD was defined as time from symptom onset to first hospital arrival.
Results: Median PD was 104 min over the 10 year period, and decreased from 108 
minutes in 1995 to 98 minutes in 2004 (p<0.0001). In multivariable analysis, some key 
characteristics associated with PD and their median estimates + 95% confidence interval 
are shown in the Table. Subgroups with prolonged PD included: female and age >80 
(median 134 minutes); nonwhite race and age >80 (median 130 minutes); and Medicare 
only and age >80 (median 130 minutes). Among patients eligible for reperfusion, the longer 
the PD, the less likely for a patient to receive any reperfusion therapy. Reperfusion therapy 
was given in 46% for PD 11-12 hours compared to 76% for PD <1 hour (p<0.0001). 
Estimate of Patient Delay In Minutes
Description PD 95% Confidence Interval P
Age
Age<60 Reference
Age 60 to 69 9.68 8.63 10.73 <.0001
Age 70 to 79 20.49 19.07 21.91 <.0001
Age>=80 30.70 28.89 32.53 <.0001
Female
No Reference
Yes 13.04 12.18 13.90 <.0001
Non-white
No Reference
Yes 8.72 7.59 9.84 <.0001
Health insurance
Commercial (HMO/PPO) only Reference
Medicare only 7.55 6.40 8.71 <.0001
Medicare with any other insurance 2.23 0.87 3.61 0.0012
Medicaid or Self 6.85 5.58 8.14 <.0001
Diabetes
No Reference
Yes 21.01 19.98 22.04 <.0001
Time of presentation: off hour
No Reference
Yes -10.92 -11.69 -10.15 <.0001
Conclusions: PD has not decreased substantially over the past 10 year period from 1995 
to 2004. Increased PD is associated with a lower likelihood of receiving any reperfusion 
therapy. Interventions to improve PD should target high risk groups and characteristics 
associated with prolonged PD.
1:30 p.m.
1024-149 “Virtual Superiority”: A New Composite Score 
for Grading the Quality of Noninferiority 
Cardiovascular Clinical Trials
Sanjay Kaul, George A. Diamond, Cedars-Sinai Medical Center, Los Angeles, CA
Background and Objective: Analysis of noninferiority (NI) should ideally be founded on 3 
prerequisite judgments: 1) new treatment (N) exhibits NI to the standard treatment (S), 2) N 
exhibits efficacy in a placebo-controlled trial, and 3) N offers nonefficacy benefits in safety, 
convenience or cost. We hereby propose a new composite score by which each of these 
attributes is graded on a 0 (unestablished) to 1 (established) scale. A score of 3 out of 3 
supports a judgment of so-called “virtual superiority” to justify consideration of N over S.
Methods: Four recent NI trials were analyzed. A conservative estimate of NI margin (d) 
was derived as 50% of the 95% lower limit of a random-effects meta-analytic estimate 
of historical odds ratio (OR). NI was established if 95% upper limit of observed OR 
<margin. Efficacy was established if N was superior to “imputed placebo” (derived OR<1). 
Nonefficacy superiority was established if OR for safety (major bleeding) <1.
Results: Efficacy was established in all trials and nonefficacy superiority in 2 (REPLACE-
2, ACUITY bivalirudin alone). However, in none of the trials was a judgment of “virtual 
superiority” supported, primarily due to lack of establishment of therapeutic NI using 
conservative criterion.
Conclusion: Balancing risks and benefits should be integral to the interpretation of NI 
trials. The composite score for assessment of “virtual superiority” may provide a useful 
tool for avoiding introduction of suboptimal treatments into routine clinical practice.
Trial
Observed 
OR,
(New vs 
Standard)
Historical 
OR,
(Placebo vs 
Standard)
Margin 
(OR)
Non-
Inferiority
Conclusion
Derived 
OR,
(New vs
Placebo)
Efficacy
Conclusion
Nonefficacy
Superiority
Conclusion
Composite
Score
(95% CI) (95% CI) d (95% CI)
REPLACE-2
(Bivalirudin vs
Hep + GPI)
1.09 (0.92, 
1.32)
1.79 (1.42, 
2.27) 1.19 No (0)
0.61 
(0.45, 
0.83)
Yes (1)
Yes (1)
↓ major 
bleeding
(more 
convenient)
2
A-to-Z
(Enoxaparin + 
tirofiban vs
Hep + tirofiban)
0.88 (0.71, 
1.09)
1.47 (1.11, 
1.92) 1.06 No (0)
0.60 
(0.42, 
0.85)
Yes (1)
No (0)
No ↓ major 
bleeding
(more 
convenient)
1
SYNERGY
(Enoxaparin + 
GPI vs
Heparin + GPI)
0.96 (0.85, 
1.07)
1.10 (1.02, 
1.18) 1.01 No (0)
0.87 
(0.76, 
0.99)
Yes (1)
No (0)
↑ major 
bleeding
(more 
convenient)
1
ACUITY
(Bivalirudin vs 
Hep/Enoxaparin 
+ GPI)
1.06 (0.91, 
1.24)
1.79 (1.42, 
2.27) 1.19 No (0)
0.59 
(0.45, 
0.79)
Yes (1)
Yes (1)
↓ major 
bleeding
(more 
convenient)
2
ACUITY
(Bivalirudin + 
GPI vs Hep/
Enoxaparin 
+ GPI)
1.08 (0.92, 
1.26)
1.79 (1.42, 
2.27) 1.19 No (0)
0.60 
(0.45, 
0.80)
Yes (1)
No (0)
No ↓ major 
bleeding
1
1:30 p.m.
1024-181 Effects of Drug-Eluting Stents on Hospital Readmission 
Rates and Long-term Repeat Revascularization: 
Outcomes from a Large Clinical Registry
Kent G. Meredith, Anwar Tandar, Donald L. Lappé, Heidi T. May, Andrew D. Michaels, 
Jeffrey L. Anderson, Tami L. Bair, Joseph B. Muhlestein, LDS Hospital, Salt Lake City, 
UT, University of Utah, Salt Lake City, UT
Background: Drug-eluting stents (DES) have been shown to dramatically reduce the 
incidence of restenosis and clinically-driven target lesion revascularization (TLR). 
However, the impact of DES on long-term TLR, target-vessel revascularization (TVR), 
and hospital readmission are unknown.
Methods: Patients who received intracoronary stent placement from 1993-2005 were 
followed for up to 1000 days from index admission. Patients who received bare-metal 
stents (BMS) after the DES era (after 2003) were excluded in order to avoid potential bias 
due to BMS being used primarily in very small or very large arteries and in circumstances 
that contraindicate extended antiplatelet therapy. Cause of admission (elective/stable 
angina [SA], unstable angina [USA], or acute myocardial infarction [AMI]) was evaluated 
to determine if increased disease burden approached percutaneously since the advent of 
DES resulted in more frequent “elective” readmissions for staged procedures. Multivariate 
regression models controlled for standard cardiovascular risk factors and presentation.
Results: Patients (N=7466) were predominantly male (74.2%) and had a mean age 
of 63.5±11.9 years. DES were more likely to be used in patients with hypertension, 
dyslipidemia, diabetes, and a family history of premature coronary artery disease. 
Smoking was more prevalent in BMS patients. Compared to DES, patients with BMS 
had an increased risk of TVR (Hazard Ratio [HR] 1.42, p=0.02) and a trend toward more 
TLR (HR 1.21, p=0.08). However, the use of BMS was associated with a reduced risk for 
non-TVR (HR 0.44, p<0.001). Despite higher TVR and TLR, BMS patients had decreased 
hospital readmissions (HR 0.85, p<0.0001). Similar causes of readmission were seen in 
both DES and BMS groups for SA (53.1% vs. 49.7%), USA (48.8% vs. 48.5%), and AMI 
(41.8% vs. 38.1%) (p=NS for all comparisons).
CONCLUSION: Despite reduced TVR and TLR, the use of DES is associated with an 
increased adjusted risk of repeat hospitalization as well as increased non-target vessel 
revascularization. These results raise the possible concern that currently unrecognized 
effects of DES beyond TLR/TVR reduction might influence long-term outcomes.
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1024-182 Patients With Acute Anginal Symptoms Frequently 
Do Not Receive Initial Electrocardiography: Results 
From the Investigation of National Coronary Disease 
Identification (INCIDENT)
James Li, Nancy L. Reaven, Susan E. Funk, Vernon F. Schabert, Joseph E. Lovett, 
Anthony N. DeMaria, Strategic Health Resources, La Canada, CA
Background: Although it is generally assumed that patients presenting with anginal 
symptoms receive a resting electrocardiogram (ECG) at the initiation of cardiac 
evaluation, few data exist concerning this expectation. Using a very large database 
comprising 2% of the U.S. adult population, we assessed compliance with the ACC/AHA 
Guideline recommendations that a resting ECG be the initial diagnostic test for patients 
presenting with acute chest pain or an anginal equivalent.
Methods: Our study population of commercial and Medicare enrollees numbered 4,355,625 
patients. Entry criteria included age over 44 years; continuous enrollment from 2001 through 
2003 excepting death; a cardiac test for a diagnosis of coronary disease, heart failure, or a 
related cardiac symptom in 2001; and presentation with acute anginal symptoms. Exclusion 
criteria included any cardiac diagnostic test or intervention in the 6 months preceding the first 
cardiac test. We calculated the proportion of patients who received ECG as the initial diagnostic 
test. We further stratified these results by gender, age, comorbidities and care setting.
Results: 18,139 patients with acute angina met entry and exclusion criteria: 48% were male 
and 39% were over 64 years of age. A substantial proportion (35%, 95% confidence interval 
[CI] 34%-35%) did not undergo an initial resting ECG as recommended by ACC Guidelines. 
Patients treated in emergency departments received an initial ECG more frequently (91%, 
CI 90-92%) than patients tested in outpatient settings (61%, CI 60-62%; risk ratio [RR] 0.75, 
CI for RR 0.74-0.76) or during hospital admissions (34%, CI 32%-37%; RR 0.15, CI for RR 
0.14-0.17). Men (RR 0.90 vs. women, CI for RR 0.87-0.93) and patients over 64 years (RR 
0.89, CI for RR 0.86-0.92) had slightly lower rates of initial ECG testing.
Conclusions: In our sample of over 4 million subjects, compliance with expert guidelines 
was highest in emergency departments where most patients with angina or chest pain 
received a recommended ECG before other tests were done. However, compliance 
outside of emergency departments was poor. These data support efforts to invigorate or 
create systems that ensure proper use of diagnostic ECG.
1:30 p.m.
1024-183 In-Hospital Mortality May Not Be A Valid Predictor of Overall 
Quality of Care In Patients With Myocardial Infarction
Michael C. Kontos, Robert L. Jesse, Laura Kreisa, Charlotte S. Roberts, George W. 
Vetrovec, Virginia Commonwealth University, Richmond, VA
Background: Results from clinical trials showing improved outcomes in patients (pts) with 
myocardial infarction (MI) have led quality improvement programs to focus on compliance 
with these processes of care. In addition to process metrics, in-hospital mortality is often 
used as a surrogate for quality of care, although the number of deaths in any one hospital 
may be low, making this measurement unreliable when assessed over short time periods. 
We studied the impact on overall MI mortality rates of very high risk pts (e.g., cardiogenic 
shock, cardiac arrest), in whom survival rates are frequently low.
Methods: Data on all pts receiving a primary discharge diagnosis of MI who were 
admitted emergently was collected as part of a quality assurance program (JCAHO/
CMS). Charts were reviewed for standard quality of care indicators. Charts of pts who 
died were reviewed for co-morbidities and other clinical variables associated with a 
high risk of death.
Results: Over a 3 year period, 713 MI pts were admitted, of whom 51 died (7.0%) in-
hospital. Mean age was age 68±14 (median 71, 54% male), with 20% ≥80 years old. 
During this time frame, aspirin (98%), beta blocker (99%) and ACEI use (94%) were 
high. When analyzed in quarter increments, mortality varied from 2.9% to 12.3%, with 
no consistent trends suggesting an increase or decrease over time. Of the MI pts who 
died, 39% presented with cardiac arrest, 4% in cardiogenic shock, 8% with stroke, and 
12% with end-stage cancer or heart failure, and sepsis. Only 18 (41%) had none of these 
conditions. Excluding pts with cardiogenic shock and cardiac arrest reduced mortality to 
4.1%. Excluding all very high risk pts reduced MI mortality to 3.0%, with no one quarter 
mortality exceeding 4.7% (4 deaths).
Conclusions: Variability for in-hospital MI mortality is driven by the very high risk pts, 
particularly those with cardiac arrest, in whom expected mortality is high, and by pts with 
co-morbidities that often preclude the use of effective interventions. Hospitals with small 
MI volume, and/or high risk pt populations are at jeopardy for adverse mortality outcomes 
despite above average guideline adherence. Appropriate risk adjustments are necessary 
to assess quality of care.
1:30 p.m.
1024-184 Does a Single-Pill Antihypertensive/Lipid-
Lowering Regimen Improve Adherence in U.S. 
Managed Care Enrollees?
Mohammed A. Hussein, Richard H. Chapman, Joshua S. Benner, Simon SK Tang, 
Henry A. Solomon, Amie Joyce, Joanne Foody, ValueMedics Research, Falls Church, 
VA, Yale University, New Haven, CT
Objective: We compared adherence with single-pill combination amlodipine/
atorvastatin (amlo/atorva) vs. 2-pill regimens of a calcium channel blocker (CCB) + 
statin in a managed care population.
Methods: A retrospective cohort study was conducted among enrollees in 29 US health 
plans who filled a CCB and statin within any 30 day window between 3/2004 and 4/2005. 
The proportion of days covered (PDC) by both a CCB and statin was calculated at 6 
and 12 months post index date. Patients were “adherent” if PDC was >80%. Because 
past medication experience is a strong predictor of future adherence, patients were 
stratified into 4 groups based on CCB and statin use in the 6 months before index date. 
Multivariable logistic regression with propensity score weighting was used to adjust for 
demographic, clinical and health service variables that could be associated with treatment 
selection and adherence.
Results: At 6 months, single-pill amlo/atorva achieved greater adherence vs. 2-pill amlo + 
atorva in patients already taking a CCB or a statin (but not both) before the index date (Table). 
Compared with other 2-pill CCB + statin combinations, single-pill amlo/atorva achieved 
greater adherence irrespective of prior drug use. Results were consistent at 1 year.
Conclusions: In patients for whom concomitant CCB and statin therapy are 
indicated, a single-pill combination of amlo/atorva may improve patient adherence. 
Given the substantial healthcare/economic burden of nonadherence, a single-pill 
approach is attractive.
Table. Relative odds of being adherent at 6 months (adjusted odds ratio 
and 95% confidence interval)
Amlo/atorva vs. other CCB 
+ statin
Amlo/atorva vs. amlo 
+ atorva
Subgroups (prior CCB/statin)
Naïve/naïve (n = 3593) 1.29 (1.09, 1.52) 1.00 (0.82, 1.22)
Naïve/experienced (n = 4478) 2.81 (2.28, 3.46) 1.72 (1.34, 2.21)
Experienced/naïve (n = 2162) 2.75 (2.26, 3.34) 2.20 (1.63, 2.96)
Experienced/experienced (n 
= 25,197) 1.19 (1.06, 1.35) 1.08 (0.95, 1.23)
amlo, amlodipine; atorva, atorvastatin; CCB, calcium channel blocker
1:30 p.m.
1024-185 Gender Differences in One-Year Outcomes Following Acute 
Myocardial Infarction: Results from the PREMIER Study
Judith H. Lichtman, Kimberly J. Reid, Carole Decker, Linda Garavalia, Viola Vaccarino, 
Susmita Parashar, Norrina B. Allen, John A. Spertus, Harlan M. Krumholz, Yale School 
of Medicine, New Haven, CT, Mid America Heart Institute, Kansas City, MO
Background: Mortality following AMI has been shown to vary with age for women and 
men, but relatively little is known about non-mortality outcomes. We examined gender 
differences in rehospitalization, angina symptom burden, and mortality following AMI.
Methods: A total of 2,246 AMI patients (813 women) were prospectively enrolled 
from 17 US centers from 1/2003-6/2004. Gender differences in one-year outcomes 
were compared using multivariable proportional hazards regression models (mortality, 
rehospitalization) and multivariable modified Poisson regression (angina burden: yes/
no). Models were adjusted for site, demographic, socioeconomic, clinical, psychological, 
disease severity, and process of care factors.
Results: Unadjusted 1-year mortality (9.6% vs 6.3%, p=0.003), angina burden (22.4% vs 
18.6%; p<0.05), and rehospitalization (43.4% vs 37.8%, p=0.01) were higher for women, 
especially younger women. In risk-adjusted analyses (figure), mortality risk was similar 
for men and women (HR 1.10, 95% CI, 0.79, 1.50), but women trended towards a greater 
risk of angina (OR 1.26, 95% CI, 0.96, 1.65). Younger women (<60 years; HR 1.30, 95% 
CI, 1.10, 1.60), but not older women (60+ years; HR 0.97, 95% CI, 0.78-1.20) had an 
increased risk of rehospitalization as compared with men (age*sex interaction p<0.05).
Conclusion: Mortality at one-year following AMI did not differ for men and women, but 
the burden of angina symptoms and rehospitalization are higher for women, especially 
younger women. 
JACC  March 6, 2007    ABSTRACTS - Special Topics    289A 
S
pecial Topics
1:30 p.m.
1024-186 Dual Antiplatelet Agent Failure: A New Syndrome or a 
Clinical Non-Entity?
Geoffrey D. Barnes, Jin Li, Eva Kline-Rogers, Rebecca Juliar, David F. Armstrong, Kim 
A. Eagle, Hitinder S. Gurm, University of Michigan Medical Center, Ann Arbor, MI
Background: Aspirin resistance is a well-documented laboratory finding but the effects 
of clinical aspirin (ASA) failure on patients with acute coronary syndrome (ACS) have 
been debated. Likewise, there is some recognition of clopidogrel resistance, but the 
effects of clopidogrel failure are not well understood. We sought to determine the 6-month 
outcomes of patients who developed an ACS while on ASA or dual antiplatelet agents.
Methods: Of all patients admitted to the University of Michigan between 1999 and 2005 
with a diagnosis of ACS, 6-month follow up data was available for 3386.Those were 
divided into three groups based on medication history: no prior antiplatelet agent, ASA 
only and ASA + clopidogrel (or ticlopidine). Primary endpoint was the rate of death, MI 
and stroke or composite major adverse cardiac events (MACE) at 6-months.
Results: While overall rates of MACE were not statistically different between the three 
groups, there were an excess hazard of recurrent MI in patients with prior dual agent 
use. There was however no difference in 6-month MI rates between the ASA and 
ASA+Clopidogrel groups (p=0.53). While dual antiplatelet status was not an independent 
predictor of 6 month mortality or MACE on multivariable logistic regression, prior ASA use 
appeared to be marginally protective ( OR 0.70, 95% CI 0.50-0.98, P = 0.03) 
Total Patients
3065
No Antiplatelet 
Medication
1397
ASA 
Only
1413
ASA+Clop/
Ticl
255
P-value (chi-
squared test)
6-month f/u Death 1017.2%
100
7.1%
15
5.9% 0.74
6-month f/u MI 453.2%
75
5.3%
16
6.3% 0.009
6-month f/u Stroke 100.7%
15
1.1%
3
1.2% 0.57
6-month f/u MACE 
(Death, MI and Stroke)
153
11.0%
177
12.5%
32
12.6% 0.40
Conclusion: Patients who “fail” antiplatelet therapy do not have overall worse prognosis. 
Our data do not support ASA or dual antiplatelet agent failure as a distinct clinical entity.
1:30 p.m.
1024-187 Impact of Hospital Performance on Underuse of 
Therapies Among Patients With Chronic Kidney 
Disease and Non-ST-Segment Elevation Acute 
Coronary Syndromes
Uptal D. Patel, Fang-Shu Ou, Matthew T. Roe, E. Magnus Ohman, W. Brian Gibler, Eric 
D. Peterson, Duke Clinical Research Institute, Durham, NC
Background: Chronic kidney disease (CKD) is associated with cardiac events and 
death, yet underuse of guideline-recommended therapies is widespread. The extent to 
which hospital performance affects the care of patients with CKD and non-ST-segment 
elevation acute coronary syndromes (NSTE ACS) is unknown.
Methods: We evaluated 81,374 patients with NSTE ACS (positive cardiac markers or 
ischemic ST-segment changes) treated at 327 US hospitals participating in the CRUSADE 
Initiative. We compared treatment and outcomes of patients by continuous estimates 
of glomerular filtration rate (GFR) and quartiles of hospital performance, as measured 
by overall composite adherence to class I guidelines (acute: aspirin, beta-blockers, 
clopidogrel, heparin, glycoprotein IIb/IIIa inhibitors; discharge: aspirin, clopidogrel, 
angiotensin-enzyme inhibitors, lipid-lowering agents) in patients without contraindications. 
Models were adjusted for demographics, clinical factors, and hospital features.
Results: Prescribing rates of recommended therapies were higher among better 
performing hospitals (all p <.001), but decreased with declining GFR (all p .05). However, 
for most discharge therapies, better performing hospitals were more likely to have similar 
prescribing rates across the GFR spectrum (interaction, p <.05).
Conclusions: Patients with declining kidney function admitted with NSTE ACS are less 
likely to receive evidence-based therapies and interventions. Although higher performing 
hospitals have better rates of prescribing at all levels of kidney function, the paradoxical 
underuse among patients at highest-risk persists for most acute therapies but is mitigated 
for most discharge therapies. Thus, efforts to promote adherence to NSTE ACS guidelines 
may result in more favorable prescribing rates of recommended therapies among patients 
with CKD who are at particularly high-risk for adverse outcomes. Nonetheless, the 
reasons for persistently low prescribing rates of acute therapies at lower levels of renal 
function need to be explored.
1:30 p.m.
1024-188 Big Balloons Achieve Better Dilatation Results Below 
Burst Pressure Than Small High-Pressure Balloons 
- A Biomechanical Analysis
Johannes Nordmeyer, Claudio Capelli, Silvia Schievano, Philipp Lurz, Lorenza Petrini, 
Simone Lattanzio, Francesco Migliavacca, Philipp Bonhoeffer, UCL Institute of Child 
Health and Great Ormond Street Hospital for Children, London, United Kingdom, 
Structural Engineering Department, Politecnico di Milano, Milan, Italy
Background: Stenotic lesions resistant to balloon dilatation are clinically relevant in 
interventional cardiology. Strategies have been developed to overcome this problem, 
which differ balloon pressure and size. We questioned the belief, that balloon pressure 
would have a greater impact on expansion forces than balloon size.
Methods: In a biomechanical model, finite element analyses were performed to simulate 
the angioplasty procedure. We established a three-dimensional model of a vessel 
with a lumen diameter of 18 mm, obstructed by a 7mm-thick cylindrical stenosis. Two 
identical non-compliant balloons were designed, which only differed in nominal maximum 
diameters (10 and 16 mm). The balloons were inflated at different pressures to evaluate 
the stress distribution (Von Mises Stresses) and diameter change at the stenotic site.
Results: In order to dilate the stenosis to 10 mm lumen diameter, the bigger balloon 
needed less pressure (4.8 atm) than the smaller balloon (6 atm). At the same stress 
distribution on the balloons (polymeric material failure stress = risk of balloon rupture), 
inflation of the bigger balloon resulted in a greater lumen diameter compared to the 
smaller balloon (8.95 mm versus 7.84 mm, Figure).
Conclusions: Contrary to common belief, pressure is not linearly related to expansion 
forces. With identical balloon material, the bigger balloon achieves better dilatation below 
burst pressure. 
1:30 p.m.
1024-189 The Use of Simulation-based Training to Enhance Patient 
Safety for Cardiac Catheterization: A Randomized 
Controlled Multi-Center Study
Andrew J. Klein, John C. Messenger, John Combes, John S. Rumsfeld, Mary 
Pittman, Samantha MaWhinney, Kathy Kioussopoulous, John D. Carroll, University 
of Colorado Health Sciences, Denver, CO, Health Research and Educational 
Trust, Chicago, IL
Background: Recognition of adverse events during cardiac catheterization is critical 
to reduce morbidity and mortality. Trainees develop these skills through an apprentice 
model with minimal formal didactic training. Simulation-based training is a novel tool, 
but randomized controlled trials (RCT) in cardiovascular care are lacking.
Methods: We conducted a multi-center RCT, involving 28 cardiology fellows, 
comparing standard of care (n=15) to simulation-based patient safety curriculum 
(n=13). The control group was provided clinical guidelines for cardiac catheterization. 
The study group completed six patient safety training modules with the simulated 
cases. All subjects completed a pre- and post-test multiple choice questionnaire 
(MCQ) in addition to the simulated cases. Each case had a simulated adverse event 
(SAE). Each group’s time to recognition of a SAE and performance on the MCQs 
were compared using Wilcoxon rank sum tests.
Results: Pre-test performance was equivalent. (68% correct in both). Compared to 
controls, simulation-trained subjects performed better on the post-exam (66% vs. 52%, 
p<.0001) and in their recognition of a SAE (448 seconds vs. 801 seconds, p=.02) (Fig.1). 
Of interest, 22% of SAE’s were not recognized by cardiovascular trainees.
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Conclusions: This study demonstrates that simulation-based cardiac catheterization 
training is feasible and leads to a greater knowledge base and improved recognition and 
management of commonly encountered adverse events in the cath lab. 
1:30 p.m.
1024-190 Optimizing Use of Telemetry Resources in an 
Academic Medical Center
Elden R. Rand, Paul B. Lamb, Bernie J. Rubal, Joseph C. Lee, Brooke Army Medical 
Center, Fort Sam Houston, TX
Background: The optimal management of telemetry assets is poorly defined in the 
literature. In our academic medical center, telemetry related closures were increasing, 
leading to loss of educational opportunities and lost revenue. Hence this project was 
undertaken to improve telemetry utilization in our facility.
Methods: A multidisciplinary telemetry policy was drafted which delineated proper use of 
telemetry beds. Prior to implementation, baseline telemetry use was prospectively assessed 
in 162 consecutive telemetry admissions using prespecified endpoints. Telemetry use post-
implementation was then assessed in 1025 consecutive admissions. All codes and deaths 
were independently reviewed, and admission and closure data were analyzed.
Results: Numerous improvements were seen with implementation of the new policy. 
Appropriate telemetry admissions increased from 76.5% to 91.8% (p<0.001); appropriate 
duration of use increased from 66.7% to 81.4% (p<0.001); telemetry ordering compliance 
increased from 78.4% to 89.9% (p<0.001); management changes directly related to 
telemetry use remained unchanged at 10.5% to 10.7% (p=NS). A predictive logistic model 
showed a 17% increase in daily hospital closure threshold (figure).
Conclusions: Implementation of a universal telemetry policy and a multidisciplinary team 
approach increased the hospital admission capacity for telemetry patients without an 
increase in personnel, unit beds, cost, or compromise of patient care and safety. 
1:30 p.m.
1024-191 Prediction of Long-Term Survival in Revascularized 
Coronary Artery Disease Patients
Shun Kohsaka, Masashi Goto, Vei Vei Lee, Tharak Reddy, MacArthur A. Elayda, Noriaki 
Aoki, James M. Wilson, Texas Heart Institute, Baylor College of Medicine, Houston, TX
Background: Little is known about whether findings of detailed angiographic data can 
be combined with other clinical risk factors to offer precise guidance about long-term 
outcome in patients with coronary artery disease (CAD).
Methods: We identified 2661 patients with CAD who underwent an initial revascularization 
procedure by either stenting or CABG between January 1995 and December 1999 to 
develop a risk stratification model. We used decision tree induction to develop a practical and 
user-friendly method of risk stratification for 5-year survival among patients who underwent 
coronary revascularization procedures.Initially, 1495 patients were analyzed to develop a 
decision tree and the validity of the tree was tested using data from 1166 patients.
Results: The overall mortality rate was 6.6% at a median of 5.2 years in this dataset. 
Recursive partitioning of the derivation cohort indicated that the best single predictor of 
long-term mortality was history of congestive heart failure (CHF), followed by proximal left 
circumflex artery (LCx) lesion or patient’s age older than 65 (Figure). This model identified 
patient groups with mortality ranging from 4.9% to 34.6%. Cox-regression modeling also 
showed that the presence of proximal LCx lesion was the best predictor of long-term 
mortality in patients with a history of CHF (OR 1.76 95%CI 1.06-5.31; p=0.003).
Conclusions: This decision tree model provides an accurate estimate of 5-year survival 
with simple clinical demographics and angiographic data. 
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817-3 High-Dose Atorvastatin - Better Value for Money: The 
Treating to New Targets Trial US Economic Substudy in 
5,308 Stable Coronary Heart Disease Patients
Daniel B. Mark, J. David Knight, Patricia A. Cowper, Linda Davidson-Ray, Kevin J. 
Anstrom, Duke Clinical Research Institute, Durham, NC
Background: In the Treating to New Targets (TNT) trial, 80 mg/day atorvastatin produced 
a 22% relative risk reduction in the composite primary endpoint of coronary heart disease 
(CHD) death, nonfatal myocardial infarction, resuscitation from cardiac arrest, or stroke 
compared to 10 mg/day atorvastatin in stable CHD patients (p<0.001). In 1998, we 
initiated a prospective economic study of all US patients enrolled in TNT.
Methods: We collected hospital bills for 4,211 cardiovascular hospitalizations recorded 
over a median of 4.9 years follow-up. Department-level cost-to-charge ratios were used to 
convert charges to costs. Physician fees were assigned using the Medicare Fee schedule 
for all evident physician services. Atorvastatin costs were assigned based on observed 
days on therapy using a discounted Average Wholesale Price. Costs were discounted at 
3% per year and expressed as 2004 $US.
Results: Among the US patients, baseline characteristics were well balanced by treatment 
group. Major clinical outcomes in the US cohort were consistent with the overall clinical 
results of TNT. During follow-up, cardiovascular hospitalization was reduced (35% versus 
41%, p<0.001) and revascularization was less frequent (16% versus 22%, p<0.001) in the 
high dose arm. Rates of noncardiovascular hospitalization were balanced in the two arms.
At the end of 5 years, hospital plus physician cost was $8,960, atorvastatin cost was 
$3,167, and total cost was $12,127 in the low dose arm (N=2,656). Hospital plus 
physician cost was $7,598, atorvastatin cost was $4,710, and total cost was $12,308 in 
the high dose arm (N=2,652).
The net 5 year cost of the high dose arm was $181. In 1,000 bootstrap samples, the high 
dose arm had a lower net cost in 39% of samples, while an additional 33% of samples 
had a cost difference <$500. Hospital costs alone were lower in the high dose arm in 99% 
of bootstrap samples.
Conclusions: In the 5,308 US patients randomized into the TNT study, high dose 
atorvastatin provided significantly better clinical outcomes with almost no additional cost 
over 5 years by reducing the need for cardiovascular procedures and hospitalizations 
when compared to low dose atorvastatin.
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817-4 The Cost Effectiveness of Functional Cardiac Testing 
in the Diagnosis and Management of Coronary Artery 
Disease: Principal Results from the CECaT Trial
Andrew M. Crean, Linda Sharples, Vikki Hughes, Matthew Dyer, Martin Buxton, Martin 
Buxton, Kim Goldsmith, David Stone, Papworth Hospital, Cambridge, United Kingdom
Background: A prospective randomised controlled trial in patients with stable chest pain 
to assess the:
• feasibility of functional cardiac tests as a gateway to angiography for diagnosis of IHD
• ability of diagnostic strategies including functional tests to identify patients who gain 
most from revascularisation.
• most cost-effective diagnostic strategy for patients with suspected coronary artery disease.
Methods: 898 patients investigated for stable chest pain were randomised to one of 
four initial tests : angiography (controls); SPECT MIBI; stress cardiac MRI; stress 
echocardiography.
Principal outcome measures were:
(a) Primary: exercise treadmill time at 18 months after randomisation; cost-effectiveness 
18 months after randomisation compared with angiography.
(b) Secondary: exercise treadmill time at 6 months after treatment;Canadian Cardiovascular 
Society classification of angina; health-related quality of life; revascularisation rate; 
serious adverse events; clinician confidence in test results.
Results: 22% of MIBI patients, 20% MRI patients and 25% of stress echo patients were 
not subsequently referred for an angiogram. At 18 months, comparing SPECT MIBI 
and stress echo with angiography there was no clinically significant difference in total 
exercise time The cardiac MRI group had significantly shorter mean total exercise time 
of 35 seconds .There was no significant difference among the groups in CCS class at 
either 6 or 18 month assessment. There was no significant difference in the number 
of patients reporting non-fatal events (1.59 (95%CI: 0.90, 2.79), p=0.327) between the 
groups. The mean (95% confidence interval) total additional costs over 18 months, 
compared with angiography, were £297 (-£200, £802) for SPECT MIBI, £362 (-£58, £921) 
for cardiac MRI and £899 (£294, £1,679) for stress echocardiography. Clinically important 
differences in health-related quality of life between functional test groups and controls 
could be ruled out.
Conclusions: Between 20% and 25% of patients can avoid invasive testing by the use 
of functional cardiac testing as a gateway to angiography, without substantial effects 
on outcomes.
2:30 p.m.
817-5 A School-based Health Education Program Identifies 
Children at Risk for Cardiovascular Disease and 
Diabetes: Baseline Data From The Project Healthy 
Schools 2005-06 Pilot Program
Lin Kimberly, Karen Goldberg, Timothy Cotts, Susan Aaronson, Gurm Roopa, Bruce Rogers, 
Eva Kline-Rogers, Kim A. Eagle, University of Michigan Medical Center, Ann Arbor, MI
Background: Overweight and obese status in children is becoming increasingly 
prevalent across the nation. Risk factors for atherosclerosis and glucose intolerance are 
now identified at a younger age. Project Healthy Schools (PHS) was launched in 2004-
05 as a school-based multidisciplinary education program designed to promote healthy 
habits in middle school children. This community-university collaboration includes three 
middle schools in the college town of Ann Arbor, Michigan during the 2005-06 academic 
year. The aim of this study was to determine the incidence of atherosclerotic risk factors 
in sixth grade students.
Methods: Voluntary baseline screening of each sixth grade student included measurement 
of height, weight, body mass index (BMI), blood pressure, and a questionnaire about 
current health habits and knowledge. In addition, baseline laboratory tests including total 
cholesterol, LDL, HDL, triglyceride, and random glucose were obtained. Patients were 
considered “at-risk” if they had measurements greater than the 90th percentile for age, 
height, and weight in each category.
Results: Of 711 sixth grade students in three middle schools, 285 consented to study 
participation, of whom 223 consented to laboratory testing as well. Amongst study 
participants, mean age was 11.51 years old, and 133 (47.2%) were male. Risk factor 
analysis revealed the following information:
39 of 149 (26.2%) females and 51 of 131 (38.9%) males were overweight or obese by 
body mass index (BMI)
17 of 282 (6%) students had a systolic blood pressure (SBP) >/= 124
100 of 222 (45%) students had a total cholesterol >/=170
9 of 203 (4.4%) students had a low density lipoprotein level (LDL) > 130
38 of 223 (17%) students had a high density lipoprotein level (HDL) < 45
10 of 221 (4.5%) students had a random glucose > 126.
In total, 175 of 285 (61.4%) students were “at-risk” in at least one of the six major risk 
factor categories (BMI, SBP, total cholesterol, LDL, HDL, random glucose).
Conclusions: This study identifies a high proportion of sixth grade students in a mid-
sized college town who are at risk for future atherosclerotic disease. The potential for 
environmental and behavioral change among middle school children is high.
2:45 p.m.
817-6 Trends In Profile And Mortality Of Patients With Acute 
Myocardial Infarction From 1987 To 2002: A New Jersey 
Statewide Study.
Abel E. Moreyra, William J. Kostis, Stephen W. Marcella, Yu-Hsuan Shao, Alan 
C. Wilson, Kitaw Demissie, UMDNJ-Robert Wood Johnson Medical School, New 
Brunswick, NJ, UMDNJ-School of Public Health, Piscataway, NJ
Background:Over the last two decades, important changes in the management of acute 
myocardial infarction have occurred, however the impact on the association between 
changing patients’ profile and mortality is not well known.
Methods:We studied all non-federal admissions for first acute myocardial infarction in 
New Jersey (N=231,164) over the 16-year period 1987-2002 and examined changes 
in demographics, comorbidities, complications, length of stay, use of invasive cardiac 
procedures, and outcomes by four-year subgroups.
Results:In the years under study, there was an increase in patient age (67.1 years 
in 1987-1990, 67.4 in 1991-1994, 68.3 in 1995-1998, and 69.4 in 1999-2002). The 
percentage of women with MI also increased (39.2, 39.6, 40.5, and 42.0%, respectively, 
p<0.0001). The percentages of patients with comorbidities increased: diabetes (23.7, 
25.1, 26.4, 27.7%, p<0.0001), hypertension (36.5, 41.3, 47.7, 53.7%, p<0.0001), renal 
disease (p<0.0001), and cerebrovascular disease (p=0.0002). However, there was a 
decrease in the occurrence of mechanical (37.5, 34.3, 31.8, 31.6%) and electrical (44.0, 
40.2, 36.9, 33.3%) complications (p<0.0001 for both). Length of hospital stay decreased 
from 11.7 to 10.5, 8.0, and 7.3 days (p<0.0001). The probability of having invasive cardiac 
procedures within 30 days of admission increased from 31.2 to 56.0% for CATH, 7.8 to 
31.8% for PCI, and 6.2 to 13.6% for CABG (p<0.0001 for all). Time from admission to 
procedures decreased from 6.1 to 2.2 days for CATH, 6.1 to 1.3 days for PCI, and 8.7 to 
3.9 days for CABG (p<0.0001 for all). Thirty-day mortality decreased from 15.3 to 12.3%, 
in-hospital mortality from 14.7 to 9.4%, same day mortality from 2.3 to 1.2%, and next day 
cumulative mortality from 4.7 to 2.9% (p<0.0001 for all).
Conclusions:Between 1987 and 2002, there was a steady increase in early 
revascularization procedures following hospital admission for first myocardial infarction 
and despite an increase in age and comorbidities, there was a significant decrease in 
both in-hospital and 30-day mortality.
3:00 p.m.
817-7 What is the Best Measure for Rewarding Quality of 
Care: Defect-Free vs. Composite Scoring? An Analysis 
From the American Heart Association’s Get With The 
Guidelines-Coronary Artery Disease (GWTG-CAD) 
Program?
Adrian F. Hernandez, Gregg C. Fonarow, Dadi Dai, Sean M. O’Brien, Kenneth A. 
LaBresh, Lee H. Schwamm, Christopher P. Cannon, GWTG Steering Committee and 
Hospitals., Duke Clinical Research Institute, Durham, NC
Background: Pay-for-Performance (P4P) rate centers based on combining multiple 
indicators into a score. Two methods are: i) the CMS opportunity-based composite 
method; and ii) the all-or-none (defect-free) method. It is unknown what method should 
be used for P4P programs.
Methods: Data were collected from GWTG-CAD hospitals for 5 performance measures 
at discharge: ASA use, BB use, ACEI/ARB use, smoking cessation counseling and 
lipid lowering medication. The CMS composite score is defined as the total number of 
instances across measures in which the hospital performed a required care process 
divided by the total number of instances in which care processes were required. Defect-
free care was calculated as the percent of patients who received all 5 care processes. 
Hospitals were then ranked by each method and compared.
Results: There were 270,655 patients with CAD from 457 hospitals during 2000-2006. 
The mean CMS Composite Score was 79.3% with lowest 29.0% and highest 96.7%. The 
mean Defect Free Score was 55.0% with lowest 4.5% and highest 92.1%. The Defect-
Free Score and CMS Composite Scores are highly correlated (r=0.88), but 41.8% of 
hospitals changed ranks by at least 1 decile and 11.4% by more that 2 deciles.
Conclusions: Methods for ranking hospitals in P4P may differ materially and financially. 
Further research is needed to determine the most appropriate method to reward high 
quality centers.
Figure: Distribution of rank differences between Defect Free Score (DF) and Composite 
Score (Comp) methodology. 
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3:15 p.m.
817-8 Determinants of the Impact of Guideline Based Review 
on Utilization of Myocardial Stress Perfusion Imaging: 
Roles of Self-Referral, Physician Specialty, Patient Age 
and Type of Insurance.
Nathaniel Reichek, David Grossman, Russell Amico, Gary Gerstenblith, Jeffrey A. Brinker, 
Stephen Winters, Hugh Calkins, Jing Han, Joseph Levine, St. Francis Hospital, Roslyn, NY, 
Stony Brook University, Stony Brook, NY
Background: Rapid growth in outpatient radionuclide stress testing (MPI) volume has raised 
concerns regarding radiation exposure, cost and the potential role of self-referral in increasing 
utilization. We recently showed that guideline-driven precertification for MPI results in lower 
approval rates (-24.8%) and a drop in requests. To identify correlates of approval rates, 
we examined their relationship to physician specialty, self-referral, patient age, gender and 
insurance type.
Methods: A precertification algorithm (Care Core Cardiology Management), based on 
ACC/AHA/ASNC practice guidelines and appropriateness criteria was used from 2/03/06-
4/30/06 in a population of 829,360 covered lives with commercial (95.1%, ages 20-90 yrs)) or 
Medicare insurance(ages30-90 years) to evaluate 9,311 requests for MPI(16% Medicare).
Results: Most tests were requested by cardiologists (74%) who had higher approval rates 
(81.6%) than other physicians (70.7%, p<0.0001). Most cardiologist-requested tests were 
self-referred(59.5%). Self-referred tests were approved more often (81.4%) than other-
referred tests (76.4%, p<0.001) but approval rates did not differ after adjustment for physician 
specialty. Approval rates were associated with patient age (odds ratio 1.7 per decade, 95% 
limits 1.62-1.79) and physician specialty, cardiologist vs. non-cardiologist (odds ratio 1.62, 
limits 1.45-1.80) and were higher for Medicare (90%) than for commercial insurance (76.5%, 
p<0.001) patients. After age adjustment, insurance type had no effect on approval rates. Self-
referral rates did not differ for Medicare versus commercial insurance,
Conclusions: Using guideline-based algorithms for MPI, approval rates were higher for older 
patients and for tests requested by cardiologists. No independent effect of self-referral on 
guideline-driven approval rate adjusted for medical specialty was found. These results do not 
demonstrate adverse effects of self-referral and suggest that cardiologists have integrated 
guidelines and appropriateness criteria for MPI into practice more completely than have other 
physicians who order such testing.
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826-3 Abciximab or Eptifibatide: Differences in outcomes of 
Patients Treated with Abciximab versus Eptifibatide as 
Adjunct Therapy for Primary Percutaneous Coronary 
Interventions for ST Elevation Myocardial Infarction.
Gurm Hitinder, David Share, Dean E. Smith, Thomas LaLonde, Michael O’Donnell, 
Arthur Riba, Hameem Changezi, Marcel Zughaib, Harish Chandra, Robert Safian, 
Mauro Moscucci, University of Michigan Medical Center, Ann Arbor, MI
Background: Pooled data from randomized controlled trials suggest that use of abciximab 
may be associated with a survival advantage in patients undergoing primary PCI. A large 
proportion of patients in the community are however treated with eptifibatide, an agent 
that shares some but not all pharmacological properties with abciximab. It is not clear if 
this therapeutic switch is associated with any deleterious impact on patient outcome.
Methods: We evaluated the outcome of 3237 patients with ST elevation MI that 
underwent primary PCI for acute ST elevation MI from October 2002 to March 2006 in 
a large regional consortium (BMC2), and who were treated with abciximab (n=671) or 
with eptifibatide (n=2566).We excluded patients treated after 12 hours of symptom onset, 
those transferred from another institution or those undergoing rescue PCI.
Results: Patients treated with abciximab were slightly older (59.7 vs. 53.2 yrs., p=0.01) 
and more likely to have angiographically evident thrombus (68.3% versus 57.3%, p 
<0.0001).There was no difference in other baseline demographic, clinical or angiographic 
variables. There was no difference in the incidence of in-hospital death (4.17% with 
abciximab versus 3.55 % with eptifibatide, P =0.44) or stroke/TIA (0.78% versus 0.75%, 
P = 0.92) while there was a trend towards decreased recurrent MI with abciximab (0.75% 
versus 1.75%, P = 0.059). There was no difference in the need for blood transfusion 
(12.37 % versus 11.26 %, P = 0.42) while there was a trend towards greater risk of GI 
bleeding with abciximab (4.47% versus 2.96, P = 0.051). In parsimonious risk adjusted 
models no significant difference between abciximab and eptifibatide was seen with 
respect to any of the outcome measures.
Conclusions: Currently, eptifibatide is used as the adjunct anti-platelet agent in majority 
of patients undergoing primary PCI. There is no apparent difference in early outcome of 
patients treated with eptifibatide compared to those treated with abciximab.
4:30 p.m.
826-5 Gender Differences in Medical Care and In-Hospital 
Mortality After Acute Myocardial Infarction
Hani Jneid, Gregg Fonarow, Gray Ellrodt, Andrew O. Maree, George V. Moukarbel, 
Igor F. Palacios, Kenneth LaBresh, Li Lang, L. Kristin Newby, Gerald Fletcher, Eric 
Peterson, Chris P. Cannon, Laura Wexler, Massachusetts General Hospital and 
Harvard Medical School, Boston, MA
Background: Prior studies suggested that women receive suboptimal medical care after 
acute myocardial infarction (AMI) compared with men. Large efforts have been undertaken 
to improve AMI management. It is unclear whether these efforts have mitigated gender 
disparities in AMI care.
Methods: We examined gender differences in medical care and in-hospital mortality using 
a retrospective analysis of 78,254 AMI hospitalizations at 420 US hospitals participating 
in the Get With the Guidelines program between Jan 2001 and Apr 2006.
Gender disparities in recommended therapies, timing of treatments and 
in-hospital mortality
OUTCOMES OVERALL RATE (N)
MEN %
(N)
WOMEN 
%
(N)
Adjusted OR 
(Women
vs. Men)
95% Confidence 
Interval For 
Adjusted OR
Adjusted 
P-Value
Early ASA (within 24h) 92.4%(65,018)
93.3%
(40,332)
91.0%
(24,686) 0.84 0.80-0.89 < 0.0001
Early Beta Blockers (within 
24 h)
86.2%
(55,777)
87.2%
(34,653)
84.7%
(21,124) 0.89 0.86-0.93 <0.0001
Cardiac Catheterization 52.1%(40,745)
56.2%
(26,733)
45.6%
(14,012) 0.91 0.87-0.94 <0.0001
Percutaneous Coronary 
Intervention
45.9%
(32,323)
52.3%
(22,253)
36.1%
(10,070) 0.76 0.73-0.80 <0.0001
Fibrinolytic Therapy 3.7%(2,634)
4.4%
(1,867)
2.8%
(767) 0.81 0.75-87 <0.0001
Coronary Artery Bypass Graft 7.7%(5,394)
9.2%
(3,893)
5.4%
(1,501) 0.61 0.56-0.66 <0.0001
Revascularization 52.6%(37,023)
60.2%
(25,614)
40.9%
(11,409) 0.67 0.64-0.70 <0.0001
Exercise Stress Test 1.5%(1,206)
1.5%
(728)
1.6%
(478) 0.98 0.89-1.08 0.73
Door-to-needle time within 
30 min
(in STEMI patients)
33.2%
(933)
35.2%
(711)
28.3%
(222) 0.79 0.67-0.94 0.01
Door-to-Balloon time within 
90 min
(in STEMI patients)
43.2%
(3,316)
44.8%
(2,510)
39.0%
(806) 0.86 0.78-0.96 0.01
Reperfusion (PCI or fibrinolytic 
therapy in STEMI patients)
67.3%
(17,058)
73.0%
(12,184)
56.3%
(4,879) 0.74 0.69-0.79 <0.0001
Median Door-to-needle time
(in STEMI patients) 40 min 39 min 47 min 1.14 1.05-1.23 0.001
Median Door-to-Balloon time
(in STEMI patients) 97 min 95 min 103 min 1.07 1.03-1.11 0.002
In-Hospital Mortality 6.7%(4,709)
5.7%
(2,412)
8.3%
(2,297) 1.06 1.01-1.12 0.03
Results: Rates of use of recommended therapies and timing of treatments are shown 
in the Table. Compared with men, women were less likely to receive early aspirin 
and beta-blockers, and less likely to undergo cardiac catheterization, percutaneous 
coronary intervention, fibrinolytic therapy, coronary artery bypass graft surgery, or any 
revascularization. The percentage of patients with door-to-needle time <30 min and door-
to-balloon time <90 min were also less in women. Women were more likely to die during 
the index hospitalization (8.2 vs. 5.7%, P <0.0001; adjusted OR, 1.06 (95% CI, 1.01-
1.12). Results were similar among most age, body mass index and diabetes subgroups.
Conclusions: In our retrospective analysis, women hospitalized for AMI received 
less medical therapy and invasive procedures and experienced longer delays in acute 
reperfusion compared with men. This was associated with a small but statistically 
significant increase in in-hospital mortality among women. 
4:45 p.m.
826-6 Poor Outcomes in Patients With Chronic Kidney 
Disease With and Without Reperfusion After 
Presentation with ST Elevation Infarction/Left Bundle 
Branch Block
Caroline Medi, Gilles Montalescot, Andrzej Budaj, Keith A. Fox, José López-Sendón, 
Gordon FitzGerald, David B. Brieger, Concord Hospital, Sydney, Australia, Center for 
Outcomes Research University of Massachusetts Medical School, Worcester, MA
Introduction Chronic kidney disease (CKD) is associated with aggressive vascular disease, 
higher event rates and poorer outcomes after an acute coronary syndrome. Relative benefit 
of reperfusion over conservative treatment with STE/LBBB in CKD is unclear.
Methods STE/LBBB patients (n=10,661) enrolled in GRACE were stratified by renal 
function and receipt of either fibrinolysis or primary PCI. Hospital mortality, adverse 
events, and 6-month mortality were compared. CKD was defined as glomerular filtration 
rate (GFR) <60 mL/min.
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Results Hospital mortality increases significantly as renal function declines, across all 
treatment groups (p<.0001). There was no significant difference in hospital mortality in 
patients with CKD treated with vs without reperfusion (15 vs 19%, P=.07). Mortality rates 
with primary PCI or fibrinolysis were comparable (both 15%). Patients with normal renal 
function had a clear benefit associated with primary PCI vs fibrinolysis in the combined 
efficacy/safety endpoint (Table), an effect not observed in those with CKD. Reperfusion 
vs no reperfusion was associated with lower 6-month mortality in patients with GFR ≥30 
but not <30. 
GFR (mL/min) P for 
interactionPatients with STE/LBBB N ≥60 30-59 <30
Hospital mortality 10,661 7684 2573 404
- Primary PCI 118 2% 14% 30%
- Fibrinolysis 205 3% 13% 30%
- Reperfusion (primary PCI and 
fibrinolysis) 323 3% 15%*
- No reperfusion 419 4% 15% 34%19%*
Death/myocardial infarction/stroke/major bleeding
- Primary PCI 282 8% 25% 38% <0.001
- Fibrinolysis 629 16% 27% 38%
- Reperfusion (primary PCI and 
fibrinolysis) 911 12% 28%*
- No reperfusion 890 14% 26% 43%29%*
Six-month mortality 
- With in-hospital reperfusion (primary PCI) 2% 4% 25%
- With in-hospital reperfusion (fibrinolysis) 2% 5% 20%
- With in-hospital reperfusion- combined 
(primary PCI and fibrinolysis) 122 2% 5%
22%
6%* <0.001
- Without reperfusion therapy 223 4% 13% 15%
*(GFR 0-60ml/min)
Conclusions In STE/LBBB and CKD, mortality rates are high. In these patients 
reperfusion is associated with a non-statistically significant lower hospital mortality. In-
hospital reperfusion is not associated with improved 6-month mortality when GFR<30.
5:00 p.m.
826-7 Potential Unintended Financial Consequences of Pay-
For-Performance
Amrita Karve, Fang-Shu Ou, Barbara Lytle, Eric D. Peterson, Duke Clinical Research 
Institute, Durham, NC
Background: Medicare’s pay-for-performance (PFP) pilot provides financial incentives 
(or penalties) to hospitals whose care rank in the highest (or lowest) quintile relative 
to peers. While PFP is intended to promote quality, centers serving large minority 
populations may disproportionately suffer financial hardship if their initial performance 
is below their peers.
Methods: Using publicly available PFP data, 2,785 US hospitals were ranked based on 
composite process metrics for acute myocardial infarction (AMI), community acquired 
pneumonia (CAP), and heart failure (HF). Centers with >20% African American (AA) 
patients were compared to those with <5% AA. Results were adjusted for hospital facility 
type, academic status, bed size, population density, and region.
Results: After adjustment, hospitals treating >20% AA patients (n=438) had slightly lower 
composite performance scores and lower likelihood for being a “top quintile performer” 
for AMI and CAP (p<0.001) versus centers treating <5% AA (n=1,156). Similarly high AA 
hospitals were significantly more likely to rank in the “bottom quintile” for AMI, CAP and 
HF (table).
Conclusions: Hospitals treating large AA populations will fair worse on PFP process 
performance assessment. Thus, PFP’s financial impact may further exacerbate existing 
care disparities. 
AMI CAP HF
% Composite Score at sites with >20% AA pts 88.50 75.00 69.67
% Composite Score at sites with <5% AA pts 90.40 79.53 70.28
“Top Quintile Center” Adjusted OR* (95% CI) 0.77(0.76-0.78)
0.37
(0.36-0.37)
1.11
(1.09-1.12)
“Bottom Quintile Center” Adjusted OR* (95% CI) 2.91(2.87-2.96)
3.19
(3.15-3.23)
1.68
(1.65-1.71)
*Hospitals with >20% AA patients relative to those <5% AA as reference
5:15 p.m.
826-8 Do Core Measures and Other Evidence Based Practices 
Reduce Risk-Adjusted In-Hospital Mortality for Acute 
Myocardial Infarction in Community Practice?
Aaron D. Kugelmass, Phillip P. Brown, Allan Anderson, Lynn G. Tarkington, Rebecca 
Steed, Steve D. Culler, April W. Simon, Henry Ford Healthcare System, Detroit, MI, HCA 
CCMN, Nashville, TN
Background: Little is known about the impact of variation in CMS core measures and 
other evidence-based best practices on community hospital acute myocardial infarction 
(AMI) mortality.
Methods: A retrospective analysis was conducted using three HCA Databases: 1) 
Casemix, an administrative database of consecutive patients admitted to any HCA 
hospital; 2) Heart Service Standards Database, information collected from a web-based 
survey regarding structures and processes in place at each of 158 HCA hospitals, and 
3) COMET, an clinical database containing core measures of care for AMI. The study 
population is 103 hospitals that perform PCI and treated more than 52 AMI patients during 
2005 (32,263 patients). A logistic regression equation (controlling for 24 demographic 
characteristics and co-morbidities) was estimated to predict hospital mortality for each 
patient. Hospitals were divided into four tiers based on their average risk-adjusted 
mortality rate.
Results: The Table reports averages for all hospitals in each tier for selected measures. 
For example, the door-to-balloon (D2B) time averages 145 minutes for Tier I hospitals 
compared to 188 minutes for Tier IV hospitals. D2B time is significant for risk-adjusted 
mortality, with a Pearson correlation coefficient of 0.20, p=0.047.
Conclusions: This study finds shorter D2B times, higher acute PCI rates, and greater 
cardiologist coverage in typical top tier vs. bottom tier hospitals based on risk-adjusted 
mortality rate.
Selected Core Measures and Evidence Based Practices Across AMI 
Hospital Performance Tiers
Hospital 
Tier
Risk 
Adjusted 
Mortality
Door to 
Balloon (D2B) 
Time
ASA on 
Arrival
Beta 
Blocker on 
Arrival
Acute PCI 
(Same Day)
Cardiologists 
Available 24/7
All 7.2% 157+ 85 95.1% 90.1% 31.7% 86.4%
I 4.6% 145+ 55 95.3% 89.8% 31.9% 92.0%
II 6.3% 142+ 51 95.8% 92.6% 33.8% 80.8%
III 7.8% 151+ 62 94.3% 87.9% 32.4% 84.6%
IV 9.9% 188+ 137 94.9% 90.2% 28.8% 88.5%
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1030-146 Prognostic Significance of Dyspnea in Acute 
Coronary Syndromes
Ameeth Vedre, Jin Li, Hitinder Gurm, Kim Eagle, Eva Kline-Rogers, Umesh Tamhane, Vijay 
S. Ramanath, James B. Froehlich, University of Michigan Medical Center, Ann Arbor, MI
Background: The prognostic significance of dyspnea in patients with an Acute Coronary 
Syndrome (ACS) has not been studied.
Methods: A prospective cohort study was conducted on 1942 consecutive patients(pts.) 
admitted to University of Michigan between 1999 and 2002 with a discharge diagnosis of ACS. 
Patients were categorized based on their primary complaint at the time of admission. Group I 
(N=178) had primary symptoms of dyspnea only and no chest pain. Group II (N=1764) had no 
symptoms of dyspnea. In-Hospital and 6 month follow up data was collected.
Results: Patients with dyspnea were older and had more co-morbidities.They also had 
worse In-Hospital outcomes and post discharge survival.In a multivariable model dyspnea 
was however not an independent predictor of adverse outcomes.
Conclusions: Primary dyspnea is the chief complaint in about 10% of ACS pts. Dyspnea 
294A    ABSTRACTS - Special Topics  JACC  March 6, 2007 
S
pe
ci
al
 T
op
ic
s
is more common in certain patient subsets as shown in table 1.While dyspnea is a 
univariate predictor of poor outcomes,it is not an independent predictor of outcomes.
Practitioners must be aware that dyspnea is not infrequently the primary complaint 
among pts with ACS, and is associated with greater co-morbidity.
Table 1 Results
ACS Patients With
Complaints of 
Dyspnea Only
(N=178)
ACS Patients 
With No
Complaints of 
Dyspnea
(N=1764)
P-Value
Baseline Characteristics 
Median Age (Years)
Prior CHF
72.1
77 (43.3%)
63.5
307 (17.4%)
<.0001
<.0001
Diagnosis
ST-Elevation Myocardial 
Infarction((STEMI)
NSTEMI
Unstable Angina(USA)
29(16.3%)
129 (72.5%)
20(11.2%)
307(17.4%)
924 (52.4%)
533(30.2)
.006
<.0001
<.0001
Diabetes 68(38.2%) 519(29.4%) .001
Clinical Presentation
Pulse (bpm)
Serum Creatinine(mg/dl)
92.4 +/- 31.1
1.6+/-1.76
79.5 +/- 22.0
1.26+/-0.99
<.0001
<.0001
Killip I
Killip II
Killip III
76 (42.7%)
51 (28.7%)
40 (22.5%)
1461 (82.8%)
191 (10.8%)
49 (2.8%)
<.0001
<.0001
<.0001
In-Hospital Outcomes 
Congestive Heart Failure(CHF)
Atrial Fibrillation
47 (26.4%)
33(18.5%)
128 (7.3%)
126(7.1%)
<.0001
<.0001
NSTEMI Pts.(With prior CAD)
NSTEMI Pts.(Without prior CAD)
56(74.7%)
73(70.9%)
348(48.2%)
576(55.3%)
<0.0002
<.0001
In-Hospital Outcomes
Death
MACE(Major Adverse Cardiac 
Events)
19(10.7%)
26(14.6%)
79(4.5%)
105(6.0%)
.003
<0.0001
Hospital Management
Beta Blockers<24hours
Statins<24 hours
87(67.4%)
43(33.3%)
736(79.7%)
441(47.7%)
.0001
.0001
9:00 a.m.
1030-147 Impact of Payer Type on the Utilization of Drug-
Eluting Stents for Patients With and Without Acute 
Myocardial Infarction
Kirsten Hall Long, Nilay D. Shah, Ritesh Banerjee, Douglas L. Wood, Charanjit S. Rihal, 
Henry H. Ting, Mayo Clinic College of Medicine, Rochester, MN
Background: Randomized trials have demonstrated improved outcomes with drug-
eluting stents (DES) compared with bare-metal stents (BMS) for patients with and without 
acute myocardial infarction (AMI and non-AMI). While age, gender, and race have been 
reported to influence adoption of this technology, the impact of payer type is not known.
Methods: We identified all AMI and non-AMI patients undergoing percutaneous coronary 
intervention (PCI) with DES or BMS (2004 and 2005 inclusive) in a large nationally representative 
non-profit hospital database (Premier’s Perspective Comparative Database). Patient, payer, 
and hospital characteristics were used in multivariate logistic modeling for AMI and non-AMI 
populations to assess the independent impact of payer type on the likelihood of DES use.
Results: A total of 73,341 AMI PCI and 162,582 non-AMI PCI patients were identified of 
whom 79% and 88%, respectively received a DES. In adjusted analyses, payer type was 
significantly associated with DES use as shown in the Table. Additionally being younger, 
female, white, and of lower estimated clinical severity was associated with an increased 
likelihood of receiving a DES.
Conclusion: Payer type is associated with DES utilization and has a larger effect than age, 
gender, or race. The mechanisms of how commercial and managed care payers influence 
DES utilization will require further investigation and may include managing access and 
diverting patients to specific providers such as those with high procedural volume. 
AMI
Odds Ratio 95% CI
Non-AMI
Odds Ratio 95% CI
Payer type
Medicaid reference reference
Medicare 1.20 1.08, 1.33 1.14 1.01, 1.28
Managed Care 1.45 1.31, 1.60 1.37 1.21, 1.55
Commercial 1.34 1.18, 1.51 1.43 1.23, 1.65
Age
>80 reference reference
70-79 1.07 0.98, 1.16 1.15 1.08, 1.21
60-69 1.07 0.98, 1.17 1.18 1.11, 1.26
<60 1.09 1.00, 1.19 1.22 1.14, 1.31
Male reference reference
Female 1.22 1.16, 1.29 1.19 1.14, 1.24
Black reference reference
White 1.13 1.05, 1.22 1.14 1.05, 1.23
Low volume reference reference
High volume 1.62 1.03, 2.53 1.65 1.06, 2.55
9:00 a.m.
1030-148 Celecoxib Increases the Risk of Myocardial Infarction 
but Not of Death or Stroke: A Meta-Analysis of 
Randomized Controlled Trials
Rehan Qayyum, Kavitha Ramaswamy, Jurga Adomaityte, Kashif Chaudhry, Peter 
Danyi, Johns Hopkins University School of Medicine, Baltimore, MD
Background: Two cyclooxygenase-2 inhibitors (C2I) have recently been withdrawn 
from US market due to increased risk of cardiovascular (CV) events. Whether celecoxib, 
another C2I, has similarly increased CV risk is unknown. Clinical trials have not been 
sufficiently powered to evaluate the effect of celecoxib on CV events or mortality.
Methods: Therefore, we performed a meta-analysis of randomized controlled trials (RCT) 
that compared celecoxib with either placebo or other non-C2I, reported data on mortality, 
myocardial infarction, or stroke, and had at least 12 weeks of follow-up. We identified 
RCT by searching PubMed, EMBASE, and Cochrane Clinical Trials Register databases 
and by hand-search of the references of retrieved articles.
Results: Nine trials, including 27,366 patients, (median age = 59 years, range 49 to 67 
years; median follow-up = 6 months, range 3 to 36 months) met inclusion criteria. There 
were 78 deaths in the celecoxib group versus 42 deaths in the non-celecoxib group (odds 
ratio [OR] = 1.09, 95% confidence interval [CI] = 0.74 to 1.62). There were significantly 
more myocardial infarctions in the celecoxib group as compared to non-celecoxib group 
(57 vs. 20, OR = 1.95, 95% CI = 1.15 to 3.31). On the other hand, the incidence of strokes 
was similar in celecoxib and non-celecoxib groups (OR = 0.92, 95% CI = 0.48 to 1.77).
Conclusions: Three months or longer treatment with celecoxib is associated with 
increased risk of myocardial infarction but not of mortality or stroke. 
9:00 a.m.
1030-181 Economic Evaluation of Intensive Atorvastatin 
Compared to Standard Simvastatin in Patients With 
Acute Coronary Syndrome From the IDEAL Trial
Peter Lindgren, Bengt Jonsson, On behalf of the IDEAL trial investigators, European Health 
Economics, Stockholm, Sweden, Stockholm School of Economics, Stockholm, Sweden
Background: In the IDEAL trial, intensive atorvastatin 80mg (A80) versus simvastatin 
20-40mg (S20-40); a subset analysis of patients randomized <2 months following an 
MI found A80 reduced major coronary events by 34% (p=0.02), non-fatal MI by 46% 
(p=0.04), and any cardiovascular event by 21% (p=0.02) compared to S20-40. The safety 
profiles of A80 and S20-40 were similar. An economic evaluation was performed on this 
population to assess the incremental cost-effectiveness of A80 compared with S20-S40, 
accounting for generic S20-40 prices.
Methods: Costs were estimated for each arm by multiplying US cost estimates by 
resource consumption from the clinical trial, including study drug used, hospitalizations 
based upon adjudicated endpoint related diagnosis related groups, and lost work days 
for the duration of the study. Concomitant medications and adverse events requiring 
hospitalization were not included as they were similar in both arms. The measure of 
effectiveness was total number of events avoided. Breakeven analysis was performed on 
S20-40 prices as they impact cost effectiveness.
Results: Over a median 4.8 years, 1 in 5 CV events were prevented with A80 compared 
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with S20-40 (0.67 vs. 0.84 events/person). Based on current generic S20-40 pricing, 
total costs for treating patients with A80 were lower ($30,723) than S20-40 ($32,129). 
Total cost comprised the following for A80 vs. S20-S40, respectively: drug costs ($4,677 
vs $5,699), hospitalization costs ($6,427 vs $8,179), and cost due to lost productivity 
($19,620 vs $18,251). If the US S20-40 cost fell 90% to $0.36/day, the cost paid by the 
payer would be $2,355 more for A80 over the study duration, resulting in an incremental 
cost per event avoided of $14,145.
Conclusions: At current US prices, A80 is a cost-saving treatment vs. S20-40 in patients 
with recent MI and provides greater reduction in cardiovascular events. Even in a low 
cost generic market, A80 vs. S20-40 treatment in ACS patients is predicted to reduce CV 
events at an acceptable incremental cost, similar to that established in prior analyses of 
primary and secondary prevention studies where the comparator was no treatment.
9:00 a.m.
1030-182 Statin Under-Treatment and its Predictors: Results 
From a Large Community Survey
Ella Zomer, Alice Owen, Philippa Clarke, Kate Webb, Mendel Grobler, Danny Liew, 
NHMRC Centre for Clinical Research in Therapeutics, DEPM, Monash Univeristy, 
Melbourne, Australia, Pfizer Australia, Sydney, Australia
Background: HMG CoA reductase inhibitors (‘statins’) are widely prescribed for the 
primary and secondary prevention of cardiovascular disease. We sought to examine the 
proportions of patients taking statins who were being treated to target lipid levels according 
to recommended guidelines and their ‘success’ or otherwise in reaching targets.
Methods: A survey was undertaken of patients prescribed statins by 287 randomly-
recruited primary care physicians from across Australia in late 2004. Anonymous data 
for 2414 patients taking statins were collected, including data on age, gender, co-
morbidities, details on statin prescription and lipid parameters at two time periods: before 
statin initiation and at least three months after. Clustering was minimized by accepting a 
maximum of ten patient survey forms from any one physician.
Results: Of the 2414 patients, physicians had set target lipid levels for only 1954 (66.0%). 
The targets were those recommended in either the Australian Lipid Management guidelines 
(90%) or the National Cholesterol Education Program (NCEP) guidelines. Of the patients 
for whom target lipid levels had been set, only 11.2% reached the relevant targets. 
Among patients for whom no target lipid levels were set, only 4.1% attained lipid levels 
recommended by the Australian Lipid Management guidelines. In multivariate analyses, 
being elderly (age ≥ 65years), having existing coronary heart disease and having diabetes 
were independent predictors of who would reach target lipid levels. The respective odds 
ratios were: 0.61 (95%CI 0.42-0.88), 0.31 (95%CI 0.21-0.45) and 0.56 (95%CI 0.38-0.82).
Conclusions: A large proportion of patients being prescribed statins do not have 
recommended target lipid levels set by their physicians. Even for those who are, most 
are not being effectively treated to the recommended target levels. Being non-elderly, not 
having existing coronary heart disease and not being diabetic are independent risk factors 
for inadequate treatment. Even though statins are widely prescribed for the prevention of 
cardiovascular disease, the scope for further risk reduction remains large.
9:00 a.m.
1030-183 Effect of Payer Status on Interventional Utilization Patterns: 
Current Results From the NHLBI Dynamic Registry
William B. Borden, David P. Faxon, Faith Selzer, Kevin E. Kip, Warren K. Laskey, 
Elizabeth M. Holper, University of Chicago, Chicago, IL, University of Pittsburgh, 
Pittsburgh, PA
Background: Payer status has been demonstrated to influence rates of invasive 
cardiovascular procedures and revascularization in acute coronary syndrome (ACS). No 
study has examined whether utilization of resources within the catheterization laboratory 
varies with patients’ insurance.
Methods: We evaluated 5,332 patients undergoing percutaneous coronary intervention 
(PCI) for an ACS in Waves 1-4 of the NHLBI Dynamic Registry. Baseline characteristics 
and usage of balloons, stents, and peri-procedural medications were compared for patients 
with the payer status of Medicare (n=2215), Public (n=568), and Private (n=2549).
Results: Medicare patients were significantly older, more commonly female, more 
commonly had prior revascularization, and had more non-cardiac comorbid disease (all 
p<0.0001). In an unadjusted model, patients with public insurance were less commonly 
on glycoprotein IIb/IIIa inhibitors and thienopyridines prior to the procedure, and were less 
likely to receive stents. Table 1 shows the adjusted odds ratio of device and medication 
use when compared to Medicare patients.
Conclusions: While payer status has been shown to influence choice of an invasive 
versus conservative strategy for ACS, once referred for PCI, insurance status does not 
affect the rate of stent usage. However, private patients received higher rates of IIb/IIIa 
inhibitors, a finding which requires further study.
Table 1: 
Device or Medication Use OR 95% CI P-value
Balloon Alone
Other public
Private
1.27
1.00
0.85-1.89
0.75-1.33
0.25
0.98
Stent (any type)
Other public
Private
1.00
0.97
0.73-1.37
0.78-1.20
0.99
0.76
Procedural thienopyridine
Other public
Private
0.85
0.96
0.65-1.11
0.80-1.15
0.24
0.65
Procedural IIb/IIIa
Other public
Private
0.93
1.25
0.71-1.22
1.05-1.49
0.60
0.013
Cypher stent†
Other public
Private
1.60
1.18
0.93-2.73
0.89-1.57
0.087
0.24
Taxus stent†
Other public
Private
0.52
1.18
0.26-1.02
0.85-1.63
0.057
0.33
†Restricted to wave 4 (2004) (Medicare n=361,
Other public n=69, Private n=440)
9:00 a.m.
1030-184 Quality of VA Heart Failure Care, 2004-2005
Paul A. Heidenreich, Anju Sahay, Barry Massie, VA Palo Alto Health Care System, Palo Alto, CA
Background: Certain life-prolonging treatments and other processes of heart failure care 
are now considered performance measures. We sought to determine the current quality 
of VA HF care using ACC/AHA performance measures.
Methods: We used 2004-2005 data from the VA’s national External Peer Review 
program that identified patients at all VA facilities with both an outpatient and an inpatient 
diagnosis of HF (N=11,326). Their charts were reviewed by trained abstractors to confirm 
the diagnosis of HF and determine treatment provided.
Results: The mean age of the 11,326 patients was 70 years. An LVEF measure was 
documented in 93% (10,545)-Figure. Of those with an ejection fraction below 40% and 
no documented contraindication, 88% (4909/5590) were treated with an angiotensin 
converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) and 85% 
(4646/5497) were treated with a beta-blocker (BB). Of those treated with a BB, 2565 
(55%) were treated with a BB known to prolong survival (carvedilol, metoprolol succinate 
or bisoprolol). Rates of education at discharge were 89% for weight, 96% for medication, 
and 98% for diet. From first quarter 2004 to last quarter 2005 BB use increased (83% vs 
88%) while ACEi/ARB use decreased (94% vs 85%, p for trend < 0.001 for both).
Conclusion: Heart failure care within the VA is higher than historical data for other U.S. 
systems for many performance measures. However only half of VA heart failure patients 
are treated with beta-blockers know to prolong survival. 
9:00 a.m.
1030-185 Differences in Medical Care in Patients Presenting 
with Acute Myocardial Infarction During Holidays and 
Weekends vs. Weekdays
Hani Jneid, Gregg Fonarow, Andrew O. Maree, Kenneth LaBresh, Li Lang, Roberto 
Bolli, L. Kristin Newby, Gerald Fletcher, Igor F. Palacios, Laura Wexler, Eric Peterson, 
Massachusetts General Hospital and Harvard Medical School, Boston, MA
Background: Few studies have examined the relationship between the time of admission 
and medical care in patients with acute myocardial infarction (AMI). It is unclear whether 
the improvement in AMI management have mitigated the disparities in care with respect 
to the time of admission.
Methods: We studied the impact of admission during weekends and holidays (vs. 
weekdays) on medical care in 62,814 AMI patients who presented to 379 US hospitals 
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participating in the “Get With The Guideline” program between July 2000 and September 
2005. We compared therapies between groups, first without adjustment, then with 
adjustment for demographic and medical characteristics by multiple logistic regression.
Results: Compared with admission on weekdays, patients presenting on weekends 
and holidays were more likely to receive early aspirin, early beta blocker and fibrinolytic 
therapy but less likely to undergo revascularization. In patients with ST-segment elevation 
MI, admission on weekends and holidays was associated with longer door-to-balloon time 
and lesser likelihood to achieve door-to-balloon time < 90 min. No differences in hospital 
mortality with respect to admission time was observed. Rates of use of recommended 
therapies and timing of treatments are shown in the Table.
Conclusions: Patients presenting with AMI on weekends and holidays were more likely 
to receive acute medical therapy but less likely to undergo timely invasive therapy. This 
was not associated with differences in hospital mortality. 
Outcomes
Overall 
rate % 
(N)
Weekends/ 
Holidays 
% (N)
Weekdays 
% 
(N)
Unadjusted
P-value
Adjusted OR 
(weekends/
holidays vs. 
weekdays)
95% 
Confidence 
Interval for 
adjusted OR
Adjusted 
P-value
Early ASA (within 
24 h)
91.3 %
(51,562)
91.7 %
(17,776)
91.1 %
(33,786) 0.01 1.08 1.03-1.14 0.003
Early Beta 
Blockers (within 
24 h)
84.4 %
(44,162)
85.0 %
(15,233)
84.0 %
(28,929) 0.003 1.07 1.02-1.12 0.003
Percutaneous 
Coronary 
Intervention 
42.5 %
(25,682)
41.8 %
(8,629)
42.9 %
(17,053) 0.01 0.97 0.93-1.00 0.054
Fibrinolytic 
Therapy
5.4 %
(3,240)
6.2 %
(1,284)
4.9 %
(1,956) <0.0001 1.23 1.15-1.31 <0.0001
Coronary Artery 
Bypass Graft
7.4%
(4,493)
6.9%
(1,426)
7.7%
(3,067) 0.0003 0.87 0.80-0.95 0.001
Revascularization 49.0%(29,590)
47.7%
(9,845)
49.7%
(19,745) <0.0001 0.93 0.90-0.96 <0.0001
Door-to-needle 
time within 30 
min (in the STEMI 
subgroup only)
34.1 %
(756)
33.6 %
(315)
34.5 %
(441) 0.67 0.96 0.78-1.18 0.72
Door-to-Balloon 
time within 90 
min (in the STEMI 
subgroup only)
41.8 %
(2,281)
31.3 %
(583)
47.3 %
(1698) <0.0001 0.47 0.40-0.54 < 0.0001
Median Door-to-
needle time 
(in the STEMI 
subgroup only)
40 min
(2,216)
40 min
(937)
40 min
(1,279) 0.77 1.03 0.92-1.14 0.62
Median Door-
to-Balloon time 
(in the STEMI 
subgroup only)
99 min
(5,454)
108 min
(1,862)
93 min
(3,592) <0.0001 1.16 1.11-1.21 <0.0001
In-Hospital 
Mortality
7.2 %
(4,035)
7.1 %
(1,365)
7.2 %
(2,670) 0.9 0.98 0.91-1.05 0.59
9:00 a.m.
1030-186 Variation in CABG and PCI Outcomes Across Four 
Revascularization Centers in Northern New England 
and its Relation to Community Survival
Mirle A. Kellet, Jr., Thomas J. Ryan, Jr., F. Lee Lucas, Andrea Siewers, Todd A. 
MacKenzie, David J. Malenka, Maine Medical Center, Portland, ME, The Northern New 
England Cardiovascular Disease Study Group, Lebanon, NH
Background: Three year survival after revascularization therapy (RT) should be 
optimized when patients are referred to the procedure with best predicted survival and 
it is performed optimally. We have studied the variation in referral decision and here we 
examine the variation in CABG and PCI outcomes across 4 centers in the Northern New 
England (NNE) and its relation to community RT survival.
Methods: From our NNE PCI and CABG relational database with NDI-derived vital 
statistics we identified 14,239 consecutive patients undergoing a first revascularization 
procedure (CABG 10,395 PCI 3844) for 2 and 3 vessel disease with procedures performed 
between 1996-2001 at 4 NNE centers. We developed prediction rules for in-hospital and 
3 year mortality for CABG and PCI. We compared center specific Observed/Expected 
(O/E) performance for CABG, PCI, and RT.
Results: Three year survival was 90.6% and risk adjusted survival was not different 
across centers. However the relative frequency of CABG v. PCI and the outcomes vary 
across centers. The O/E ratios for CABG, PCI and RT are presented in the table below.
Conclusions: Risk adjusted outcomes for RT across four NNE centers are similar despite 
significant variation in the use of CABG v PCI by center. The risk adjusted outcomes for 
PCI and CABG vary significantly across centers. A heart center needs to understand 
variation in selection of RT strategy and site specific outcomes to optimize the long-term 
survival of their patients referred for multi-vessel revascularization.
Three-year O/E Ratios by Center andd Procedure
Site CABG Deaths PCI deaths RT Deaths
Site (CABG/PCI) O/E % O/E % O/E %
All (10,395/3,844)
Site 1 (2,311/959) 191/192 0.99 98/90 1.09 289/280 1.03
Site 2 (1,759/407) 139/165 0.84 57/40 1.42 196/208 0.94
Site 3 (4,098/1,271) 396/367 1.08 108/130 0.83 504/497 1.01
Site 4 (2,220/1,066) 218/219 0.99 120/123 0.98 338/342 0.99
9:00 a.m.
1030-187 Value of Common Preoperative Risk Indices After 
Hip Surgery
Jeanne M. Huddleston, Dirk Larson, L. Joseph Melton, III, Rachel Gullerud, Sherine E. 
Gabriel, Veronique L. Roger, Mayo Clinic, Rochester, MN
Background: The ACC/AHA guideline for CV risk stratification in noncardiac surgery references 
studies using pooled surgery data. It is unknown if rates of myocardial infarction (MI) or death 
differ by types of hip surgery (elective replacement vs fracture repair). Further, the value of CV 
risk assessment tools to predict postoperative MI or death after hip surgery is unknown.
Methods: All 1609 Olmsted County, MN, residents hospitalized for hip surgery from 
1988 to end 2002 were evaluated for MI and death to 1 year postoperatively. Data on 
preoperative morbidity and components of 3 preoperative risk indices were obtained from 
complete (in- and outpatient) community medical records.
Results: The risk of MI or death after hip fracture repair was 34% (95% CI 31, 38) vs 8% (95% CI 
6, 10) for elective replacement. Controlling for sex, age and ASA score, the relative risk of MI and 
death in fracture repair vs elective replacement was 3.6 (95% CI 2.5, 5.2). For fracture repair, the 
Revised Lee index was significantly associated with an increased risk of MI or death with each 
incremental increase in the index score. ASA score provided similar incremental information in 
elective replacement. The concordances from logistic regression models are tabulated. 
Hip fracture repair Hip replacement
Revised Lee Index 0.62 0.65
ASA score 0.60 0.71
ACC/AHA classification 0.60 0.63
Conclusion: Hip fracture repair has a greater risk of postoperative MI/death than elective 
replacement. In fracture patients the Revised Lee Index adds valuable information for risk 
stratification, but none of these commonly used risk indices ideally predict MI and death.
9:00 a.m.
1030-188 Determination of Optimal Viewing Angles for X-ray 
Coronary Angiography Based on a Quantitative 
Analysis of 3D Reconstructed Models
Andrew J. Klein, Joel A. Garcia, Babak Movassaghi, Onno Wink, S.-Y. James Chen, 
John C. Messenger, Adam Hansgen, Nathan E. Green, John D. Carroll, University of 
Colorado Health Sciences, Denver, CO, Philips Medical Systems, Bothell, WA
Background: Coronary angiography uses expert-recommended viewing angles which are 
limited by patient variability in vessel foreshortening and overlap. Via three dimensional 
(3-D) coronary modeling, we propose that a scientifically designed, population-
based universal optimal view map (UOVM) may be generated which minimizes these 
shortcomings. This UOVM would provide quantitatively valid viewing angles for all first 
and second order coronary arterial segments.
Methods: We analyzed 137 angiograms and created 3-D models of each coronary 
tree which allowed quantitative assessment of vessel foreshortening and generation of 
patient-specific optimal view maps. From this data, a UOVM (see figure) was generated. 
This permitted a quantitative comparison between traditional (non-scientifically based) 
and UOVM-derived viewing angles.
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Results: In all major vessel segments, the traditional viewing angles provided 17% vessel 
foreshortening and 13% overlap, while the UOVM provided 5.6% foreshortening and 6.4% 
overlap, a 60% reduction in foreshortening (P<.05) and a 31% reduction (p=NS) in overlap.
Conclusions: 1) This study demonstrates an innovative and scientifically-based method 
of obtaining optimal view angles 2) UOVM use decreases vessel foreshortening and 
overlap, i.e. facilitating the acquisition of better images with less contrast and radiation. 3) 
The UOVM permits the design of single injection trajectories for each coronary tree using 
dual-axis rotational angiography (see figure). 
9:00 a.m.
1030-189 Hematological and Biochemical Variables Strongly 
Predict Death at 1-Year After Percutaneous Coronary 
Intervention (PCI)
Khan Pohlel, Sasidhar Guthikonda, Viola Vaccarino, Emir Veledar, Abdul Sheikh, Ziyad 
B. Ghazzal, Emory University School of Medicine, Atlanta, GA
Background: Many clinical characteristics are well-established prognostic indicators at 
the time of PCI, but the combined prognostic value of hematological and biochemical 
laboratory data is less clear. We sought to use these test results to develop a risk model 
to predict 1-year mortality after PCI.
Methods: We performed an analysis of 1701 patients with complete laboratory data and 
one year follow-up who underwent PCI at the Emory University Hospital from 2001 to 
2004. We used logistic regression analysis to predict 1-year death with the following 
candidate variables: demographic and medical history factors, ejection fraction, angina 
class, HDL cholesterol(HDL-C), white blood cell count (WBC), glomerular filtration rates 
(GFR), creatinine, hemoglobin (Hg) and troponin I.
Results: There were 69 deaths at 1-year follow-up. The following variables were 
associated with the highest risk of death in the final model: hemoglobin, WBC, HDL-
C, GFR and age. A nomogram based on the regression coefficient of these variables 
was created and a composite score for risk of death was calculated, showing a 
steep increased probability of death with an increasing risk score (Table 1). The c 
statistic of the model was 0.764.
Variables Points Composite Risk Score(from 5 criteria)
Probability of 
Death at 1 year 
following PCI
Age 40 0 64 0.005
(Years) 50 20 98 0.010
60 40 133 0.020
70 60 169 0.040
80 80 190 0.060
90 100 205 0.080
HDL-C 10-34 55 217 0.100
(mg/dL) 35-40 13 240 0.150
quartiles 41-47 19 257 0.200
>47 0 272 0.250
WBC 2.1-6.0 20 284 0.300
(103/µL) 6.1-7.2 0 295 0.350
quartiles 7.3-8.3 40 306 0.400
>8.3 65 316 0.450
Hg <11.5 74 326 0.500
(gm/dL) 11.5-15.5 44 336 0.550
>15.5 0 346 0.600
GFR <30 70
(mL/min/1.73m2) 31-60 25
>61 0
Table 1. Nomogram to predict death.
Conclusions: Hematologic and biochemical variables strongly predict death at one year 
following PCI. We propose a risk score based on levels of hemoglobin, HDL-C, WBC count, 
GFR and age that is more predictive of 1-year mortality than traditional clinical variables.
9:00 a.m.
1030-190 Simulation-based Crisis Resource Management 
Program In a Pediatric Cardiac Intensive Care 
Unit Improves Participants Self-Perception of 
Resuscitation Skills
Catherine K. Allan, Dorothy M. Beke, Liana J. Kappus, Peter C. Laussen, Ravi R. 
Thiagarajan, Children’s Hospital Boston, Boston, MA
Background: Medical Simulation is an important training tool in critical care 
settings. In our pediatric cardiac ICU (CICU), resuscitation events are frequent, 
complex, and specific treatment modalities often fall outside the scope of PALS 
guidelines. We have developed a crisis resource management (CRM) training 
program tailored specifically to our clinical setting to teach specific resuscitation 
and teamwork skills.
Methods: We developed a CRM curriculum utilizing specific scenarios encountered 
in our CICU. Training in the CICU utilizes a high fidelity simulated patient 
(SimMan, Laerdal, Inc.) along with airway and resuscitation equipment, including 
an ECMO circuit. Participants (nurses, fellows, and staff physicians) replicate the 
composition of a clinical team during a true resuscitation event. Each scenario 
is videotaped, and extensive debriefing follows, focusing on technical aspects of 
resuscitation and CRM principles such as communication, leadership, and team 
organization. Participants complete pre- and post-participation questionnaires 
about the program and their level of comfort participating in resuscitation events.
Results: 70 clinicians participated in our CRM program in 2005 (50 nurses, 
17 fellows, 3 staff physicians). Participants had a median of 9 years (1 - 43) of 
clinical experience. Analysis of questionnaires showed all participants scored the 
usefulness of the program and specific scenarios as ≥ 4 on a Likert scale of 1 (least) 
to 5 (most useful). There was significant improvement in participant’s perceived 
ability to function as a member of a code team and confidence in participating in a 
code following CRM training (p < .001). Participants were significantly more likely 
to raise concerns about inappropriate management to the code leader following 
CRM training (p < .001).
Conclusions: We developed a CRM training program in a pediatric CICU to teach 
technical resuscitation skills and improve team function. Participants found the 
experience useful and reported improved ability to function in a code situation. 
Further work is needed to determine whether participation in the CRM program 
objectively improves code team function during real resuscitation events.
9:00 a.m.
1030-191 Paging The Worldwide Cardiology Consultant: The 
Army Knowledge Online Telemedicine Consultation 
Program In Cardiology
Elden R. Rand, Joseph C. Lee, Charles M. Lappan, James L. Furgerson, Brooke Army 
Medical Center, Fort Sam Houston, TX
Background: Global operations place large numbers of servicemembers and older 
civilian contractors in austere environments. They often require medical evacuation for 
common cardiovascular issues at great expense and effort. The Army Knowledge Online 
(AKO) Telemedicine Consultation Program was initiated by the Office of the Surgeon 
General to electronically link deployed medical providers with subspecialty consultants 
via the internet to assist and guide with downrange triage and disposition.
Methods: Receipt of a consultation on the global network triggered a text page to an on-
call staff cardiologist at Brooke Army Medical Center, Texas, who would then retrieve and 
evaluate the consultation. The primary means of communication was email, however the 
option for phone consultation was also available. All consultations from project inception 
in September 2005 through August 2006 were reviewed and analyzed for efficacy 
by consult question, final diagnosis, recommendations, and number of aeromedical 
evacuations.
Results: A total of 62 cardiology teleconsults were managed. Patient types included 
military (United States and coalition), civilian contractors, foreign citizens, detainees, and 
earthquake refugees. Consultations were received from multiple countries in southwest 
Asia to southeast Asia and the Pacific rim. The average response time for cardiology 
teleconsultation since inception is 3 hours 37 minutes. The three most prevalent reasons 
for cardiology teleconsultation are electrocardiographic abnormalities, chest pain 
syndromes, and syncope. Avoidance of 3 aeromedical evacuations was accomplished, 
and facilitation of 9 aeromedical evacuations was aided. Given an estimated cost of 
$24,000 per medical evacuation, an estimated $72,000 was saved plus intangible benefits 
to multiple patients regarding management and disposition to appropriate facility of care.
Conclusions: Cardiology consultation via the internet provides a valuable service to 
deployed providers around the world, decreases medical evacuation costs, and facilitates 
transfer of patients to appropriate facilities for care.
